{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "Z-Qpfl-1ii56"
   },
   "source": [
    "# Урок 3. Data Science: разработке и тестировании лекарств\n",
    "\n",
    "## Домашнее задание."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "yTlJ_AAQii5_"
   },
   "source": [
    "> В онлайн-инструментах (и не только) используются данные о химических веществах в формате SMILES. Обычно он используется для описания структуры химических молекул. SMILES - это аббревиатура от Simplified Molecular Input Line Entry Specification.\n",
    "Все основные данные о веществах можно найти в базе данных PubChem. PubChem в основном содержит небольшие молекулы, но также и более крупные молекулы, такие как нуклеотиды, углеводы, липиды, пептиды и химически модифицированные макромолекулы. Также есть информация о химических структурах, идентификаторах, химических и физических свойствах, биологической активности, патентах, данных о здоровье, безопасности, токсичности и многом другом.\n",
    "Некоторые инструменты для предсказания мишеней:\n",
    "> - **SwissTargetPrediction** - позволяет оценить наиболее вероятные макромолекулярные мишени небольшой молекулы, предполагаемой как биологически активная. Предсказание основано на сочетании двухмерного и трехмерного сходства с библиотекой из 370 000 известных активных веществ для более чем 3000 белков трех разных видов.\n",
    "> - **Super-PRED** - веб-сервер прогнозирования соединений, основанный на модели машинного обучения с использованием логистической регрессии.\n",
    ">- **Tools4miRs** - представляет собой веб-мета-сервер прогнозирования целей, включающий определяемые пользователем методы прогнозирования целей при анализе предоставленных пользователями данных.\n",
    "\n",
    "### Задание:  \n",
    "Найдите в интернете лекарство, вышедшее из употребления, сделайте поиск его структуры по химическим базам данных. Затем с помощью одного из описанных выше тулов предскажите мишени для этого лекарства. Изучите найденные мишени и предположите, какие заболевания может лечить данное лекарство при взаимодействии с предсказанными мишенями.\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2023-10-13T20:23:49.965112Z",
     "start_time": "2023-10-13T20:23:49.946029Z"
    }
   },
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import numpy as np\n",
    "import os\n",
    "# import tarfile\n",
    "import pprint\n",
    "import seaborn as sns \n",
    "import matplotlib.pyplot as plt\n",
    "%matplotlib inline"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2023-10-13T14:14:41.393191Z",
     "start_time": "2023-10-13T14:14:41.317485Z"
    },
    "scrolled": false
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Active code page: 65001\n"
     ]
    }
   ],
   "source": [
    "!chcp 65001"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "**Для изучения инструментов драг-дизайна возьмем лекарственное вещество _Фузафунгин_ (ТМ Биопарокс$^{®}$ (Bioparox$^{®}$), ЛАБОРАТОРИИ СЕРВЬЕ, ФРАНЦИЯ, РУ № П N015629/01). Полипептидный антибиотик для местного применения. Выделен из культуры гриба Fusarium lateritium (штамм 437). Использовался для лечения бактериальных инфекций верхних дыхательных путей. На текущий момент является лекарством с недоказанной эффективностью. Применение запрещено по всему миру**  \n",
    "  \n",
    "**Брутто формула: C$_{33}$H$_{57}$N$_3$O$_9$**\n",
    "\n",
    "![Структура молекулы Фузафунгина](20_3_files/Fusafungine.png \"Структура молекулы Фузафунгина\")  \n",
    "\n",
    "\n",
    "**В формате SMILES Фузафунгин записан так:**  \n",
    "CC(C)C1C(=O)OC(C(=O)N(C(C(=O)OC(C(=O)N(C(C(=O)OC(C(=O)N1C)C(C)C)C(C)C)C)C(C)C)C(C)C)C)C(C)C\n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Результаты SwissTargetPrediction  \n",
    "Инструмент выдал 100 возможных мишеней для указанной структуры. У всех мишеней вероятность около `0,05`, что само по себе очень мало. Тем не менее рассмотрим результаты."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2023-10-13T19:51:31.857034Z",
     "start_time": "2023-10-13T19:51:31.847060Z"
    }
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['Fusafungine.png',\n",
       " 'Indications.csv',\n",
       " 'SwissTargetPrediction.csv',\n",
       " 'Targets.csv']"
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "os.listdir('20_3_files')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2023-10-13T19:52:25.419499Z",
     "start_time": "2023-10-13T19:52:25.400570Z"
    }
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Target</th>\n",
       "      <th>Common name</th>\n",
       "      <th>Uniprot ID</th>\n",
       "      <th>ChEMBL ID</th>\n",
       "      <th>Target Class</th>\n",
       "      <th>Probability*</th>\n",
       "      <th>Known actives (3D/2D)</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>FK506-binding protein 1A</td>\n",
       "      <td>FKBP1A</td>\n",
       "      <td>P62942</td>\n",
       "      <td>CHEMBL1902</td>\n",
       "      <td>Isomerase</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>157 /  83</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>P-glycoprotein 1</td>\n",
       "      <td>ABCB1</td>\n",
       "      <td>P08183</td>\n",
       "      <td>CHEMBL4302</td>\n",
       "      <td>Primary active transporter</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>63 /  1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Proteasome Macropain subunit MB1</td>\n",
       "      <td>PSMB5</td>\n",
       "      <td>P28074</td>\n",
       "      <td>CHEMBL4662</td>\n",
       "      <td>Protease</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>58 /  21</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Cholecystokinin A receptor</td>\n",
       "      <td>CCKAR</td>\n",
       "      <td>P32238</td>\n",
       "      <td>CHEMBL1901</td>\n",
       "      <td>Family A G protein-coupled receptor</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>84 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Vasopressin V1a receptor</td>\n",
       "      <td>AVPR1A</td>\n",
       "      <td>P37288</td>\n",
       "      <td>CHEMBL1889</td>\n",
       "      <td>Family A G protein-coupled receptor</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>129 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>95</th>\n",
       "      <td>Complement factor D</td>\n",
       "      <td>CFD</td>\n",
       "      <td>P00746</td>\n",
       "      <td>CHEMBL2176771</td>\n",
       "      <td>Protease</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>190 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>96</th>\n",
       "      <td>Nuclear receptor ROR-beta</td>\n",
       "      <td>RORB</td>\n",
       "      <td>Q92753</td>\n",
       "      <td>CHEMBL3091268</td>\n",
       "      <td>Nuclear receptor</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>6 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>97</th>\n",
       "      <td>Peregrin</td>\n",
       "      <td>BRPF1</td>\n",
       "      <td>P55201</td>\n",
       "      <td>CHEMBL3132741</td>\n",
       "      <td>Reader</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>35 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>98</th>\n",
       "      <td>Mineralocorticoid receptor</td>\n",
       "      <td>NR3C2</td>\n",
       "      <td>P08235</td>\n",
       "      <td>CHEMBL1994</td>\n",
       "      <td>Nuclear receptor</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>61 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>99</th>\n",
       "      <td>Neuropeptide Y receptor type 5   (by homology)</td>\n",
       "      <td>NPY5R</td>\n",
       "      <td>Q15761</td>\n",
       "      <td>CHEMBL4561</td>\n",
       "      <td>Family A G protein-coupled receptor</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>251 /  0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>100 rows × 7 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                            Target Common name Uniprot ID  \\\n",
       "0                         FK506-binding protein 1A      FKBP1A     P62942   \n",
       "1                                 P-glycoprotein 1       ABCB1     P08183   \n",
       "2                 Proteasome Macropain subunit MB1       PSMB5     P28074   \n",
       "3                       Cholecystokinin A receptor       CCKAR     P32238   \n",
       "4                         Vasopressin V1a receptor      AVPR1A     P37288   \n",
       "..                                             ...         ...        ...   \n",
       "95                             Complement factor D         CFD     P00746   \n",
       "96                       Nuclear receptor ROR-beta        RORB     Q92753   \n",
       "97                                        Peregrin       BRPF1     P55201   \n",
       "98                      Mineralocorticoid receptor       NR3C2     P08235   \n",
       "99  Neuropeptide Y receptor type 5   (by homology)       NPY5R     Q15761   \n",
       "\n",
       "        ChEMBL ID                         Target Class  Probability*  \\\n",
       "0      CHEMBL1902                            Isomerase      0.055648   \n",
       "1      CHEMBL4302           Primary active transporter      0.055648   \n",
       "2      CHEMBL4662                             Protease      0.055648   \n",
       "3      CHEMBL1901  Family A G protein-coupled receptor      0.055648   \n",
       "4      CHEMBL1889  Family A G protein-coupled receptor      0.055648   \n",
       "..            ...                                  ...           ...   \n",
       "95  CHEMBL2176771                             Protease      0.055648   \n",
       "96  CHEMBL3091268                     Nuclear receptor      0.055648   \n",
       "97  CHEMBL3132741                               Reader      0.055648   \n",
       "98     CHEMBL1994                     Nuclear receptor      0.055648   \n",
       "99     CHEMBL4561  Family A G protein-coupled receptor      0.055648   \n",
       "\n",
       "   Known actives (3D/2D)  \n",
       "0         157 /  83       \n",
       "1           63 /  1       \n",
       "2          58 /  21       \n",
       "3           84 /  0       \n",
       "4          129 /  0       \n",
       "..                   ...  \n",
       "95         190 /  0       \n",
       "96           6 /  0       \n",
       "97          35 /  0       \n",
       "98          61 /  0       \n",
       "99         251 /  0       \n",
       "\n",
       "[100 rows x 7 columns]"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "stp = pd.read_csv('20_3_files/SwissTargetPrediction.csv', sep=',')\n",
    "stp"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2023-10-13T19:52:58.961936Z",
     "start_time": "2023-10-13T19:52:58.939752Z"
    }
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Probability*</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>count</th>\n",
       "      <td>1.000000e+02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>mean</th>\n",
       "      <td>5.564795e-02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>std</th>\n",
       "      <td>2.789540e-17</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>min</th>\n",
       "      <td>5.564795e-02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25%</th>\n",
       "      <td>5.564795e-02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>50%</th>\n",
       "      <td>5.564795e-02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>75%</th>\n",
       "      <td>5.564795e-02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>max</th>\n",
       "      <td>5.564795e-02</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "       Probability*\n",
       "count  1.000000e+02\n",
       "mean   5.564795e-02\n",
       "std    2.789540e-17\n",
       "min    5.564795e-02\n",
       "25%    5.564795e-02\n",
       "50%    5.564795e-02\n",
       "75%    5.564795e-02\n",
       "max    5.564795e-02"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "stp.describe()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Вероятность взаимодействия со всеми мишенями одинакова, посмотрим уникальные значения в колонке `'Target'`"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2023-10-13T20:26:20.730349Z",
     "start_time": "2023-10-13T20:26:20.713308Z"
    }
   },
   "outputs": [],
   "source": [
    "pd.set_option('display.max_rows', None)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2023-10-13T20:26:23.355483Z",
     "start_time": "2023-10-13T20:26:23.338127Z"
    },
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Target\n",
       "FK506-binding protein 1A                                     1\n",
       "Smoothened homolog   (by homology)                           1\n",
       "Cyclin-dependent kinase 2/cyclin A                           1\n",
       "Cyclin-dependent kinase 1/cyclin B                           1\n",
       "Sodium channel protein type II alpha subunit                 1\n",
       "Matrix metalloproteinase 14                                  1\n",
       "Sodium channel protein type V alpha subunit                  1\n",
       "MAP kinase ERK2                                              1\n",
       "JAK2/JAK1                                                    1\n",
       "JAK3/JAK1                                                    1\n",
       "Phosphodiesterase 11A                                        1\n",
       "Phosphodiesterase 5A                                         1\n",
       "Neuropeptide Y receptor type 1                               1\n",
       "P-glycoprotein 1                                             1\n",
       "Histone deacetylase 1                                        1\n",
       "Histone deacetylase 6                                        1\n",
       "Cannabinoid receptor 1                                       1\n",
       "Arachidonate 15-lipoxygenase                                 1\n",
       "TNF-alpha                                                    1\n",
       "Voltage-gated T-type calcium channel alpha-1G subunit        1\n",
       "PI3-kinase p110-gamma subunit                                1\n",
       "PI3-kinase p110-beta subunit                                 1\n",
       "PI3-kinase p110-delta subunit                                1\n",
       "Phosphodiesterase 4A                                         1\n",
       "SUMO-activating enzyme                                       1\n",
       "Adenosine A3 receptor                                        1\n",
       "Bradykinin B1 receptor                                       1\n",
       "Corticotropin releasing factor receptor 1   (by homology)    1\n",
       "Mineralocorticoid receptor                                   1\n",
       "Peregrin                                                     1\n",
       "Nuclear receptor ROR-beta                                    1\n",
       "Complement factor D                                          1\n",
       "Nuclear receptor ROR-gamma                                   1\n",
       "Leukocyte elastase                                           1\n",
       "Proteinase-activated receptor 2                              1\n",
       "Urokinase plasminogen activator surface receptor             1\n",
       "Apoptosis regulator Bcl-2                                    1\n",
       "Sphingosine 1-phosphate receptor Edg-3                       1\n",
       "Metabotropic glutamate receptor 5   (by homology)            1\n",
       "Neurokinin 3 receptor                                        1\n",
       "Melanin-concentrating hormone receptor 1                     1\n",
       "Thioredoxin reductase 1                                      1\n",
       "Bromodomain-containing protein 3                             1\n",
       "Bromodomain-containing protein 2                             1\n",
       "Bromodomain-containing protein 4                             1\n",
       "c-Jun N-terminal kinase 3                                    1\n",
       "Type-1 angiotensin II receptor                               1\n",
       "c-Jun N-terminal kinase 1                                    1\n",
       "Vasopressin V1b receptor                                     1\n",
       "Voltage-gated L-type calcium channel alpha-1C subunit        1\n",
       "Sodium channel protein type X alpha subunit                  1\n",
       "Acetyl-CoA carboxylase 2                                     1\n",
       "Cyclin-dependent kinase 5/CDK5 activator 1                   1\n",
       "Tyrosine-protein kinase SYK                                  1\n",
       "Kinesin-like protein 1                                       1\n",
       "Phosphodiesterase 10A                                        1\n",
       "DGAT1 protein                                                1\n",
       "Tyrosine-protein kinase JAK2                                 1\n",
       "Tyrosine-protein kinase JAK1                                 1\n",
       "Tyrosine-protein kinase JAK3                                 1\n",
       "Serine/threonine-protein kinase Aurora-A                     1\n",
       "Tyrosine-protein kinase ITK/TSK                              1\n",
       "Adenosine A2a receptor                                       1\n",
       "Adenosine A1 receptor                                        1\n",
       "Lysosomal Pro-X carboxypeptidase                             1\n",
       "Arachidonate 5-lipoxygenase                                  1\n",
       "Thrombin and coagulation factor X                            1\n",
       "Cholecystokinin B receptor   (by homology)                   1\n",
       "Calpain 1                                                    1\n",
       "C-C chemokine receptor type 8                                1\n",
       "Sodium channel protein type IX alpha subunit                 1\n",
       "Vasopressin V1a receptor                                     1\n",
       "Cholecystokinin A receptor                                   1\n",
       "Proteasome Macropain subunit MB1                             1\n",
       "Bradykinin B2 receptor                                       1\n",
       "Cyclin-dependent kinase 2/cyclin E1                          1\n",
       "Isocitrate dehydrogenase [NADP] cytoplasmic                  1\n",
       "Oxytocin receptor   (by homology)                            1\n",
       "Purinergic receptor P2Y12                                    1\n",
       "Cytochrome P450 1A1   (by homology)                          1\n",
       "Prostanoid EP1 receptor                                      1\n",
       "Vasopressin V2 receptor   (by homology)                      1\n",
       "Translocator protein   (by homology)                         1\n",
       "Focal adhesion kinase 1                                      1\n",
       "Orexin receptor 1                                            1\n",
       "p53-binding protein Mdm-2                                    1\n",
       "Orexin receptor 2                                            1\n",
       "Tyrosine-protein kinase TIE-2                                1\n",
       "Fibroblast growth factor receptor 1                          1\n",
       "Vascular endothelial growth factor receptor 2                1\n",
       "Vascular endothelial growth factor receptor 3                1\n",
       "Stem cell growth factor receptor                             1\n",
       "Platelet-derived growth factor receptor beta                 1\n",
       "Vascular endothelial growth factor receptor 1                1\n",
       "Tyrosine-protein kinase ABL                                  1\n",
       "Macrophage colony stimulating factor receptor                1\n",
       "Carnitine O-palmitoyltransferase 1, liver isoform            1\n",
       "Cyclin-dependent kinase 2                                    1\n",
       "Acyl-CoA desaturase   (by homology)                          1\n",
       "Neuropeptide Y receptor type 5   (by homology)               1\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 18,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "stp['Target'].value_counts()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Все значения в колонке `'Target'` уникальны. Нет возможности выделить какую либо мишень в качестве приоритетеной.\n",
    "Возможно получится получить информациюи из колонки `'Target Class'`:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2023-10-13T20:27:01.812387Z",
     "start_time": "2023-10-13T20:27:01.801404Z"
    }
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Target Class\n",
       "Family A G protein-coupled receptor           24\n",
       "Kinase                                        24\n",
       "Enzyme                                         8\n",
       "Protease                                       7\n",
       "Voltage-gated ion channel                      6\n",
       "Phosphodiesterase                              4\n",
       "Reader                                         4\n",
       "Nuclear receptor                               3\n",
       "Other cytosolic protein                        3\n",
       "Eraser                                         2\n",
       "Oxidoreductase                                 2\n",
       "Membrane receptor                              2\n",
       "Other ion channel                              1\n",
       "Family C G protein-coupled receptor            1\n",
       "Family B G protein-coupled receptor            1\n",
       "Frizzled family G protein-coupled receptor     1\n",
       "Isomerase                                      1\n",
       "Secreted protein                               1\n",
       "Ligase                                         1\n",
       "Cytochrome P450                                1\n",
       "Primary active transporter                     1\n",
       "Unclassified protein                           1\n",
       "Other nuclear protein                          1\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 19,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "stp['Target Class'].value_counts()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Наиболее часто встречается класс мишеней G-белок связанных рецепторов семейства А (GPCR), а также Киназы. Офильтруем значения по этим классам."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2023-10-13T20:43:03.948862Z",
     "start_time": "2023-10-13T20:43:03.912460Z"
    }
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Target</th>\n",
       "      <th>Common name</th>\n",
       "      <th>Uniprot ID</th>\n",
       "      <th>ChEMBL ID</th>\n",
       "      <th>Target Class</th>\n",
       "      <th>Probability*</th>\n",
       "      <th>Known actives (3D/2D)</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>46</th>\n",
       "      <td>Cytochrome P450 1A1   (by homology)</td>\n",
       "      <td>CYP1A1</td>\n",
       "      <td>P04798</td>\n",
       "      <td>CHEMBL2231</td>\n",
       "      <td>Cytochrome P450</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>7 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>Acyl-CoA desaturase   (by homology)</td>\n",
       "      <td>SCD</td>\n",
       "      <td>O00767</td>\n",
       "      <td>CHEMBL5555</td>\n",
       "      <td>Enzyme</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>46 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>48</th>\n",
       "      <td>Isocitrate dehydrogenase [NADP] cytoplasmic</td>\n",
       "      <td>IDH1</td>\n",
       "      <td>O75874</td>\n",
       "      <td>CHEMBL2007625</td>\n",
       "      <td>Enzyme</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>160 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53</th>\n",
       "      <td>PI3-kinase p110-delta subunit</td>\n",
       "      <td>PIK3CD</td>\n",
       "      <td>O00329</td>\n",
       "      <td>CHEMBL3130</td>\n",
       "      <td>Enzyme</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>184 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>Carnitine O-palmitoyltransferase 1, liver isoform</td>\n",
       "      <td>CPT1A</td>\n",
       "      <td>P50416</td>\n",
       "      <td>CHEMBL1293194</td>\n",
       "      <td>Enzyme</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>124 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>54</th>\n",
       "      <td>PI3-kinase p110-beta subunit</td>\n",
       "      <td>PIK3CB</td>\n",
       "      <td>P42338</td>\n",
       "      <td>CHEMBL3145</td>\n",
       "      <td>Enzyme</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>102 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>74</th>\n",
       "      <td>SUMO-activating enzyme</td>\n",
       "      <td>SAE1 UBA2</td>\n",
       "      <td>Q9UBE0 Q9UBT2</td>\n",
       "      <td>CHEMBL2095174</td>\n",
       "      <td>Enzyme</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>11 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>55</th>\n",
       "      <td>PI3-kinase p110-gamma subunit</td>\n",
       "      <td>PIK3CG</td>\n",
       "      <td>P48736</td>\n",
       "      <td>CHEMBL3267</td>\n",
       "      <td>Enzyme</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>137 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>58</th>\n",
       "      <td>Arachidonate 15-lipoxygenase</td>\n",
       "      <td>ALOX15</td>\n",
       "      <td>P16050</td>\n",
       "      <td>CHEMBL2903</td>\n",
       "      <td>Enzyme</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>29 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>61</th>\n",
       "      <td>Histone deacetylase 1</td>\n",
       "      <td>HDAC1</td>\n",
       "      <td>Q13547</td>\n",
       "      <td>CHEMBL325</td>\n",
       "      <td>Eraser</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>225 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>60</th>\n",
       "      <td>Histone deacetylase 6</td>\n",
       "      <td>HDAC6</td>\n",
       "      <td>Q9UBN7</td>\n",
       "      <td>CHEMBL1865</td>\n",
       "      <td>Eraser</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>91 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>59</th>\n",
       "      <td>Cannabinoid receptor 1</td>\n",
       "      <td>CNR1</td>\n",
       "      <td>P21554</td>\n",
       "      <td>CHEMBL218</td>\n",
       "      <td>Family A G protein-coupled receptor</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>1197 /  14</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>Bradykinin B2 receptor</td>\n",
       "      <td>BDKRB2</td>\n",
       "      <td>P30411</td>\n",
       "      <td>CHEMBL3157</td>\n",
       "      <td>Family A G protein-coupled receptor</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>53 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>99</th>\n",
       "      <td>Neuropeptide Y receptor type 5   (by homology)</td>\n",
       "      <td>NPY5R</td>\n",
       "      <td>Q15761</td>\n",
       "      <td>CHEMBL4561</td>\n",
       "      <td>Family A G protein-coupled receptor</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>251 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>47</th>\n",
       "      <td>Purinergic receptor P2Y12</td>\n",
       "      <td>P2RY12</td>\n",
       "      <td>Q9H244</td>\n",
       "      <td>CHEMBL2001</td>\n",
       "      <td>Family A G protein-coupled receptor</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>8 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45</th>\n",
       "      <td>Prostanoid EP1 receptor</td>\n",
       "      <td>PTGER1</td>\n",
       "      <td>P34995</td>\n",
       "      <td>CHEMBL1811</td>\n",
       "      <td>Family A G protein-coupled receptor</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>63 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>44</th>\n",
       "      <td>Vasopressin V2 receptor   (by homology)</td>\n",
       "      <td>AVPR2</td>\n",
       "      <td>P30518</td>\n",
       "      <td>CHEMBL1790</td>\n",
       "      <td>Family A G protein-coupled receptor</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>146 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>Oxytocin receptor   (by homology)</td>\n",
       "      <td>OXTR</td>\n",
       "      <td>P30559</td>\n",
       "      <td>CHEMBL2049</td>\n",
       "      <td>Family A G protein-coupled receptor</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>188 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>62</th>\n",
       "      <td>Neuropeptide Y receptor type 1</td>\n",
       "      <td>NPY1R</td>\n",
       "      <td>P25929</td>\n",
       "      <td>CHEMBL4777</td>\n",
       "      <td>Family A G protein-coupled receptor</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>51 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>39</th>\n",
       "      <td>Orexin receptor 2</td>\n",
       "      <td>HCRTR2</td>\n",
       "      <td>O43614</td>\n",
       "      <td>CHEMBL4792</td>\n",
       "      <td>Family A G protein-coupled receptor</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>867 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>75</th>\n",
       "      <td>Adenosine A3 receptor</td>\n",
       "      <td>ADORA3</td>\n",
       "      <td>P0DMS8</td>\n",
       "      <td>CHEMBL256</td>\n",
       "      <td>Family A G protein-coupled receptor</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>413 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>92</th>\n",
       "      <td>Proteinase-activated receptor 2</td>\n",
       "      <td>F2RL1</td>\n",
       "      <td>P55085</td>\n",
       "      <td>CHEMBL5963</td>\n",
       "      <td>Family A G protein-coupled receptor</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>5 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>89</th>\n",
       "      <td>Sphingosine 1-phosphate receptor Edg-3</td>\n",
       "      <td>S1PR3</td>\n",
       "      <td>Q99500</td>\n",
       "      <td>CHEMBL3892</td>\n",
       "      <td>Family A G protein-coupled receptor</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>99 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Cholecystokinin A receptor</td>\n",
       "      <td>CCKAR</td>\n",
       "      <td>P32238</td>\n",
       "      <td>CHEMBL1901</td>\n",
       "      <td>Family A G protein-coupled receptor</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>84 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Vasopressin V1a receptor</td>\n",
       "      <td>AVPR1A</td>\n",
       "      <td>P37288</td>\n",
       "      <td>CHEMBL1889</td>\n",
       "      <td>Family A G protein-coupled receptor</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>129 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>C-C chemokine receptor type 8</td>\n",
       "      <td>CCR8</td>\n",
       "      <td>P51685</td>\n",
       "      <td>CHEMBL4596</td>\n",
       "      <td>Family A G protein-coupled receptor</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>27 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>87</th>\n",
       "      <td>Neurokinin 3 receptor</td>\n",
       "      <td>TACR3</td>\n",
       "      <td>P29371</td>\n",
       "      <td>CHEMBL4429</td>\n",
       "      <td>Family A G protein-coupled receptor</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>143 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>41</th>\n",
       "      <td>Orexin receptor 1</td>\n",
       "      <td>HCRTR1</td>\n",
       "      <td>O43613</td>\n",
       "      <td>CHEMBL5113</td>\n",
       "      <td>Family A G protein-coupled receptor</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>731 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>Cholecystokinin B receptor   (by homology)</td>\n",
       "      <td>CCKBR</td>\n",
       "      <td>P32239</td>\n",
       "      <td>CHEMBL298</td>\n",
       "      <td>Family A G protein-coupled receptor</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>494 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>80</th>\n",
       "      <td>Type-1 angiotensin II receptor</td>\n",
       "      <td>AGTR1</td>\n",
       "      <td>P30556</td>\n",
       "      <td>CHEMBL227</td>\n",
       "      <td>Family A G protein-coupled receptor</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>72 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>78</th>\n",
       "      <td>Vasopressin V1b receptor</td>\n",
       "      <td>AVPR1B</td>\n",
       "      <td>P47901</td>\n",
       "      <td>CHEMBL1921</td>\n",
       "      <td>Family A G protein-coupled receptor</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>4 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>Adenosine A1 receptor</td>\n",
       "      <td>ADORA1</td>\n",
       "      <td>P30542</td>\n",
       "      <td>CHEMBL226</td>\n",
       "      <td>Family A G protein-coupled receptor</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>648 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>Adenosine A2a receptor</td>\n",
       "      <td>ADORA2A</td>\n",
       "      <td>P29274</td>\n",
       "      <td>CHEMBL251</td>\n",
       "      <td>Family A G protein-coupled receptor</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>521 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>76</th>\n",
       "      <td>Bradykinin B1 receptor</td>\n",
       "      <td>BDKRB1</td>\n",
       "      <td>P46663</td>\n",
       "      <td>CHEMBL4308</td>\n",
       "      <td>Family A G protein-coupled receptor</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>49 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>86</th>\n",
       "      <td>Melanin-concentrating hormone receptor 1</td>\n",
       "      <td>MCHR1</td>\n",
       "      <td>Q99705</td>\n",
       "      <td>CHEMBL344</td>\n",
       "      <td>Family A G protein-coupled receptor</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>41 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>77</th>\n",
       "      <td>Corticotropin releasing factor receptor 1   (b...</td>\n",
       "      <td>CRHR1</td>\n",
       "      <td>P34998</td>\n",
       "      <td>CHEMBL1800</td>\n",
       "      <td>Family B G protein-coupled receptor</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>179 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>88</th>\n",
       "      <td>Metabotropic glutamate receptor 5   (by homology)</td>\n",
       "      <td>GRM5</td>\n",
       "      <td>P41594</td>\n",
       "      <td>CHEMBL3227</td>\n",
       "      <td>Family C G protein-coupled receptor</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>702 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>63</th>\n",
       "      <td>Smoothened homolog   (by homology)</td>\n",
       "      <td>SMO</td>\n",
       "      <td>Q99835</td>\n",
       "      <td>CHEMBL5971</td>\n",
       "      <td>Frizzled family G protein-coupled receptor</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>97 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>FK506-binding protein 1A</td>\n",
       "      <td>FKBP1A</td>\n",
       "      <td>P62942</td>\n",
       "      <td>CHEMBL1902</td>\n",
       "      <td>Isomerase</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>157 /  83</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>37</th>\n",
       "      <td>Fibroblast growth factor receptor 1</td>\n",
       "      <td>FGFR1</td>\n",
       "      <td>P11362</td>\n",
       "      <td>CHEMBL3650</td>\n",
       "      <td>Kinase</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>71 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>67</th>\n",
       "      <td>JAK2/JAK1</td>\n",
       "      <td>JAK1 JAK2</td>\n",
       "      <td>P23458 O60674</td>\n",
       "      <td>CHEMBL3038492</td>\n",
       "      <td>Kinase</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>6 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>Tyrosine-protein kinase SYK</td>\n",
       "      <td>SYK</td>\n",
       "      <td>P43405</td>\n",
       "      <td>CHEMBL2599</td>\n",
       "      <td>Kinase</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>323 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>Cyclin-dependent kinase 5/CDK5 activator 1</td>\n",
       "      <td>CDK5R1 CDK5</td>\n",
       "      <td>Q15078 Q00535</td>\n",
       "      <td>CHEMBL1907600</td>\n",
       "      <td>Kinase</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>206 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>68</th>\n",
       "      <td>MAP kinase ERK2</td>\n",
       "      <td>MAPK1</td>\n",
       "      <td>P28482</td>\n",
       "      <td>CHEMBL4040</td>\n",
       "      <td>Kinase</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>128 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>38</th>\n",
       "      <td>Tyrosine-protein kinase TIE-2</td>\n",
       "      <td>TEK</td>\n",
       "      <td>Q02763</td>\n",
       "      <td>CHEMBL4128</td>\n",
       "      <td>Kinase</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>41 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>Cyclin-dependent kinase 2/cyclin E1</td>\n",
       "      <td>CCNE1 CDK2</td>\n",
       "      <td>P24864 P24941</td>\n",
       "      <td>CHEMBL1907605</td>\n",
       "      <td>Kinase</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>47 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>Cyclin-dependent kinase 2</td>\n",
       "      <td>CDK2</td>\n",
       "      <td>P24941</td>\n",
       "      <td>CHEMBL301</td>\n",
       "      <td>Kinase</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>162 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>Macrophage colony stimulating factor receptor</td>\n",
       "      <td>CSF1R</td>\n",
       "      <td>P07333</td>\n",
       "      <td>CHEMBL1844</td>\n",
       "      <td>Kinase</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>114 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>Tyrosine-protein kinase JAK1</td>\n",
       "      <td>JAK1</td>\n",
       "      <td>P23458</td>\n",
       "      <td>CHEMBL2835</td>\n",
       "      <td>Kinase</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>146 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>Tyrosine-protein kinase JAK3</td>\n",
       "      <td>JAK3</td>\n",
       "      <td>P52333</td>\n",
       "      <td>CHEMBL2148</td>\n",
       "      <td>Kinase</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>286 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>Serine/threonine-protein kinase Aurora-A</td>\n",
       "      <td>AURKA</td>\n",
       "      <td>O14965</td>\n",
       "      <td>CHEMBL4722</td>\n",
       "      <td>Kinase</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>216 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>Tyrosine-protein kinase ITK/TSK</td>\n",
       "      <td>ITK</td>\n",
       "      <td>Q08881</td>\n",
       "      <td>CHEMBL2959</td>\n",
       "      <td>Kinase</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>68 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>Tyrosine-protein kinase ABL</td>\n",
       "      <td>ABL1</td>\n",
       "      <td>P00519</td>\n",
       "      <td>CHEMBL1862</td>\n",
       "      <td>Kinase</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>175 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32</th>\n",
       "      <td>Vascular endothelial growth factor receptor 1</td>\n",
       "      <td>FLT1</td>\n",
       "      <td>P17948</td>\n",
       "      <td>CHEMBL1868</td>\n",
       "      <td>Kinase</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>123 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33</th>\n",
       "      <td>Platelet-derived growth factor receptor beta</td>\n",
       "      <td>PDGFRB</td>\n",
       "      <td>P09619</td>\n",
       "      <td>CHEMBL1913</td>\n",
       "      <td>Kinase</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>99 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>34</th>\n",
       "      <td>Stem cell growth factor receptor</td>\n",
       "      <td>KIT</td>\n",
       "      <td>P10721</td>\n",
       "      <td>CHEMBL1936</td>\n",
       "      <td>Kinase</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>84 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>Vascular endothelial growth factor receptor 3</td>\n",
       "      <td>FLT4</td>\n",
       "      <td>P35916</td>\n",
       "      <td>CHEMBL1955</td>\n",
       "      <td>Kinase</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>45 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>79</th>\n",
       "      <td>c-Jun N-terminal kinase 1</td>\n",
       "      <td>MAPK8</td>\n",
       "      <td>P45983</td>\n",
       "      <td>CHEMBL2276</td>\n",
       "      <td>Kinase</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>285 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>42</th>\n",
       "      <td>Focal adhesion kinase 1</td>\n",
       "      <td>PTK2</td>\n",
       "      <td>Q05397</td>\n",
       "      <td>CHEMBL2695</td>\n",
       "      <td>Kinase</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>114 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36</th>\n",
       "      <td>Vascular endothelial growth factor receptor 2</td>\n",
       "      <td>KDR</td>\n",
       "      <td>P35968</td>\n",
       "      <td>CHEMBL279</td>\n",
       "      <td>Kinase</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>603 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>81</th>\n",
       "      <td>c-Jun N-terminal kinase 3</td>\n",
       "      <td>MAPK10</td>\n",
       "      <td>P53779</td>\n",
       "      <td>CHEMBL2637</td>\n",
       "      <td>Kinase</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>177 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>66</th>\n",
       "      <td>JAK3/JAK1</td>\n",
       "      <td>JAK3 JAK1</td>\n",
       "      <td>P52333 P23458</td>\n",
       "      <td>CHEMBL3038491</td>\n",
       "      <td>Kinase</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>25 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>Tyrosine-protein kinase JAK2</td>\n",
       "      <td>JAK2</td>\n",
       "      <td>O60674</td>\n",
       "      <td>CHEMBL2971</td>\n",
       "      <td>Kinase</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>298 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49</th>\n",
       "      <td>Acetyl-CoA carboxylase 2</td>\n",
       "      <td>ACACB</td>\n",
       "      <td>O00763</td>\n",
       "      <td>CHEMBL4829</td>\n",
       "      <td>Ligase</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>149 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>91</th>\n",
       "      <td>Urokinase plasminogen activator surface receptor</td>\n",
       "      <td>PLAUR</td>\n",
       "      <td>Q03405</td>\n",
       "      <td>CHEMBL4883</td>\n",
       "      <td>Membrane receptor</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>3 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>43</th>\n",
       "      <td>Translocator protein   (by homology)</td>\n",
       "      <td>TSPO</td>\n",
       "      <td>P30536</td>\n",
       "      <td>CHEMBL5742</td>\n",
       "      <td>Membrane receptor</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>329 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>96</th>\n",
       "      <td>Nuclear receptor ROR-beta</td>\n",
       "      <td>RORB</td>\n",
       "      <td>Q92753</td>\n",
       "      <td>CHEMBL3091268</td>\n",
       "      <td>Nuclear receptor</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>6 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>94</th>\n",
       "      <td>Nuclear receptor ROR-gamma</td>\n",
       "      <td>RORC</td>\n",
       "      <td>P51449</td>\n",
       "      <td>CHEMBL1741186</td>\n",
       "      <td>Nuclear receptor</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>115 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>98</th>\n",
       "      <td>Mineralocorticoid receptor</td>\n",
       "      <td>NR3C2</td>\n",
       "      <td>P08235</td>\n",
       "      <td>CHEMBL1994</td>\n",
       "      <td>Nuclear receptor</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>61 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>Kinesin-like protein 1</td>\n",
       "      <td>KIF11</td>\n",
       "      <td>P52732</td>\n",
       "      <td>CHEMBL4581</td>\n",
       "      <td>Other cytosolic protein</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>38 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>72</th>\n",
       "      <td>Cyclin-dependent kinase 1/cyclin B</td>\n",
       "      <td>CCNB3 CDK1 CCNB1 CCNB2</td>\n",
       "      <td>Q8WWL7 P06493 P14635 O95067</td>\n",
       "      <td>CHEMBL2094127</td>\n",
       "      <td>Other cytosolic protein</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>54 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>73</th>\n",
       "      <td>Cyclin-dependent kinase 2/cyclin A</td>\n",
       "      <td>CDK2 CCNA1 CCNA2</td>\n",
       "      <td>P24941 P78396 P20248</td>\n",
       "      <td>CHEMBL2094128</td>\n",
       "      <td>Other cytosolic protein</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>98 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>90</th>\n",
       "      <td>Apoptosis regulator Bcl-2</td>\n",
       "      <td>BCL2</td>\n",
       "      <td>P10415</td>\n",
       "      <td>CHEMBL4860</td>\n",
       "      <td>Other ion channel</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>20 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>40</th>\n",
       "      <td>p53-binding protein Mdm-2</td>\n",
       "      <td>MDM2</td>\n",
       "      <td>Q00987</td>\n",
       "      <td>CHEMBL5023</td>\n",
       "      <td>Other nuclear protein</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>145 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>85</th>\n",
       "      <td>Thioredoxin reductase 1</td>\n",
       "      <td>TXNRD1</td>\n",
       "      <td>Q16881</td>\n",
       "      <td>CHEMBL1927</td>\n",
       "      <td>Oxidoreductase</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>2 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>Arachidonate 5-lipoxygenase</td>\n",
       "      <td>ALOX5</td>\n",
       "      <td>P09917</td>\n",
       "      <td>CHEMBL215</td>\n",
       "      <td>Oxidoreductase</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>64 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>64</th>\n",
       "      <td>Phosphodiesterase 5A</td>\n",
       "      <td>PDE5A</td>\n",
       "      <td>O76074</td>\n",
       "      <td>CHEMBL1827</td>\n",
       "      <td>Phosphodiesterase</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>327 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>Phosphodiesterase 10A</td>\n",
       "      <td>PDE10A</td>\n",
       "      <td>Q9Y233</td>\n",
       "      <td>CHEMBL4409</td>\n",
       "      <td>Phosphodiesterase</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>1117 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>52</th>\n",
       "      <td>Phosphodiesterase 4A</td>\n",
       "      <td>PDE4A</td>\n",
       "      <td>P27815</td>\n",
       "      <td>CHEMBL254</td>\n",
       "      <td>Phosphodiesterase</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>117 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>65</th>\n",
       "      <td>Phosphodiesterase 11A</td>\n",
       "      <td>PDE11A</td>\n",
       "      <td>Q9HCR9</td>\n",
       "      <td>CHEMBL2717</td>\n",
       "      <td>Phosphodiesterase</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>7 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>P-glycoprotein 1</td>\n",
       "      <td>ABCB1</td>\n",
       "      <td>P08183</td>\n",
       "      <td>CHEMBL4302</td>\n",
       "      <td>Primary active transporter</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>63 /  1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>95</th>\n",
       "      <td>Complement factor D</td>\n",
       "      <td>CFD</td>\n",
       "      <td>P00746</td>\n",
       "      <td>CHEMBL2176771</td>\n",
       "      <td>Protease</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>190 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Proteasome Macropain subunit MB1</td>\n",
       "      <td>PSMB5</td>\n",
       "      <td>P28074</td>\n",
       "      <td>CHEMBL4662</td>\n",
       "      <td>Protease</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>58 /  21</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>Calpain 1</td>\n",
       "      <td>CAPN1 CAPNS1</td>\n",
       "      <td>P07384 P04632</td>\n",
       "      <td>CHEMBL2111357</td>\n",
       "      <td>Protease</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>36 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>Thrombin and coagulation factor X</td>\n",
       "      <td>F10</td>\n",
       "      <td>P00742</td>\n",
       "      <td>CHEMBL244</td>\n",
       "      <td>Protease</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>368 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70</th>\n",
       "      <td>Matrix metalloproteinase 14</td>\n",
       "      <td>MMP14</td>\n",
       "      <td>P50281</td>\n",
       "      <td>CHEMBL3869</td>\n",
       "      <td>Protease</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>12 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>Lysosomal Pro-X carboxypeptidase</td>\n",
       "      <td>PRCP</td>\n",
       "      <td>P42785</td>\n",
       "      <td>CHEMBL2335</td>\n",
       "      <td>Protease</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>17 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>93</th>\n",
       "      <td>Leukocyte elastase</td>\n",
       "      <td>ELANE</td>\n",
       "      <td>P08246</td>\n",
       "      <td>CHEMBL248</td>\n",
       "      <td>Protease</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>187 /  5</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>84</th>\n",
       "      <td>Bromodomain-containing protein 3</td>\n",
       "      <td>BRD3</td>\n",
       "      <td>Q15059</td>\n",
       "      <td>CHEMBL1795186</td>\n",
       "      <td>Reader</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>79 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>83</th>\n",
       "      <td>Bromodomain-containing protein 2</td>\n",
       "      <td>BRD2</td>\n",
       "      <td>P25440</td>\n",
       "      <td>CHEMBL1293289</td>\n",
       "      <td>Reader</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>73 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>82</th>\n",
       "      <td>Bromodomain-containing protein 4</td>\n",
       "      <td>BRD4</td>\n",
       "      <td>O60885</td>\n",
       "      <td>CHEMBL1163125</td>\n",
       "      <td>Reader</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>151 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>97</th>\n",
       "      <td>Peregrin</td>\n",
       "      <td>BRPF1</td>\n",
       "      <td>P55201</td>\n",
       "      <td>CHEMBL3132741</td>\n",
       "      <td>Reader</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>35 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>57</th>\n",
       "      <td>TNF-alpha</td>\n",
       "      <td>TNF</td>\n",
       "      <td>P01375</td>\n",
       "      <td>CHEMBL1825</td>\n",
       "      <td>Secreted protein</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>3 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>DGAT1 protein</td>\n",
       "      <td>DGAT1</td>\n",
       "      <td>Q9BRH5</td>\n",
       "      <td>CHEMBL3638325</td>\n",
       "      <td>Unclassified protein</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>4 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>51</th>\n",
       "      <td>Voltage-gated L-type calcium channel alpha-1C ...</td>\n",
       "      <td>CACNA1C</td>\n",
       "      <td>Q13936</td>\n",
       "      <td>CHEMBL1940</td>\n",
       "      <td>Voltage-gated ion channel</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>11 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Sodium channel protein type IX alpha subunit</td>\n",
       "      <td>SCN9A</td>\n",
       "      <td>Q15858</td>\n",
       "      <td>CHEMBL4296</td>\n",
       "      <td>Voltage-gated ion channel</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>141 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>50</th>\n",
       "      <td>Sodium channel protein type X alpha subunit</td>\n",
       "      <td>SCN10A</td>\n",
       "      <td>Q9Y5Y9</td>\n",
       "      <td>CHEMBL5451</td>\n",
       "      <td>Voltage-gated ion channel</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>24 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>71</th>\n",
       "      <td>Sodium channel protein type II alpha subunit</td>\n",
       "      <td>SCN2A</td>\n",
       "      <td>Q99250</td>\n",
       "      <td>CHEMBL4187</td>\n",
       "      <td>Voltage-gated ion channel</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>38 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>56</th>\n",
       "      <td>Voltage-gated T-type calcium channel alpha-1G ...</td>\n",
       "      <td>CACNA1G</td>\n",
       "      <td>O43497</td>\n",
       "      <td>CHEMBL4641</td>\n",
       "      <td>Voltage-gated ion channel</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>4 /  0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>69</th>\n",
       "      <td>Sodium channel protein type V alpha subunit</td>\n",
       "      <td>SCN5A</td>\n",
       "      <td>Q14524</td>\n",
       "      <td>CHEMBL1980</td>\n",
       "      <td>Voltage-gated ion channel</td>\n",
       "      <td>0.055648</td>\n",
       "      <td>33 /  0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                               Target             Common name  \\\n",
       "46                Cytochrome P450 1A1   (by homology)                  CYP1A1   \n",
       "27                Acyl-CoA desaturase   (by homology)                     SCD   \n",
       "48        Isocitrate dehydrogenase [NADP] cytoplasmic                    IDH1   \n",
       "53                      PI3-kinase p110-delta subunit                  PIK3CD   \n",
       "29  Carnitine O-palmitoyltransferase 1, liver isoform                   CPT1A   \n",
       "54                       PI3-kinase p110-beta subunit                  PIK3CB   \n",
       "74                             SUMO-activating enzyme               SAE1 UBA2   \n",
       "55                      PI3-kinase p110-gamma subunit                  PIK3CG   \n",
       "58                       Arachidonate 15-lipoxygenase                  ALOX15   \n",
       "61                              Histone deacetylase 1                   HDAC1   \n",
       "60                              Histone deacetylase 6                   HDAC6   \n",
       "59                             Cannabinoid receptor 1                    CNR1   \n",
       "23                             Bradykinin B2 receptor                  BDKRB2   \n",
       "99     Neuropeptide Y receptor type 5   (by homology)                   NPY5R   \n",
       "47                          Purinergic receptor P2Y12                  P2RY12   \n",
       "45                            Prostanoid EP1 receptor                  PTGER1   \n",
       "44            Vasopressin V2 receptor   (by homology)                   AVPR2   \n",
       "26                  Oxytocin receptor   (by homology)                    OXTR   \n",
       "62                     Neuropeptide Y receptor type 1                   NPY1R   \n",
       "39                                  Orexin receptor 2                  HCRTR2   \n",
       "75                              Adenosine A3 receptor                  ADORA3   \n",
       "92                    Proteinase-activated receptor 2                   F2RL1   \n",
       "89             Sphingosine 1-phosphate receptor Edg-3                   S1PR3   \n",
       "3                          Cholecystokinin A receptor                   CCKAR   \n",
       "4                            Vasopressin V1a receptor                  AVPR1A   \n",
       "6                       C-C chemokine receptor type 8                    CCR8   \n",
       "87                              Neurokinin 3 receptor                   TACR3   \n",
       "41                                  Orexin receptor 1                  HCRTR1   \n",
       "8          Cholecystokinin B receptor   (by homology)                   CCKBR   \n",
       "80                     Type-1 angiotensin II receptor                   AGTR1   \n",
       "78                           Vasopressin V1b receptor                  AVPR1B   \n",
       "12                              Adenosine A1 receptor                  ADORA1   \n",
       "13                             Adenosine A2a receptor                 ADORA2A   \n",
       "76                             Bradykinin B1 receptor                  BDKRB1   \n",
       "86           Melanin-concentrating hormone receptor 1                   MCHR1   \n",
       "77  Corticotropin releasing factor receptor 1   (b...                   CRHR1   \n",
       "88  Metabotropic glutamate receptor 5   (by homology)                    GRM5   \n",
       "63                 Smoothened homolog   (by homology)                     SMO   \n",
       "0                            FK506-binding protein 1A                  FKBP1A   \n",
       "37                Fibroblast growth factor receptor 1                   FGFR1   \n",
       "67                                          JAK2/JAK1               JAK1 JAK2   \n",
       "22                        Tyrosine-protein kinase SYK                     SYK   \n",
       "24         Cyclin-dependent kinase 5/CDK5 activator 1             CDK5R1 CDK5   \n",
       "68                                    MAP kinase ERK2                   MAPK1   \n",
       "38                      Tyrosine-protein kinase TIE-2                     TEK   \n",
       "25                Cyclin-dependent kinase 2/cyclin E1              CCNE1 CDK2   \n",
       "28                          Cyclin-dependent kinase 2                    CDK2   \n",
       "30      Macrophage colony stimulating factor receptor                   CSF1R   \n",
       "17                       Tyrosine-protein kinase JAK1                    JAK1   \n",
       "16                       Tyrosine-protein kinase JAK3                    JAK3   \n",
       "15           Serine/threonine-protein kinase Aurora-A                   AURKA   \n",
       "14                    Tyrosine-protein kinase ITK/TSK                     ITK   \n",
       "31                        Tyrosine-protein kinase ABL                    ABL1   \n",
       "32      Vascular endothelial growth factor receptor 1                    FLT1   \n",
       "33       Platelet-derived growth factor receptor beta                  PDGFRB   \n",
       "34                   Stem cell growth factor receptor                     KIT   \n",
       "35      Vascular endothelial growth factor receptor 3                    FLT4   \n",
       "79                          c-Jun N-terminal kinase 1                   MAPK8   \n",
       "42                            Focal adhesion kinase 1                    PTK2   \n",
       "36      Vascular endothelial growth factor receptor 2                     KDR   \n",
       "81                          c-Jun N-terminal kinase 3                  MAPK10   \n",
       "66                                          JAK3/JAK1               JAK3 JAK1   \n",
       "18                       Tyrosine-protein kinase JAK2                    JAK2   \n",
       "49                           Acetyl-CoA carboxylase 2                   ACACB   \n",
       "91   Urokinase plasminogen activator surface receptor                   PLAUR   \n",
       "43               Translocator protein   (by homology)                    TSPO   \n",
       "96                          Nuclear receptor ROR-beta                    RORB   \n",
       "94                         Nuclear receptor ROR-gamma                    RORC   \n",
       "98                         Mineralocorticoid receptor                   NR3C2   \n",
       "21                             Kinesin-like protein 1                   KIF11   \n",
       "72                 Cyclin-dependent kinase 1/cyclin B  CCNB3 CDK1 CCNB1 CCNB2   \n",
       "73                 Cyclin-dependent kinase 2/cyclin A        CDK2 CCNA1 CCNA2   \n",
       "90                          Apoptosis regulator Bcl-2                    BCL2   \n",
       "40                          p53-binding protein Mdm-2                    MDM2   \n",
       "85                            Thioredoxin reductase 1                  TXNRD1   \n",
       "10                        Arachidonate 5-lipoxygenase                   ALOX5   \n",
       "64                               Phosphodiesterase 5A                   PDE5A   \n",
       "20                              Phosphodiesterase 10A                  PDE10A   \n",
       "52                               Phosphodiesterase 4A                   PDE4A   \n",
       "65                              Phosphodiesterase 11A                  PDE11A   \n",
       "1                                    P-glycoprotein 1                   ABCB1   \n",
       "95                                Complement factor D                     CFD   \n",
       "2                    Proteasome Macropain subunit MB1                   PSMB5   \n",
       "7                                           Calpain 1            CAPN1 CAPNS1   \n",
       "9                   Thrombin and coagulation factor X                     F10   \n",
       "70                        Matrix metalloproteinase 14                   MMP14   \n",
       "11                   Lysosomal Pro-X carboxypeptidase                    PRCP   \n",
       "93                                 Leukocyte elastase                   ELANE   \n",
       "84                   Bromodomain-containing protein 3                    BRD3   \n",
       "83                   Bromodomain-containing protein 2                    BRD2   \n",
       "82                   Bromodomain-containing protein 4                    BRD4   \n",
       "97                                           Peregrin                   BRPF1   \n",
       "57                                          TNF-alpha                     TNF   \n",
       "19                                      DGAT1 protein                   DGAT1   \n",
       "51  Voltage-gated L-type calcium channel alpha-1C ...                 CACNA1C   \n",
       "5        Sodium channel protein type IX alpha subunit                   SCN9A   \n",
       "50        Sodium channel protein type X alpha subunit                  SCN10A   \n",
       "71       Sodium channel protein type II alpha subunit                   SCN2A   \n",
       "56  Voltage-gated T-type calcium channel alpha-1G ...                 CACNA1G   \n",
       "69        Sodium channel protein type V alpha subunit                   SCN5A   \n",
       "\n",
       "                     Uniprot ID      ChEMBL ID  \\\n",
       "46                       P04798     CHEMBL2231   \n",
       "27                       O00767     CHEMBL5555   \n",
       "48                       O75874  CHEMBL2007625   \n",
       "53                       O00329     CHEMBL3130   \n",
       "29                       P50416  CHEMBL1293194   \n",
       "54                       P42338     CHEMBL3145   \n",
       "74                Q9UBE0 Q9UBT2  CHEMBL2095174   \n",
       "55                       P48736     CHEMBL3267   \n",
       "58                       P16050     CHEMBL2903   \n",
       "61                       Q13547      CHEMBL325   \n",
       "60                       Q9UBN7     CHEMBL1865   \n",
       "59                       P21554      CHEMBL218   \n",
       "23                       P30411     CHEMBL3157   \n",
       "99                       Q15761     CHEMBL4561   \n",
       "47                       Q9H244     CHEMBL2001   \n",
       "45                       P34995     CHEMBL1811   \n",
       "44                       P30518     CHEMBL1790   \n",
       "26                       P30559     CHEMBL2049   \n",
       "62                       P25929     CHEMBL4777   \n",
       "39                       O43614     CHEMBL4792   \n",
       "75                       P0DMS8      CHEMBL256   \n",
       "92                       P55085     CHEMBL5963   \n",
       "89                       Q99500     CHEMBL3892   \n",
       "3                        P32238     CHEMBL1901   \n",
       "4                        P37288     CHEMBL1889   \n",
       "6                        P51685     CHEMBL4596   \n",
       "87                       P29371     CHEMBL4429   \n",
       "41                       O43613     CHEMBL5113   \n",
       "8                        P32239      CHEMBL298   \n",
       "80                       P30556      CHEMBL227   \n",
       "78                       P47901     CHEMBL1921   \n",
       "12                       P30542      CHEMBL226   \n",
       "13                       P29274      CHEMBL251   \n",
       "76                       P46663     CHEMBL4308   \n",
       "86                       Q99705      CHEMBL344   \n",
       "77                       P34998     CHEMBL1800   \n",
       "88                       P41594     CHEMBL3227   \n",
       "63                       Q99835     CHEMBL5971   \n",
       "0                        P62942     CHEMBL1902   \n",
       "37                       P11362     CHEMBL3650   \n",
       "67                P23458 O60674  CHEMBL3038492   \n",
       "22                       P43405     CHEMBL2599   \n",
       "24                Q15078 Q00535  CHEMBL1907600   \n",
       "68                       P28482     CHEMBL4040   \n",
       "38                       Q02763     CHEMBL4128   \n",
       "25                P24864 P24941  CHEMBL1907605   \n",
       "28                       P24941      CHEMBL301   \n",
       "30                       P07333     CHEMBL1844   \n",
       "17                       P23458     CHEMBL2835   \n",
       "16                       P52333     CHEMBL2148   \n",
       "15                       O14965     CHEMBL4722   \n",
       "14                       Q08881     CHEMBL2959   \n",
       "31                       P00519     CHEMBL1862   \n",
       "32                       P17948     CHEMBL1868   \n",
       "33                       P09619     CHEMBL1913   \n",
       "34                       P10721     CHEMBL1936   \n",
       "35                       P35916     CHEMBL1955   \n",
       "79                       P45983     CHEMBL2276   \n",
       "42                       Q05397     CHEMBL2695   \n",
       "36                       P35968      CHEMBL279   \n",
       "81                       P53779     CHEMBL2637   \n",
       "66                P52333 P23458  CHEMBL3038491   \n",
       "18                       O60674     CHEMBL2971   \n",
       "49                       O00763     CHEMBL4829   \n",
       "91                       Q03405     CHEMBL4883   \n",
       "43                       P30536     CHEMBL5742   \n",
       "96                       Q92753  CHEMBL3091268   \n",
       "94                       P51449  CHEMBL1741186   \n",
       "98                       P08235     CHEMBL1994   \n",
       "21                       P52732     CHEMBL4581   \n",
       "72  Q8WWL7 P06493 P14635 O95067  CHEMBL2094127   \n",
       "73         P24941 P78396 P20248  CHEMBL2094128   \n",
       "90                       P10415     CHEMBL4860   \n",
       "40                       Q00987     CHEMBL5023   \n",
       "85                       Q16881     CHEMBL1927   \n",
       "10                       P09917      CHEMBL215   \n",
       "64                       O76074     CHEMBL1827   \n",
       "20                       Q9Y233     CHEMBL4409   \n",
       "52                       P27815      CHEMBL254   \n",
       "65                       Q9HCR9     CHEMBL2717   \n",
       "1                        P08183     CHEMBL4302   \n",
       "95                       P00746  CHEMBL2176771   \n",
       "2                        P28074     CHEMBL4662   \n",
       "7                 P07384 P04632  CHEMBL2111357   \n",
       "9                        P00742      CHEMBL244   \n",
       "70                       P50281     CHEMBL3869   \n",
       "11                       P42785     CHEMBL2335   \n",
       "93                       P08246      CHEMBL248   \n",
       "84                       Q15059  CHEMBL1795186   \n",
       "83                       P25440  CHEMBL1293289   \n",
       "82                       O60885  CHEMBL1163125   \n",
       "97                       P55201  CHEMBL3132741   \n",
       "57                       P01375     CHEMBL1825   \n",
       "19                       Q9BRH5  CHEMBL3638325   \n",
       "51                       Q13936     CHEMBL1940   \n",
       "5                        Q15858     CHEMBL4296   \n",
       "50                       Q9Y5Y9     CHEMBL5451   \n",
       "71                       Q99250     CHEMBL4187   \n",
       "56                       O43497     CHEMBL4641   \n",
       "69                       Q14524     CHEMBL1980   \n",
       "\n",
       "                                  Target Class  Probability*  \\\n",
       "46                             Cytochrome P450      0.055648   \n",
       "27                                      Enzyme      0.055648   \n",
       "48                                      Enzyme      0.055648   \n",
       "53                                      Enzyme      0.055648   \n",
       "29                                      Enzyme      0.055648   \n",
       "54                                      Enzyme      0.055648   \n",
       "74                                      Enzyme      0.055648   \n",
       "55                                      Enzyme      0.055648   \n",
       "58                                      Enzyme      0.055648   \n",
       "61                                      Eraser      0.055648   \n",
       "60                                      Eraser      0.055648   \n",
       "59         Family A G protein-coupled receptor      0.055648   \n",
       "23         Family A G protein-coupled receptor      0.055648   \n",
       "99         Family A G protein-coupled receptor      0.055648   \n",
       "47         Family A G protein-coupled receptor      0.055648   \n",
       "45         Family A G protein-coupled receptor      0.055648   \n",
       "44         Family A G protein-coupled receptor      0.055648   \n",
       "26         Family A G protein-coupled receptor      0.055648   \n",
       "62         Family A G protein-coupled receptor      0.055648   \n",
       "39         Family A G protein-coupled receptor      0.055648   \n",
       "75         Family A G protein-coupled receptor      0.055648   \n",
       "92         Family A G protein-coupled receptor      0.055648   \n",
       "89         Family A G protein-coupled receptor      0.055648   \n",
       "3          Family A G protein-coupled receptor      0.055648   \n",
       "4          Family A G protein-coupled receptor      0.055648   \n",
       "6          Family A G protein-coupled receptor      0.055648   \n",
       "87         Family A G protein-coupled receptor      0.055648   \n",
       "41         Family A G protein-coupled receptor      0.055648   \n",
       "8          Family A G protein-coupled receptor      0.055648   \n",
       "80         Family A G protein-coupled receptor      0.055648   \n",
       "78         Family A G protein-coupled receptor      0.055648   \n",
       "12         Family A G protein-coupled receptor      0.055648   \n",
       "13         Family A G protein-coupled receptor      0.055648   \n",
       "76         Family A G protein-coupled receptor      0.055648   \n",
       "86         Family A G protein-coupled receptor      0.055648   \n",
       "77         Family B G protein-coupled receptor      0.055648   \n",
       "88         Family C G protein-coupled receptor      0.055648   \n",
       "63  Frizzled family G protein-coupled receptor      0.055648   \n",
       "0                                    Isomerase      0.055648   \n",
       "37                                      Kinase      0.055648   \n",
       "67                                      Kinase      0.055648   \n",
       "22                                      Kinase      0.055648   \n",
       "24                                      Kinase      0.055648   \n",
       "68                                      Kinase      0.055648   \n",
       "38                                      Kinase      0.055648   \n",
       "25                                      Kinase      0.055648   \n",
       "28                                      Kinase      0.055648   \n",
       "30                                      Kinase      0.055648   \n",
       "17                                      Kinase      0.055648   \n",
       "16                                      Kinase      0.055648   \n",
       "15                                      Kinase      0.055648   \n",
       "14                                      Kinase      0.055648   \n",
       "31                                      Kinase      0.055648   \n",
       "32                                      Kinase      0.055648   \n",
       "33                                      Kinase      0.055648   \n",
       "34                                      Kinase      0.055648   \n",
       "35                                      Kinase      0.055648   \n",
       "79                                      Kinase      0.055648   \n",
       "42                                      Kinase      0.055648   \n",
       "36                                      Kinase      0.055648   \n",
       "81                                      Kinase      0.055648   \n",
       "66                                      Kinase      0.055648   \n",
       "18                                      Kinase      0.055648   \n",
       "49                                      Ligase      0.055648   \n",
       "91                           Membrane receptor      0.055648   \n",
       "43                           Membrane receptor      0.055648   \n",
       "96                            Nuclear receptor      0.055648   \n",
       "94                            Nuclear receptor      0.055648   \n",
       "98                            Nuclear receptor      0.055648   \n",
       "21                     Other cytosolic protein      0.055648   \n",
       "72                     Other cytosolic protein      0.055648   \n",
       "73                     Other cytosolic protein      0.055648   \n",
       "90                           Other ion channel      0.055648   \n",
       "40                       Other nuclear protein      0.055648   \n",
       "85                              Oxidoreductase      0.055648   \n",
       "10                              Oxidoreductase      0.055648   \n",
       "64                           Phosphodiesterase      0.055648   \n",
       "20                           Phosphodiesterase      0.055648   \n",
       "52                           Phosphodiesterase      0.055648   \n",
       "65                           Phosphodiesterase      0.055648   \n",
       "1                   Primary active transporter      0.055648   \n",
       "95                                    Protease      0.055648   \n",
       "2                                     Protease      0.055648   \n",
       "7                                     Protease      0.055648   \n",
       "9                                     Protease      0.055648   \n",
       "70                                    Protease      0.055648   \n",
       "11                                    Protease      0.055648   \n",
       "93                                    Protease      0.055648   \n",
       "84                                      Reader      0.055648   \n",
       "83                                      Reader      0.055648   \n",
       "82                                      Reader      0.055648   \n",
       "97                                      Reader      0.055648   \n",
       "57                            Secreted protein      0.055648   \n",
       "19                        Unclassified protein      0.055648   \n",
       "51                   Voltage-gated ion channel      0.055648   \n",
       "5                    Voltage-gated ion channel      0.055648   \n",
       "50                   Voltage-gated ion channel      0.055648   \n",
       "71                   Voltage-gated ion channel      0.055648   \n",
       "56                   Voltage-gated ion channel      0.055648   \n",
       "69                   Voltage-gated ion channel      0.055648   \n",
       "\n",
       "   Known actives (3D/2D)  \n",
       "46           7 /  0       \n",
       "27          46 /  0       \n",
       "48         160 /  0       \n",
       "53         184 /  0       \n",
       "29         124 /  0       \n",
       "54         102 /  0       \n",
       "74          11 /  0       \n",
       "55         137 /  0       \n",
       "58          29 /  0       \n",
       "61         225 /  0       \n",
       "60          91 /  0       \n",
       "59       1197 /  14       \n",
       "23          53 /  0       \n",
       "99         251 /  0       \n",
       "47           8 /  0       \n",
       "45          63 /  0       \n",
       "44         146 /  0       \n",
       "26         188 /  0       \n",
       "62          51 /  0       \n",
       "39         867 /  0       \n",
       "75         413 /  0       \n",
       "92           5 /  0       \n",
       "89          99 /  0       \n",
       "3           84 /  0       \n",
       "4          129 /  0       \n",
       "6           27 /  0       \n",
       "87         143 /  0       \n",
       "41         731 /  0       \n",
       "8          494 /  0       \n",
       "80          72 /  0       \n",
       "78           4 /  0       \n",
       "12         648 /  0       \n",
       "13         521 /  0       \n",
       "76          49 /  0       \n",
       "86          41 /  0       \n",
       "77         179 /  0       \n",
       "88         702 /  0       \n",
       "63          97 /  0       \n",
       "0         157 /  83       \n",
       "37          71 /  0       \n",
       "67           6 /  0       \n",
       "22         323 /  0       \n",
       "24         206 /  0       \n",
       "68         128 /  0       \n",
       "38          41 /  0       \n",
       "25          47 /  0       \n",
       "28         162 /  0       \n",
       "30         114 /  0       \n",
       "17         146 /  0       \n",
       "16         286 /  0       \n",
       "15         216 /  0       \n",
       "14          68 /  0       \n",
       "31         175 /  0       \n",
       "32         123 /  0       \n",
       "33          99 /  0       \n",
       "34          84 /  0       \n",
       "35          45 /  0       \n",
       "79         285 /  0       \n",
       "42         114 /  0       \n",
       "36         603 /  0       \n",
       "81         177 /  0       \n",
       "66          25 /  0       \n",
       "18         298 /  0       \n",
       "49         149 /  0       \n",
       "91           3 /  0       \n",
       "43         329 /  0       \n",
       "96           6 /  0       \n",
       "94         115 /  0       \n",
       "98          61 /  0       \n",
       "21          38 /  0       \n",
       "72          54 /  0       \n",
       "73          98 /  0       \n",
       "90          20 /  0       \n",
       "40         145 /  0       \n",
       "85           2 /  0       \n",
       "10          64 /  0       \n",
       "64         327 /  0       \n",
       "20        1117 /  0       \n",
       "52         117 /  0       \n",
       "65           7 /  0       \n",
       "1           63 /  1       \n",
       "95         190 /  0       \n",
       "2          58 /  21       \n",
       "7           36 /  0       \n",
       "9          368 /  0       \n",
       "70          12 /  0       \n",
       "11          17 /  0       \n",
       "93         187 /  5       \n",
       "84          79 /  0       \n",
       "83          73 /  0       \n",
       "82         151 /  0       \n",
       "97          35 /  0       \n",
       "57           3 /  0       \n",
       "19           4 /  0       \n",
       "51          11 /  0       \n",
       "5          141 /  0       \n",
       "50          24 /  0       \n",
       "71          38 /  0       \n",
       "56           4 /  0       \n",
       "69          33 /  0       "
      ]
     },
     "execution_count": 20,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "stp.sort_values(by='Target Class')"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Так как с GPCR связывается достаточно большое количество регуляторных агентов, возможно для дальнейшего использования потребуется некоторая модификация молекулы. Либо использование ее в качестве субстрата/транспорта. "
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Результаты Super-PRED  \n",
    "Инструмент выдает мишени, а также заболевания, связанные с мишенями."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2023-10-13T21:00:34.265198Z",
     "start_time": "2023-10-13T21:00:34.226086Z"
    }
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Target Name</th>\n",
       "      <th>ChEMBL-ID</th>\n",
       "      <th>UniProt ID</th>\n",
       "      <th>PDB Visualization</th>\n",
       "      <th>TTD ID</th>\n",
       "      <th>Probability</th>\n",
       "      <th>Model accuracy</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Cannabinoid CB2 receptor</td>\n",
       "      <td>CHEMBL253</td>\n",
       "      <td>P34972</td>\n",
       "      <td>6KPF</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>95.73%</td>\n",
       "      <td>97.25%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Cathepsin D</td>\n",
       "      <td>CHEMBL2581</td>\n",
       "      <td>P07339</td>\n",
       "      <td>4OD9</td>\n",
       "      <td>T67102</td>\n",
       "      <td>91.51%</td>\n",
       "      <td>98.95%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>G-protein coupled receptor 55</td>\n",
       "      <td>CHEMBL1075322</td>\n",
       "      <td>Q9Y2T6</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>T87670</td>\n",
       "      <td>88.35%</td>\n",
       "      <td>78.15%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Nuclear factor NF-kappa-B p105 subunit</td>\n",
       "      <td>CHEMBL3251</td>\n",
       "      <td>P19838</td>\n",
       "      <td>1SVC</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>88.05%</td>\n",
       "      <td>96.09%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Transcription intermediary factor 1-alpha</td>\n",
       "      <td>CHEMBL3108638</td>\n",
       "      <td>O15164</td>\n",
       "      <td>4YBM</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>86.87%</td>\n",
       "      <td>95.56%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Bloom syndrome protein</td>\n",
       "      <td>CHEMBL1293237</td>\n",
       "      <td>P54132</td>\n",
       "      <td>4O3M</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>84.37%</td>\n",
       "      <td>70.06%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>Tyrosyl-DNA phosphodiesterase 1</td>\n",
       "      <td>CHEMBL1075138</td>\n",
       "      <td>Q9NUW8</td>\n",
       "      <td>6N0D</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>83.47%</td>\n",
       "      <td>71.22%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>Acyl coenzyme A:cholesterol acyltransferase</td>\n",
       "      <td>CHEMBL2265</td>\n",
       "      <td>P23141</td>\n",
       "      <td>5A7G</td>\n",
       "      <td>T76369</td>\n",
       "      <td>81.39%</td>\n",
       "      <td>85.94%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>Cyclophilin A</td>\n",
       "      <td>CHEMBL1949</td>\n",
       "      <td>P62937</td>\n",
       "      <td>4N1M</td>\n",
       "      <td>T47081</td>\n",
       "      <td>80.31%</td>\n",
       "      <td>98.57%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>Heat shock protein HSP 90-beta</td>\n",
       "      <td>CHEMBL4303</td>\n",
       "      <td>P08238</td>\n",
       "      <td>5FWK</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>80%</td>\n",
       "      <td>96.77%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>Glycine receptor subunit alpha-1</td>\n",
       "      <td>CHEMBL5845</td>\n",
       "      <td>P23415</td>\n",
       "      <td>4X5T</td>\n",
       "      <td>T50269</td>\n",
       "      <td>79.44%</td>\n",
       "      <td>90.71%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>Casein kinase II alpha/beta</td>\n",
       "      <td>CHEMBL3038477</td>\n",
       "      <td>P67870</td>\n",
       "      <td>6TLS</td>\n",
       "      <td>T51565</td>\n",
       "      <td>79.37%</td>\n",
       "      <td>99.23%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>Cytochrome P450 19A1</td>\n",
       "      <td>CHEMBL1978</td>\n",
       "      <td>P11511</td>\n",
       "      <td>3S79</td>\n",
       "      <td>T13260</td>\n",
       "      <td>78.78%</td>\n",
       "      <td>91.76%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>Histone deacetylase 10</td>\n",
       "      <td>CHEMBL5103</td>\n",
       "      <td>Q969S8</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>T94324</td>\n",
       "      <td>78.4%</td>\n",
       "      <td>90.08%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>Aminopeptidase N</td>\n",
       "      <td>CHEMBL1907</td>\n",
       "      <td>P15144</td>\n",
       "      <td>4FYT</td>\n",
       "      <td>T67272</td>\n",
       "      <td>77.49%</td>\n",
       "      <td>93.31%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>G-protein coupled bile acid receptor 1</td>\n",
       "      <td>CHEMBL5409</td>\n",
       "      <td>Q8TDU6</td>\n",
       "      <td>7CFM</td>\n",
       "      <td>T86273</td>\n",
       "      <td>77.18%</td>\n",
       "      <td>93.65%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>Formyl peptide receptor 1</td>\n",
       "      <td>CHEMBL3359</td>\n",
       "      <td>P21462</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>T87831</td>\n",
       "      <td>75.29%</td>\n",
       "      <td>93.56%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>Hypoxia-inducible factor 1 alpha</td>\n",
       "      <td>CHEMBL4261</td>\n",
       "      <td>Q16665</td>\n",
       "      <td>4H6J</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>75.28%</td>\n",
       "      <td>85.14%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>Cathepsin B</td>\n",
       "      <td>CHEMBL4072</td>\n",
       "      <td>P07858</td>\n",
       "      <td>3PBH</td>\n",
       "      <td>T61746</td>\n",
       "      <td>75.23%</td>\n",
       "      <td>93.67%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>Matrix metalloproteinase 9</td>\n",
       "      <td>CHEMBL321</td>\n",
       "      <td>P14780</td>\n",
       "      <td>5UE3</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>74.85%</td>\n",
       "      <td>92.12%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>Pregnane X receptor</td>\n",
       "      <td>CHEMBL3401</td>\n",
       "      <td>O75469</td>\n",
       "      <td>6TFI</td>\n",
       "      <td>T82702</td>\n",
       "      <td>74.67%</td>\n",
       "      <td>94.73%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>Integrin alpha-V/beta-3</td>\n",
       "      <td>CHEMBL1907598</td>\n",
       "      <td>P05106</td>\n",
       "      <td>6UJA</td>\n",
       "      <td>T67103</td>\n",
       "      <td>74.27%</td>\n",
       "      <td>95.71%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>Voltage-gated N-type calcium channel alpha-1B ...</td>\n",
       "      <td>CHEMBL4478</td>\n",
       "      <td>Q00975</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>T38338</td>\n",
       "      <td>73.79%</td>\n",
       "      <td>97.14%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>Matrix metalloproteinase-2</td>\n",
       "      <td>CHEMBL333</td>\n",
       "      <td>P08253</td>\n",
       "      <td>1CK7</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>73.48%</td>\n",
       "      <td>96.31%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>Lysosomal Pro-X carboxypeptidase</td>\n",
       "      <td>CHEMBL2335</td>\n",
       "      <td>P42785</td>\n",
       "      <td>3N2Z</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>71.69%</td>\n",
       "      <td>100%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>DCN1-like protein 1</td>\n",
       "      <td>CHEMBL4105838</td>\n",
       "      <td>Q96GG9</td>\n",
       "      <td>6BG3</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>71.17%</td>\n",
       "      <td>95%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>DNA topoisomerase II alpha</td>\n",
       "      <td>CHEMBL1806</td>\n",
       "      <td>P11388</td>\n",
       "      <td>6ZY5</td>\n",
       "      <td>T17048</td>\n",
       "      <td>70.97%</td>\n",
       "      <td>89%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>PI3-kinase p110-delta subunit</td>\n",
       "      <td>CHEMBL3130</td>\n",
       "      <td>O00329</td>\n",
       "      <td>6PYR</td>\n",
       "      <td>T67849</td>\n",
       "      <td>70.35%</td>\n",
       "      <td>96.47%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>G-protein coupled receptor 35</td>\n",
       "      <td>CHEMBL1293267</td>\n",
       "      <td>Q9HC97</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>69.59%</td>\n",
       "      <td>89.34%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>Adenosine A2b receptor</td>\n",
       "      <td>CHEMBL255</td>\n",
       "      <td>P29275</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>T86679</td>\n",
       "      <td>69.38%</td>\n",
       "      <td>98.59%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>NT-3 growth factor receptor</td>\n",
       "      <td>CHEMBL5608</td>\n",
       "      <td>Q16288</td>\n",
       "      <td>6KZD</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>68.76%</td>\n",
       "      <td>95.89%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>Cystic fibrosis transmembrane conductance regu...</td>\n",
       "      <td>CHEMBL4051</td>\n",
       "      <td>P13569</td>\n",
       "      <td>6MSM</td>\n",
       "      <td>T55654</td>\n",
       "      <td>68.66%</td>\n",
       "      <td>95.71%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32</th>\n",
       "      <td>Toll-like receptor 4</td>\n",
       "      <td>CHEMBL5255</td>\n",
       "      <td>O00206</td>\n",
       "      <td>4G8A</td>\n",
       "      <td>T81443</td>\n",
       "      <td>68.63%</td>\n",
       "      <td>92.5%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33</th>\n",
       "      <td>L-lactate dehydrogenase A chain</td>\n",
       "      <td>CHEMBL4835</td>\n",
       "      <td>P00338</td>\n",
       "      <td>5W8J</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>68.42%</td>\n",
       "      <td>95.34%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>34</th>\n",
       "      <td>Tryptophan 2,3-dioxygenase</td>\n",
       "      <td>CHEMBL2140</td>\n",
       "      <td>P48775</td>\n",
       "      <td>6PYZ</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>68.31%</td>\n",
       "      <td>98.46%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>Matrix metalloproteinase 8</td>\n",
       "      <td>CHEMBL4588</td>\n",
       "      <td>P22894</td>\n",
       "      <td>1I76</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>67.76%</td>\n",
       "      <td>94.66%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36</th>\n",
       "      <td>Sphingosine 1-phosphate receptor Edg-8</td>\n",
       "      <td>CHEMBL2274</td>\n",
       "      <td>Q9H228</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>T50089</td>\n",
       "      <td>67.76%</td>\n",
       "      <td>100%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>37</th>\n",
       "      <td>Serine/threonine-protein kinase mTOR</td>\n",
       "      <td>CHEMBL2842</td>\n",
       "      <td>P42345</td>\n",
       "      <td>6BCX</td>\n",
       "      <td>T75243</td>\n",
       "      <td>67.71%</td>\n",
       "      <td>92.78%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>38</th>\n",
       "      <td>Dual specificity protein kinase CLK4</td>\n",
       "      <td>CHEMBL4203</td>\n",
       "      <td>Q9HAZ1</td>\n",
       "      <td>6FYV</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>67.25%</td>\n",
       "      <td>94.45%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>39</th>\n",
       "      <td>Ribosomal protein S6 kinase alpha 1</td>\n",
       "      <td>CHEMBL2553</td>\n",
       "      <td>Q15418</td>\n",
       "      <td>2Z7Q</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>67.2%</td>\n",
       "      <td>85.11%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>40</th>\n",
       "      <td>Matrix metalloproteinase-1</td>\n",
       "      <td>CHEMBL332</td>\n",
       "      <td>P03956</td>\n",
       "      <td>1SU3</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>67.13%</td>\n",
       "      <td>94.5%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>41</th>\n",
       "      <td>Nuclear factor erythroid 2-related factor 2</td>\n",
       "      <td>CHEMBL1075094</td>\n",
       "      <td>Q16236</td>\n",
       "      <td>2FLU</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>66.67%</td>\n",
       "      <td>96%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>42</th>\n",
       "      <td>Transmembrane protease serine 6</td>\n",
       "      <td>CHEMBL1795139</td>\n",
       "      <td>Q8IU80</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>66.52%</td>\n",
       "      <td>98.33%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>43</th>\n",
       "      <td>C-C chemokine receptor type 1</td>\n",
       "      <td>CHEMBL2413</td>\n",
       "      <td>P32246</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>T16016</td>\n",
       "      <td>66.28%</td>\n",
       "      <td>89.5%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>44</th>\n",
       "      <td>Cyclin-dependent kinase 5/CDK5 activator 1</td>\n",
       "      <td>CHEMBL1907600</td>\n",
       "      <td>Q00535</td>\n",
       "      <td>1UNL</td>\n",
       "      <td>T20973</td>\n",
       "      <td>65.63%</td>\n",
       "      <td>93.03%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45</th>\n",
       "      <td>Voltage-gated T-type calcium channel alpha-1H ...</td>\n",
       "      <td>CHEMBL1859</td>\n",
       "      <td>O95180</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>T54644</td>\n",
       "      <td>65.01%</td>\n",
       "      <td>98.57%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>46</th>\n",
       "      <td>Cysteinyl leukotriene receptor 2</td>\n",
       "      <td>CHEMBL4330</td>\n",
       "      <td>Q9NS75</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>T74238</td>\n",
       "      <td>64.94%</td>\n",
       "      <td>98%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>47</th>\n",
       "      <td>Phosphodiesterase 11A</td>\n",
       "      <td>CHEMBL2717</td>\n",
       "      <td>Q9HCR9</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>64.59%</td>\n",
       "      <td>85%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>48</th>\n",
       "      <td>Dual specificity mitogen-activated protein kin...</td>\n",
       "      <td>CHEMBL2964</td>\n",
       "      <td>P36507</td>\n",
       "      <td>1S9I</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>64.44%</td>\n",
       "      <td>80%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49</th>\n",
       "      <td>T-cell protein-tyrosine phosphatase</td>\n",
       "      <td>CHEMBL3807</td>\n",
       "      <td>P17706</td>\n",
       "      <td>1L8K</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>64.24%</td>\n",
       "      <td>93%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>50</th>\n",
       "      <td>Sodium channel protein type III alpha subunit</td>\n",
       "      <td>CHEMBL5163</td>\n",
       "      <td>Q9NY46</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>T76937</td>\n",
       "      <td>63.75%</td>\n",
       "      <td>96.9%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>51</th>\n",
       "      <td>Serotonin 3a (5-HT3a) receptor</td>\n",
       "      <td>CHEMBL1899</td>\n",
       "      <td>P46098</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>T64591</td>\n",
       "      <td>63.59%</td>\n",
       "      <td>100%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>52</th>\n",
       "      <td>Proteasome subunit beta type-9</td>\n",
       "      <td>CHEMBL1944495</td>\n",
       "      <td>P28065</td>\n",
       "      <td>6E5B</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>63.5%</td>\n",
       "      <td>97.5%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53</th>\n",
       "      <td>Tyrosine-protein kinase receptor TYRO3</td>\n",
       "      <td>CHEMBL5314</td>\n",
       "      <td>Q06418</td>\n",
       "      <td>1RHF</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>63.17%</td>\n",
       "      <td>96%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>54</th>\n",
       "      <td>Multidrug resistance-associated protein 1</td>\n",
       "      <td>CHEMBL3004</td>\n",
       "      <td>P33527</td>\n",
       "      <td>4C3Z</td>\n",
       "      <td>T11288</td>\n",
       "      <td>62.6%</td>\n",
       "      <td>96.37%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>55</th>\n",
       "      <td>Vitamin K-dependent protein C</td>\n",
       "      <td>CHEMBL4444</td>\n",
       "      <td>P04070</td>\n",
       "      <td>6M3B</td>\n",
       "      <td>T24836</td>\n",
       "      <td>62.4%</td>\n",
       "      <td>93.89%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>56</th>\n",
       "      <td>Glutamate NMDA receptor; GRIN1/GRIN2B</td>\n",
       "      <td>CHEMBL1907603</td>\n",
       "      <td>Q05586</td>\n",
       "      <td>5EWM</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>62.11%</td>\n",
       "      <td>95.89%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>57</th>\n",
       "      <td>Dual specificity protein phosphatase 3</td>\n",
       "      <td>CHEMBL2635</td>\n",
       "      <td>P51452</td>\n",
       "      <td>3F81</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>62.09%</td>\n",
       "      <td>94%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>58</th>\n",
       "      <td>Sodium/hydrogen exchanger 1</td>\n",
       "      <td>CHEMBL2781</td>\n",
       "      <td>P19634</td>\n",
       "      <td>7DSX</td>\n",
       "      <td>T82028</td>\n",
       "      <td>61.84%</td>\n",
       "      <td>90.24%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>59</th>\n",
       "      <td>PRMT5/MEP50 complex</td>\n",
       "      <td>CHEMBL3137261</td>\n",
       "      <td>O14744</td>\n",
       "      <td>6V0P</td>\n",
       "      <td>T82665</td>\n",
       "      <td>61.53%</td>\n",
       "      <td>100%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>60</th>\n",
       "      <td>Kallikrein 7</td>\n",
       "      <td>CHEMBL2443</td>\n",
       "      <td>P49862</td>\n",
       "      <td>2QXI</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>61.27%</td>\n",
       "      <td>94%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>61</th>\n",
       "      <td>Protein-tyrosine phosphatase 2C</td>\n",
       "      <td>CHEMBL3864</td>\n",
       "      <td>Q06124</td>\n",
       "      <td>5EHR</td>\n",
       "      <td>T13057</td>\n",
       "      <td>61.2%</td>\n",
       "      <td>94.42%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>62</th>\n",
       "      <td>Mineralocorticoid receptor</td>\n",
       "      <td>CHEMBL1994</td>\n",
       "      <td>P08235</td>\n",
       "      <td>4PF3</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>60.67%</td>\n",
       "      <td>100%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>63</th>\n",
       "      <td>Calpain 1</td>\n",
       "      <td>CHEMBL3891</td>\n",
       "      <td>P07384</td>\n",
       "      <td>1ZCM</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>60.64%</td>\n",
       "      <td>93.04%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>64</th>\n",
       "      <td>Acyl-CoA desaturase</td>\n",
       "      <td>CHEMBL5555</td>\n",
       "      <td>O00767</td>\n",
       "      <td>4ZYO</td>\n",
       "      <td>T10897</td>\n",
       "      <td>60.11%</td>\n",
       "      <td>97.5%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>65</th>\n",
       "      <td>Kelch-like ECH-associated protein 1</td>\n",
       "      <td>CHEMBL2069156</td>\n",
       "      <td>Q14145</td>\n",
       "      <td>6WCQ</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>59.93%</td>\n",
       "      <td>82.38%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>66</th>\n",
       "      <td>Uracil nucleotide/cysteinyl leukotriene receptor</td>\n",
       "      <td>CHEMBL1075162</td>\n",
       "      <td>Q13304</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>59.8%</td>\n",
       "      <td>80.33%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>67</th>\n",
       "      <td>Niemann-Pick C1 protein</td>\n",
       "      <td>CHEMBL1293277</td>\n",
       "      <td>O15118</td>\n",
       "      <td>6W5S</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>59.8%</td>\n",
       "      <td>81.11%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>68</th>\n",
       "      <td>L-lactate dehydrogenase B chain</td>\n",
       "      <td>CHEMBL4940</td>\n",
       "      <td>P07195</td>\n",
       "      <td>1I0Z</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>59.77%</td>\n",
       "      <td>95.53%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>69</th>\n",
       "      <td>Protein kinase N1</td>\n",
       "      <td>CHEMBL3384</td>\n",
       "      <td>Q16512</td>\n",
       "      <td>4OTH</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>59.48%</td>\n",
       "      <td>80.71%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70</th>\n",
       "      <td>Lipoxin A4 receptor</td>\n",
       "      <td>CHEMBL4227</td>\n",
       "      <td>P25090</td>\n",
       "      <td>6OMM</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>58.99%</td>\n",
       "      <td>100%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>71</th>\n",
       "      <td>P2X purinoceptor 7</td>\n",
       "      <td>CHEMBL4805</td>\n",
       "      <td>Q99572</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>T63414</td>\n",
       "      <td>58.78%</td>\n",
       "      <td>97.5%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>72</th>\n",
       "      <td>C5a anaphylatoxin chemotactic receptor</td>\n",
       "      <td>CHEMBL2373</td>\n",
       "      <td>P21730</td>\n",
       "      <td>6C1R</td>\n",
       "      <td>T15439</td>\n",
       "      <td>58.71%</td>\n",
       "      <td>92.62%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>73</th>\n",
       "      <td>Matrix metalloproteinase 14</td>\n",
       "      <td>CHEMBL3869</td>\n",
       "      <td>P50281</td>\n",
       "      <td>3C7X</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>58.4%</td>\n",
       "      <td>93.1%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>74</th>\n",
       "      <td>WD repeat-containing protein 5</td>\n",
       "      <td>CHEMBL1075317</td>\n",
       "      <td>P61964</td>\n",
       "      <td>2GNQ</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>58.35%</td>\n",
       "      <td>96.33%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>75</th>\n",
       "      <td>Egl nine homolog 1</td>\n",
       "      <td>CHEMBL5697</td>\n",
       "      <td>Q9GZT9</td>\n",
       "      <td>4BQY</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>58.22%</td>\n",
       "      <td>93.4%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>76</th>\n",
       "      <td>Cyclin-dependent kinase 5</td>\n",
       "      <td>CHEMBL4036</td>\n",
       "      <td>Q00535</td>\n",
       "      <td>4AU8</td>\n",
       "      <td>T20973</td>\n",
       "      <td>58.13%</td>\n",
       "      <td>79.09%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>77</th>\n",
       "      <td>ADAM10</td>\n",
       "      <td>CHEMBL5028</td>\n",
       "      <td>O14672</td>\n",
       "      <td>6BE6</td>\n",
       "      <td>T31902</td>\n",
       "      <td>57.77%</td>\n",
       "      <td>97.5%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>78</th>\n",
       "      <td>Lysine-specific demethylase 5A</td>\n",
       "      <td>CHEMBL2424504</td>\n",
       "      <td>P29375</td>\n",
       "      <td>5V9P</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>57.76%</td>\n",
       "      <td>99.23%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>79</th>\n",
       "      <td>Ghrelin receptor</td>\n",
       "      <td>CHEMBL4616</td>\n",
       "      <td>Q92847</td>\n",
       "      <td>6KO5</td>\n",
       "      <td>T59604</td>\n",
       "      <td>57.7%</td>\n",
       "      <td>92%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>80</th>\n",
       "      <td>Dual specificity protein kinase CLK2</td>\n",
       "      <td>CHEMBL4225</td>\n",
       "      <td>P49760</td>\n",
       "      <td>6KHE</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>57.7%</td>\n",
       "      <td>80.96%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>81</th>\n",
       "      <td>Autotaxin</td>\n",
       "      <td>CHEMBL3691</td>\n",
       "      <td>Q13822</td>\n",
       "      <td>4ZG6</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>57.35%</td>\n",
       "      <td>96.39%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>82</th>\n",
       "      <td>Ras-related protein Rab-9A</td>\n",
       "      <td>CHEMBL1293294</td>\n",
       "      <td>P51151</td>\n",
       "      <td>1WMS</td>\n",
       "      <td>T66350</td>\n",
       "      <td>57.22%</td>\n",
       "      <td>87.67%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>83</th>\n",
       "      <td>Cytochrome P450 3A4</td>\n",
       "      <td>CHEMBL340</td>\n",
       "      <td>P08684</td>\n",
       "      <td>5VCC</td>\n",
       "      <td>T37848</td>\n",
       "      <td>57.14%</td>\n",
       "      <td>91.19%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>84</th>\n",
       "      <td>Neuronal acetylcholine receptor protein alpha-...</td>\n",
       "      <td>CHEMBL2492</td>\n",
       "      <td>P36544</td>\n",
       "      <td>7EKP</td>\n",
       "      <td>T34429</td>\n",
       "      <td>57.1%</td>\n",
       "      <td>88.42%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>85</th>\n",
       "      <td>Proteasome component C5</td>\n",
       "      <td>CHEMBL4208</td>\n",
       "      <td>P20618</td>\n",
       "      <td>6KWY</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>56.98%</td>\n",
       "      <td>90%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>86</th>\n",
       "      <td>Histone-lysine N-methyltransferase EZH2</td>\n",
       "      <td>CHEMBL2189110</td>\n",
       "      <td>Q15910</td>\n",
       "      <td>5HYN</td>\n",
       "      <td>T25265</td>\n",
       "      <td>56.86%</td>\n",
       "      <td>97.5%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>87</th>\n",
       "      <td>Melanocortin receptor 3</td>\n",
       "      <td>CHEMBL4644</td>\n",
       "      <td>P41968</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>T76846</td>\n",
       "      <td>56.76%</td>\n",
       "      <td>99.52%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>88</th>\n",
       "      <td>Neurotensin receptor 2</td>\n",
       "      <td>CHEMBL2514</td>\n",
       "      <td>O95665</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>56.72%</td>\n",
       "      <td>100%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>89</th>\n",
       "      <td>Androgen Receptor</td>\n",
       "      <td>CHEMBL1871</td>\n",
       "      <td>P10275</td>\n",
       "      <td>3V49</td>\n",
       "      <td>T11211</td>\n",
       "      <td>56.55%</td>\n",
       "      <td>96.43%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>90</th>\n",
       "      <td>Kruppel-like factor 5</td>\n",
       "      <td>CHEMBL1293249</td>\n",
       "      <td>Q13887</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>56.38%</td>\n",
       "      <td>86.33%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>91</th>\n",
       "      <td>Coagulation factor XIII</td>\n",
       "      <td>CHEMBL4530</td>\n",
       "      <td>P00488</td>\n",
       "      <td>4KTY</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>56.25%</td>\n",
       "      <td>96%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>92</th>\n",
       "      <td>Platelet-derived growth factor receptor</td>\n",
       "      <td>CHEMBL2095189</td>\n",
       "      <td>P09619</td>\n",
       "      <td>3MJG</td>\n",
       "      <td>T53524</td>\n",
       "      <td>55.66%</td>\n",
       "      <td>71.67%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>93</th>\n",
       "      <td>Matrix metalloproteinase 7</td>\n",
       "      <td>CHEMBL4073</td>\n",
       "      <td>P09237</td>\n",
       "      <td>2Y6D</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>55.64%</td>\n",
       "      <td>97.56%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>94</th>\n",
       "      <td>Galectin-3</td>\n",
       "      <td>CHEMBL4531</td>\n",
       "      <td>P17931</td>\n",
       "      <td>6FOF</td>\n",
       "      <td>T72038</td>\n",
       "      <td>54.97%</td>\n",
       "      <td>96.9%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>95</th>\n",
       "      <td>Melanocortin receptor 5</td>\n",
       "      <td>CHEMBL4608</td>\n",
       "      <td>P33032</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>T95302</td>\n",
       "      <td>54.78%</td>\n",
       "      <td>97%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>96</th>\n",
       "      <td>Solute carrier family 40 member 1</td>\n",
       "      <td>CHEMBL3392948</td>\n",
       "      <td>Q9NP59</td>\n",
       "      <td>6WBV</td>\n",
       "      <td>T86264</td>\n",
       "      <td>54.49%</td>\n",
       "      <td>95%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>97</th>\n",
       "      <td>Trypsin I</td>\n",
       "      <td>CHEMBL209</td>\n",
       "      <td>P07477</td>\n",
       "      <td>2RA3</td>\n",
       "      <td>T27602</td>\n",
       "      <td>54.48%</td>\n",
       "      <td>90%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>98</th>\n",
       "      <td>Cysteine protease ATG4B</td>\n",
       "      <td>CHEMBL1741221</td>\n",
       "      <td>Q9Y4P1</td>\n",
       "      <td>2CY7</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>54.42%</td>\n",
       "      <td>87.5%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>99</th>\n",
       "      <td>Platelet-derived growth factor receptor alpha</td>\n",
       "      <td>CHEMBL2007</td>\n",
       "      <td>P16234</td>\n",
       "      <td>7LBF</td>\n",
       "      <td>T53524</td>\n",
       "      <td>54.17%</td>\n",
       "      <td>91.07%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>100</th>\n",
       "      <td>C-C chemokine receptor type 2</td>\n",
       "      <td>CHEMBL4015</td>\n",
       "      <td>P41597</td>\n",
       "      <td>5T1A</td>\n",
       "      <td>T89988</td>\n",
       "      <td>54.1%</td>\n",
       "      <td>98.57%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>101</th>\n",
       "      <td>ALK tyrosine kinase receptor</td>\n",
       "      <td>CHEMBL4247</td>\n",
       "      <td>Q9UM73</td>\n",
       "      <td>4Z55</td>\n",
       "      <td>T56418</td>\n",
       "      <td>53.89%</td>\n",
       "      <td>96.86%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>102</th>\n",
       "      <td>Cyclin-dependent kinase 1/cyclin B1</td>\n",
       "      <td>CHEMBL1907602</td>\n",
       "      <td>P06493</td>\n",
       "      <td>6GU2</td>\n",
       "      <td>T49898</td>\n",
       "      <td>53.87%</td>\n",
       "      <td>91.24%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>103</th>\n",
       "      <td>Histone deacetylase 2</td>\n",
       "      <td>CHEMBL1937</td>\n",
       "      <td>Q92769</td>\n",
       "      <td>7KBG</td>\n",
       "      <td>T51191</td>\n",
       "      <td>53.52%</td>\n",
       "      <td>94.75%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>104</th>\n",
       "      <td>Histone deacetylase 11</td>\n",
       "      <td>CHEMBL3310</td>\n",
       "      <td>Q96DB2</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>53.5%</td>\n",
       "      <td>88.56%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>105</th>\n",
       "      <td>Histone deacetylase 5</td>\n",
       "      <td>CHEMBL2563</td>\n",
       "      <td>Q9UQL6</td>\n",
       "      <td>5UWI</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>52.92%</td>\n",
       "      <td>89.67%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>106</th>\n",
       "      <td>Plasminogen activator inhibitor-1</td>\n",
       "      <td>CHEMBL3475</td>\n",
       "      <td>P05121</td>\n",
       "      <td>3CVM</td>\n",
       "      <td>T15556</td>\n",
       "      <td>52.87%</td>\n",
       "      <td>83%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>107</th>\n",
       "      <td>3-phosphoinositide dependent protein kinase-1</td>\n",
       "      <td>CHEMBL2534</td>\n",
       "      <td>O15530</td>\n",
       "      <td>5LVO</td>\n",
       "      <td>T20891</td>\n",
       "      <td>52.44%</td>\n",
       "      <td>95.36%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>108</th>\n",
       "      <td>Pyroglutamylated RFamide peptide receptor</td>\n",
       "      <td>CHEMBL5852</td>\n",
       "      <td>Q96P65</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>52.44%</td>\n",
       "      <td>85%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>109</th>\n",
       "      <td>Matrix metalloproteinase 13</td>\n",
       "      <td>CHEMBL280</td>\n",
       "      <td>P45452</td>\n",
       "      <td>4FVL</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>52.2%</td>\n",
       "      <td>95.26%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>110</th>\n",
       "      <td>Cathepsin L</td>\n",
       "      <td>CHEMBL3837</td>\n",
       "      <td>P07711</td>\n",
       "      <td>6JD8</td>\n",
       "      <td>T41141</td>\n",
       "      <td>52.05%</td>\n",
       "      <td>96.61%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>111</th>\n",
       "      <td>Caspase-6</td>\n",
       "      <td>CHEMBL3308</td>\n",
       "      <td>P55212</td>\n",
       "      <td>2WDP</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>52.03%</td>\n",
       "      <td>97.56%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>112</th>\n",
       "      <td>Isocitrate dehydrogenase [NADP] cytoplasmic</td>\n",
       "      <td>CHEMBL2007625</td>\n",
       "      <td>O75874</td>\n",
       "      <td>6BKX</td>\n",
       "      <td>T69563</td>\n",
       "      <td>51.93%</td>\n",
       "      <td>99%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>113</th>\n",
       "      <td>Glutamate receptor ionotropic, AMPA 2</td>\n",
       "      <td>CHEMBL4016</td>\n",
       "      <td>P42262</td>\n",
       "      <td>2WJW</td>\n",
       "      <td>T42392</td>\n",
       "      <td>51.89%</td>\n",
       "      <td>86.92%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>114</th>\n",
       "      <td>Tyrosine-protein kinase ITK/TSK</td>\n",
       "      <td>CHEMBL2959</td>\n",
       "      <td>Q08881</td>\n",
       "      <td>4HCU</td>\n",
       "      <td>T91761</td>\n",
       "      <td>51.87%</td>\n",
       "      <td>95%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>115</th>\n",
       "      <td>Neuronal acetylcholine receptor; alpha4/beta4</td>\n",
       "      <td>CHEMBL1907591</td>\n",
       "      <td>P30926</td>\n",
       "      <td>6UR8</td>\n",
       "      <td>T70967</td>\n",
       "      <td>51.48%</td>\n",
       "      <td>100%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>116</th>\n",
       "      <td>Matrix metalloproteinase 12</td>\n",
       "      <td>CHEMBL4393</td>\n",
       "      <td>P39900</td>\n",
       "      <td>3BA0</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>51.4%</td>\n",
       "      <td>92.22%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>117</th>\n",
       "      <td>Indoleamine 2,3-dioxygenase</td>\n",
       "      <td>CHEMBL4685</td>\n",
       "      <td>P14902</td>\n",
       "      <td>6E43</td>\n",
       "      <td>T89697</td>\n",
       "      <td>51.37%</td>\n",
       "      <td>96.38%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>118</th>\n",
       "      <td>Acetyl-CoA carboxylase 1</td>\n",
       "      <td>CHEMBL3351</td>\n",
       "      <td>Q13085</td>\n",
       "      <td>6G2H</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>51.09%</td>\n",
       "      <td>93.04%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>119</th>\n",
       "      <td>Macrophage migration inhibitory factor</td>\n",
       "      <td>CHEMBL2085</td>\n",
       "      <td>P14174</td>\n",
       "      <td>6B1K</td>\n",
       "      <td>T39977</td>\n",
       "      <td>50.95%</td>\n",
       "      <td>80.78%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>120</th>\n",
       "      <td>PI3-kinase p110-alpha/p85-alpha</td>\n",
       "      <td>CHEMBL2111367</td>\n",
       "      <td>P27986</td>\n",
       "      <td>4JPS</td>\n",
       "      <td>T80276</td>\n",
       "      <td>50.89%</td>\n",
       "      <td>94.33%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121</th>\n",
       "      <td>11-beta-hydroxysteroid dehydrogenase 2</td>\n",
       "      <td>CHEMBL3746</td>\n",
       "      <td>P80365</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>T43721</td>\n",
       "      <td>50.73%</td>\n",
       "      <td>94.78%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>122</th>\n",
       "      <td>Relaxin receptor 1</td>\n",
       "      <td>CHEMBL1293316</td>\n",
       "      <td>Q9HBX9</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>T73696</td>\n",
       "      <td>50.5%</td>\n",
       "      <td>82.5%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>123</th>\n",
       "      <td>Protein kinase C alpha</td>\n",
       "      <td>CHEMBL299</td>\n",
       "      <td>P17252</td>\n",
       "      <td>4RA4</td>\n",
       "      <td>T12808</td>\n",
       "      <td>50.38%</td>\n",
       "      <td>98.03%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>124</th>\n",
       "      <td>Hexokinase type IV</td>\n",
       "      <td>CHEMBL3820</td>\n",
       "      <td>P35557</td>\n",
       "      <td>3F9M</td>\n",
       "      <td>T87166</td>\n",
       "      <td>50.33%</td>\n",
       "      <td>91.96%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>125</th>\n",
       "      <td>LSD1/CoREST complex</td>\n",
       "      <td>CHEMBL3137262</td>\n",
       "      <td>O60341</td>\n",
       "      <td>5L3D</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>50.32%</td>\n",
       "      <td>97.09%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>126</th>\n",
       "      <td>E3 SUMO-protein ligase CBX4</td>\n",
       "      <td>CHEMBL3232685</td>\n",
       "      <td>O00257</td>\n",
       "      <td>5EPL</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>50.24%</td>\n",
       "      <td>93%</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                           Target Name      ChEMBL-ID  \\\n",
       "0                             Cannabinoid CB2 receptor      CHEMBL253   \n",
       "1                                          Cathepsin D     CHEMBL2581   \n",
       "2                        G-protein coupled receptor 55  CHEMBL1075322   \n",
       "3               Nuclear factor NF-kappa-B p105 subunit     CHEMBL3251   \n",
       "4            Transcription intermediary factor 1-alpha  CHEMBL3108638   \n",
       "5                               Bloom syndrome protein  CHEMBL1293237   \n",
       "6                      Tyrosyl-DNA phosphodiesterase 1  CHEMBL1075138   \n",
       "7          Acyl coenzyme A:cholesterol acyltransferase     CHEMBL2265   \n",
       "8                                        Cyclophilin A     CHEMBL1949   \n",
       "9                       Heat shock protein HSP 90-beta     CHEMBL4303   \n",
       "10                    Glycine receptor subunit alpha-1     CHEMBL5845   \n",
       "11                         Casein kinase II alpha/beta  CHEMBL3038477   \n",
       "12                                Cytochrome P450 19A1     CHEMBL1978   \n",
       "13                              Histone deacetylase 10     CHEMBL5103   \n",
       "14                                    Aminopeptidase N     CHEMBL1907   \n",
       "15              G-protein coupled bile acid receptor 1     CHEMBL5409   \n",
       "16                           Formyl peptide receptor 1     CHEMBL3359   \n",
       "17                    Hypoxia-inducible factor 1 alpha     CHEMBL4261   \n",
       "18                                         Cathepsin B     CHEMBL4072   \n",
       "19                          Matrix metalloproteinase 9      CHEMBL321   \n",
       "20                                 Pregnane X receptor     CHEMBL3401   \n",
       "21                             Integrin alpha-V/beta-3  CHEMBL1907598   \n",
       "22   Voltage-gated N-type calcium channel alpha-1B ...     CHEMBL4478   \n",
       "23                          Matrix metalloproteinase-2      CHEMBL333   \n",
       "24                    Lysosomal Pro-X carboxypeptidase     CHEMBL2335   \n",
       "25                                 DCN1-like protein 1  CHEMBL4105838   \n",
       "26                          DNA topoisomerase II alpha     CHEMBL1806   \n",
       "27                       PI3-kinase p110-delta subunit     CHEMBL3130   \n",
       "28                       G-protein coupled receptor 35  CHEMBL1293267   \n",
       "29                              Adenosine A2b receptor      CHEMBL255   \n",
       "30                         NT-3 growth factor receptor     CHEMBL5608   \n",
       "31   Cystic fibrosis transmembrane conductance regu...     CHEMBL4051   \n",
       "32                                Toll-like receptor 4     CHEMBL5255   \n",
       "33                     L-lactate dehydrogenase A chain     CHEMBL4835   \n",
       "34                          Tryptophan 2,3-dioxygenase     CHEMBL2140   \n",
       "35                          Matrix metalloproteinase 8     CHEMBL4588   \n",
       "36              Sphingosine 1-phosphate receptor Edg-8     CHEMBL2274   \n",
       "37                Serine/threonine-protein kinase mTOR     CHEMBL2842   \n",
       "38                Dual specificity protein kinase CLK4     CHEMBL4203   \n",
       "39                 Ribosomal protein S6 kinase alpha 1     CHEMBL2553   \n",
       "40                          Matrix metalloproteinase-1      CHEMBL332   \n",
       "41         Nuclear factor erythroid 2-related factor 2  CHEMBL1075094   \n",
       "42                     Transmembrane protease serine 6  CHEMBL1795139   \n",
       "43                       C-C chemokine receptor type 1     CHEMBL2413   \n",
       "44          Cyclin-dependent kinase 5/CDK5 activator 1  CHEMBL1907600   \n",
       "45   Voltage-gated T-type calcium channel alpha-1H ...     CHEMBL1859   \n",
       "46                    Cysteinyl leukotriene receptor 2     CHEMBL4330   \n",
       "47                               Phosphodiesterase 11A     CHEMBL2717   \n",
       "48   Dual specificity mitogen-activated protein kin...     CHEMBL2964   \n",
       "49                 T-cell protein-tyrosine phosphatase     CHEMBL3807   \n",
       "50       Sodium channel protein type III alpha subunit     CHEMBL5163   \n",
       "51                      Serotonin 3a (5-HT3a) receptor     CHEMBL1899   \n",
       "52                      Proteasome subunit beta type-9  CHEMBL1944495   \n",
       "53              Tyrosine-protein kinase receptor TYRO3     CHEMBL5314   \n",
       "54           Multidrug resistance-associated protein 1     CHEMBL3004   \n",
       "55                       Vitamin K-dependent protein C     CHEMBL4444   \n",
       "56               Glutamate NMDA receptor; GRIN1/GRIN2B  CHEMBL1907603   \n",
       "57              Dual specificity protein phosphatase 3     CHEMBL2635   \n",
       "58                         Sodium/hydrogen exchanger 1     CHEMBL2781   \n",
       "59                                 PRMT5/MEP50 complex  CHEMBL3137261   \n",
       "60                                        Kallikrein 7     CHEMBL2443   \n",
       "61                     Protein-tyrosine phosphatase 2C     CHEMBL3864   \n",
       "62                          Mineralocorticoid receptor     CHEMBL1994   \n",
       "63                                           Calpain 1     CHEMBL3891   \n",
       "64                                 Acyl-CoA desaturase     CHEMBL5555   \n",
       "65                 Kelch-like ECH-associated protein 1  CHEMBL2069156   \n",
       "66    Uracil nucleotide/cysteinyl leukotriene receptor  CHEMBL1075162   \n",
       "67                             Niemann-Pick C1 protein  CHEMBL1293277   \n",
       "68                     L-lactate dehydrogenase B chain     CHEMBL4940   \n",
       "69                                   Protein kinase N1     CHEMBL3384   \n",
       "70                                 Lipoxin A4 receptor     CHEMBL4227   \n",
       "71                                  P2X purinoceptor 7     CHEMBL4805   \n",
       "72              C5a anaphylatoxin chemotactic receptor     CHEMBL2373   \n",
       "73                         Matrix metalloproteinase 14     CHEMBL3869   \n",
       "74                      WD repeat-containing protein 5  CHEMBL1075317   \n",
       "75                                  Egl nine homolog 1     CHEMBL5697   \n",
       "76                           Cyclin-dependent kinase 5     CHEMBL4036   \n",
       "77                                              ADAM10     CHEMBL5028   \n",
       "78                      Lysine-specific demethylase 5A  CHEMBL2424504   \n",
       "79                                    Ghrelin receptor     CHEMBL4616   \n",
       "80                Dual specificity protein kinase CLK2     CHEMBL4225   \n",
       "81                                           Autotaxin     CHEMBL3691   \n",
       "82                          Ras-related protein Rab-9A  CHEMBL1293294   \n",
       "83                                 Cytochrome P450 3A4      CHEMBL340   \n",
       "84   Neuronal acetylcholine receptor protein alpha-...     CHEMBL2492   \n",
       "85                             Proteasome component C5     CHEMBL4208   \n",
       "86             Histone-lysine N-methyltransferase EZH2  CHEMBL2189110   \n",
       "87                             Melanocortin receptor 3     CHEMBL4644   \n",
       "88                              Neurotensin receptor 2     CHEMBL2514   \n",
       "89                                   Androgen Receptor     CHEMBL1871   \n",
       "90                               Kruppel-like factor 5  CHEMBL1293249   \n",
       "91                             Coagulation factor XIII     CHEMBL4530   \n",
       "92             Platelet-derived growth factor receptor  CHEMBL2095189   \n",
       "93                          Matrix metalloproteinase 7     CHEMBL4073   \n",
       "94                                          Galectin-3     CHEMBL4531   \n",
       "95                             Melanocortin receptor 5     CHEMBL4608   \n",
       "96                   Solute carrier family 40 member 1  CHEMBL3392948   \n",
       "97                                           Trypsin I      CHEMBL209   \n",
       "98                             Cysteine protease ATG4B  CHEMBL1741221   \n",
       "99       Platelet-derived growth factor receptor alpha     CHEMBL2007   \n",
       "100                      C-C chemokine receptor type 2     CHEMBL4015   \n",
       "101                       ALK tyrosine kinase receptor     CHEMBL4247   \n",
       "102                Cyclin-dependent kinase 1/cyclin B1  CHEMBL1907602   \n",
       "103                              Histone deacetylase 2     CHEMBL1937   \n",
       "104                             Histone deacetylase 11     CHEMBL3310   \n",
       "105                              Histone deacetylase 5     CHEMBL2563   \n",
       "106                  Plasminogen activator inhibitor-1     CHEMBL3475   \n",
       "107      3-phosphoinositide dependent protein kinase-1     CHEMBL2534   \n",
       "108          Pyroglutamylated RFamide peptide receptor     CHEMBL5852   \n",
       "109                        Matrix metalloproteinase 13      CHEMBL280   \n",
       "110                                        Cathepsin L     CHEMBL3837   \n",
       "111                                          Caspase-6     CHEMBL3308   \n",
       "112        Isocitrate dehydrogenase [NADP] cytoplasmic  CHEMBL2007625   \n",
       "113              Glutamate receptor ionotropic, AMPA 2     CHEMBL4016   \n",
       "114                    Tyrosine-protein kinase ITK/TSK     CHEMBL2959   \n",
       "115      Neuronal acetylcholine receptor; alpha4/beta4  CHEMBL1907591   \n",
       "116                        Matrix metalloproteinase 12     CHEMBL4393   \n",
       "117                        Indoleamine 2,3-dioxygenase     CHEMBL4685   \n",
       "118                           Acetyl-CoA carboxylase 1     CHEMBL3351   \n",
       "119             Macrophage migration inhibitory factor     CHEMBL2085   \n",
       "120                    PI3-kinase p110-alpha/p85-alpha  CHEMBL2111367   \n",
       "121             11-beta-hydroxysteroid dehydrogenase 2     CHEMBL3746   \n",
       "122                                 Relaxin receptor 1  CHEMBL1293316   \n",
       "123                             Protein kinase C alpha      CHEMBL299   \n",
       "124                                 Hexokinase type IV     CHEMBL3820   \n",
       "125                                LSD1/CoREST complex  CHEMBL3137262   \n",
       "126                        E3 SUMO-protein ligase CBX4  CHEMBL3232685   \n",
       "\n",
       "    UniProt ID PDB Visualization         TTD ID Probability Model accuracy  \n",
       "0       P34972              6KPF  Not Available      95.73%         97.25%  \n",
       "1       P07339              4OD9         T67102      91.51%         98.95%  \n",
       "2       Q9Y2T6     Not Available         T87670      88.35%         78.15%  \n",
       "3       P19838              1SVC  Not Available      88.05%         96.09%  \n",
       "4       O15164              4YBM  Not Available      86.87%         95.56%  \n",
       "5       P54132              4O3M  Not Available      84.37%         70.06%  \n",
       "6       Q9NUW8              6N0D  Not Available      83.47%         71.22%  \n",
       "7       P23141              5A7G         T76369      81.39%         85.94%  \n",
       "8       P62937              4N1M         T47081      80.31%         98.57%  \n",
       "9       P08238              5FWK  Not Available         80%         96.77%  \n",
       "10      P23415              4X5T         T50269      79.44%         90.71%  \n",
       "11      P67870              6TLS         T51565      79.37%         99.23%  \n",
       "12      P11511              3S79         T13260      78.78%         91.76%  \n",
       "13      Q969S8     Not Available         T94324       78.4%         90.08%  \n",
       "14      P15144              4FYT         T67272      77.49%         93.31%  \n",
       "15      Q8TDU6              7CFM         T86273      77.18%         93.65%  \n",
       "16      P21462     Not Available         T87831      75.29%         93.56%  \n",
       "17      Q16665              4H6J  Not Available      75.28%         85.14%  \n",
       "18      P07858              3PBH         T61746      75.23%         93.67%  \n",
       "19      P14780              5UE3  Not Available      74.85%         92.12%  \n",
       "20      O75469              6TFI         T82702      74.67%         94.73%  \n",
       "21      P05106              6UJA         T67103      74.27%         95.71%  \n",
       "22      Q00975     Not Available         T38338      73.79%         97.14%  \n",
       "23      P08253              1CK7  Not Available      73.48%         96.31%  \n",
       "24      P42785              3N2Z  Not Available      71.69%           100%  \n",
       "25      Q96GG9              6BG3  Not Available      71.17%            95%  \n",
       "26      P11388              6ZY5         T17048      70.97%            89%  \n",
       "27      O00329              6PYR         T67849      70.35%         96.47%  \n",
       "28      Q9HC97     Not Available  Not Available      69.59%         89.34%  \n",
       "29      P29275     Not Available         T86679      69.38%         98.59%  \n",
       "30      Q16288              6KZD  Not Available      68.76%         95.89%  \n",
       "31      P13569              6MSM         T55654      68.66%         95.71%  \n",
       "32      O00206              4G8A         T81443      68.63%          92.5%  \n",
       "33      P00338              5W8J  Not Available      68.42%         95.34%  \n",
       "34      P48775              6PYZ  Not Available      68.31%         98.46%  \n",
       "35      P22894              1I76  Not Available      67.76%         94.66%  \n",
       "36      Q9H228     Not Available         T50089      67.76%           100%  \n",
       "37      P42345              6BCX         T75243      67.71%         92.78%  \n",
       "38      Q9HAZ1              6FYV  Not Available      67.25%         94.45%  \n",
       "39      Q15418              2Z7Q  Not Available       67.2%         85.11%  \n",
       "40      P03956              1SU3  Not Available      67.13%          94.5%  \n",
       "41      Q16236              2FLU  Not Available      66.67%            96%  \n",
       "42      Q8IU80     Not Available  Not Available      66.52%         98.33%  \n",
       "43      P32246     Not Available         T16016      66.28%          89.5%  \n",
       "44      Q00535              1UNL         T20973      65.63%         93.03%  \n",
       "45      O95180     Not Available         T54644      65.01%         98.57%  \n",
       "46      Q9NS75     Not Available         T74238      64.94%            98%  \n",
       "47      Q9HCR9     Not Available  Not Available      64.59%            85%  \n",
       "48      P36507              1S9I  Not Available      64.44%            80%  \n",
       "49      P17706              1L8K  Not Available      64.24%            93%  \n",
       "50      Q9NY46     Not Available         T76937      63.75%          96.9%  \n",
       "51      P46098     Not Available         T64591      63.59%           100%  \n",
       "52      P28065              6E5B  Not Available       63.5%          97.5%  \n",
       "53      Q06418              1RHF  Not Available      63.17%            96%  \n",
       "54      P33527              4C3Z         T11288       62.6%         96.37%  \n",
       "55      P04070              6M3B         T24836       62.4%         93.89%  \n",
       "56      Q05586              5EWM  Not Available      62.11%         95.89%  \n",
       "57      P51452              3F81  Not Available      62.09%            94%  \n",
       "58      P19634              7DSX         T82028      61.84%         90.24%  \n",
       "59      O14744              6V0P         T82665      61.53%           100%  \n",
       "60      P49862              2QXI  Not Available      61.27%            94%  \n",
       "61      Q06124              5EHR         T13057       61.2%         94.42%  \n",
       "62      P08235              4PF3  Not Available      60.67%           100%  \n",
       "63      P07384              1ZCM  Not Available      60.64%         93.04%  \n",
       "64      O00767              4ZYO         T10897      60.11%          97.5%  \n",
       "65      Q14145              6WCQ  Not Available      59.93%         82.38%  \n",
       "66      Q13304     Not Available  Not Available       59.8%         80.33%  \n",
       "67      O15118              6W5S  Not Available       59.8%         81.11%  \n",
       "68      P07195              1I0Z  Not Available      59.77%         95.53%  \n",
       "69      Q16512              4OTH  Not Available      59.48%         80.71%  \n",
       "70      P25090              6OMM  Not Available      58.99%           100%  \n",
       "71      Q99572     Not Available         T63414      58.78%          97.5%  \n",
       "72      P21730              6C1R         T15439      58.71%         92.62%  \n",
       "73      P50281              3C7X  Not Available       58.4%          93.1%  \n",
       "74      P61964              2GNQ  Not Available      58.35%         96.33%  \n",
       "75      Q9GZT9              4BQY  Not Available      58.22%          93.4%  \n",
       "76      Q00535              4AU8         T20973      58.13%         79.09%  \n",
       "77      O14672              6BE6         T31902      57.77%          97.5%  \n",
       "78      P29375              5V9P  Not Available      57.76%         99.23%  \n",
       "79      Q92847              6KO5         T59604       57.7%            92%  \n",
       "80      P49760              6KHE  Not Available       57.7%         80.96%  \n",
       "81      Q13822              4ZG6  Not Available      57.35%         96.39%  \n",
       "82      P51151              1WMS         T66350      57.22%         87.67%  \n",
       "83      P08684              5VCC         T37848      57.14%         91.19%  \n",
       "84      P36544              7EKP         T34429       57.1%         88.42%  \n",
       "85      P20618              6KWY  Not Available      56.98%            90%  \n",
       "86      Q15910              5HYN         T25265      56.86%          97.5%  \n",
       "87      P41968     Not Available         T76846      56.76%         99.52%  \n",
       "88      O95665     Not Available  Not Available      56.72%           100%  \n",
       "89      P10275              3V49         T11211      56.55%         96.43%  \n",
       "90      Q13887     Not Available  Not Available      56.38%         86.33%  \n",
       "91      P00488              4KTY  Not Available      56.25%            96%  \n",
       "92      P09619              3MJG         T53524      55.66%         71.67%  \n",
       "93      P09237              2Y6D  Not Available      55.64%         97.56%  \n",
       "94      P17931              6FOF         T72038      54.97%          96.9%  \n",
       "95      P33032     Not Available         T95302      54.78%            97%  \n",
       "96      Q9NP59              6WBV         T86264      54.49%            95%  \n",
       "97      P07477              2RA3         T27602      54.48%            90%  \n",
       "98      Q9Y4P1              2CY7  Not Available      54.42%          87.5%  \n",
       "99      P16234              7LBF         T53524      54.17%         91.07%  \n",
       "100     P41597              5T1A         T89988       54.1%         98.57%  \n",
       "101     Q9UM73              4Z55         T56418      53.89%         96.86%  \n",
       "102     P06493              6GU2         T49898      53.87%         91.24%  \n",
       "103     Q92769              7KBG         T51191      53.52%         94.75%  \n",
       "104     Q96DB2     Not Available  Not Available       53.5%         88.56%  \n",
       "105     Q9UQL6              5UWI  Not Available      52.92%         89.67%  \n",
       "106     P05121              3CVM         T15556      52.87%            83%  \n",
       "107     O15530              5LVO         T20891      52.44%         95.36%  \n",
       "108     Q96P65     Not Available  Not Available      52.44%            85%  \n",
       "109     P45452              4FVL  Not Available       52.2%         95.26%  \n",
       "110     P07711              6JD8         T41141      52.05%         96.61%  \n",
       "111     P55212              2WDP  Not Available      52.03%         97.56%  \n",
       "112     O75874              6BKX         T69563      51.93%            99%  \n",
       "113     P42262              2WJW         T42392      51.89%         86.92%  \n",
       "114     Q08881              4HCU         T91761      51.87%            95%  \n",
       "115     P30926              6UR8         T70967      51.48%           100%  \n",
       "116     P39900              3BA0  Not Available       51.4%         92.22%  \n",
       "117     P14902              6E43         T89697      51.37%         96.38%  \n",
       "118     Q13085              6G2H  Not Available      51.09%         93.04%  \n",
       "119     P14174              6B1K         T39977      50.95%         80.78%  \n",
       "120     P27986              4JPS         T80276      50.89%         94.33%  \n",
       "121     P80365     Not Available         T43721      50.73%         94.78%  \n",
       "122     Q9HBX9     Not Available         T73696       50.5%          82.5%  \n",
       "123     P17252              4RA4         T12808      50.38%         98.03%  \n",
       "124     P35557              3F9M         T87166      50.33%         91.96%  \n",
       "125     O60341              5L3D  Not Available      50.32%         97.09%  \n",
       "126     O00257              5EPL  Not Available      50.24%            93%  "
      ]
     },
     "execution_count": 22,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "sp_trg = pd.read_csv('20_3_files/Targets.csv', sep=',')\n",
    "sp_trg"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2023-10-13T21:01:21.416565Z",
     "start_time": "2023-10-13T21:01:21.391502Z"
    },
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Target Name</th>\n",
       "      <th>ChEMBL-ID</th>\n",
       "      <th>UniProt ID</th>\n",
       "      <th>PDB Visualization</th>\n",
       "      <th>TTD ID</th>\n",
       "      <th>Probability</th>\n",
       "      <th>Model accuracy</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>count</th>\n",
       "      <td>127</td>\n",
       "      <td>127</td>\n",
       "      <td>127</td>\n",
       "      <td>127</td>\n",
       "      <td>127</td>\n",
       "      <td>127</td>\n",
       "      <td>127</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>unique</th>\n",
       "      <td>127</td>\n",
       "      <td>127</td>\n",
       "      <td>126</td>\n",
       "      <td>104</td>\n",
       "      <td>68</td>\n",
       "      <td>123</td>\n",
       "      <td>100</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>top</th>\n",
       "      <td>Cannabinoid CB2 receptor</td>\n",
       "      <td>CHEMBL253</td>\n",
       "      <td>Q00535</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>57.7%</td>\n",
       "      <td>100%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>freq</th>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>24</td>\n",
       "      <td>58</td>\n",
       "      <td>2</td>\n",
       "      <td>8</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                     Target Name  ChEMBL-ID UniProt ID PDB Visualization  \\\n",
       "count                        127        127        127               127   \n",
       "unique                       127        127        126               104   \n",
       "top     Cannabinoid CB2 receptor  CHEMBL253     Q00535     Not Available   \n",
       "freq                           1          1          2                24   \n",
       "\n",
       "               TTD ID Probability Model accuracy  \n",
       "count             127         127            127  \n",
       "unique             68         123            100  \n",
       "top     Not Available       57.7%           100%  \n",
       "freq               58           2              8  "
      ]
     },
     "execution_count": 23,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "sp_trg.describe()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "В качестве наиболее вероятной (**Probability**=95,73%; **Model accuracy**=98,95%) мишени Super-PRED выдает каннабиоидный рецептор 2-го типа (CB$_2$), что в теории позволяет рассматривать Фузафунгин в качестве возможного антидепрессанта."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2023-10-13T21:04:45.646125Z",
     "start_time": "2023-10-13T21:04:45.569718Z"
    }
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Target Name</th>\n",
       "      <th>ChEMBL-ID</th>\n",
       "      <th>Indication</th>\n",
       "      <th>Probability</th>\n",
       "      <th>Model accuracy</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Cathepsin D</td>\n",
       "      <td>T67102</td>\n",
       "      <td>Hypertension [ICD-11: BA00-BA04]</td>\n",
       "      <td>91.51%</td>\n",
       "      <td>98.95%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Cathepsin D</td>\n",
       "      <td>T67102</td>\n",
       "      <td>Multiple sclerosis [ICD-11: 8A40]</td>\n",
       "      <td>91.51%</td>\n",
       "      <td>98.95%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>G-protein coupled receptor 55</td>\n",
       "      <td>T87670</td>\n",
       "      <td>Attention deficit hyperactivity disorder [ICD-...</td>\n",
       "      <td>88.35%</td>\n",
       "      <td>78.15%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Acyl coenzyme A:cholesterol acyltransferase</td>\n",
       "      <td>T76369</td>\n",
       "      <td>Acute lymphoblastic leukaemia [ICD-11: 2A85]</td>\n",
       "      <td>81.39%</td>\n",
       "      <td>85.94%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Acyl coenzyme A:cholesterol acyltransferase</td>\n",
       "      <td>T76369</td>\n",
       "      <td>Arteriosclerosis [ICD-11: BD40]</td>\n",
       "      <td>81.39%</td>\n",
       "      <td>85.94%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Acyl coenzyme A:cholesterol acyltransferase</td>\n",
       "      <td>T76369</td>\n",
       "      <td>Hypercholesterolaemia [ICD-11: 5C80.0]</td>\n",
       "      <td>81.39%</td>\n",
       "      <td>85.94%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>Acyl coenzyme A:cholesterol acyltransferase</td>\n",
       "      <td>T76369</td>\n",
       "      <td>Hyperlipidaemia [ICD-11: 5C80]</td>\n",
       "      <td>81.39%</td>\n",
       "      <td>85.94%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>Acyl coenzyme A:cholesterol acyltransferase</td>\n",
       "      <td>T76369</td>\n",
       "      <td>Peripheral vascular disease [ICD-11: BD4Z]</td>\n",
       "      <td>81.39%</td>\n",
       "      <td>85.94%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>Acyl coenzyme A:cholesterol acyltransferase</td>\n",
       "      <td>T76369</td>\n",
       "      <td>Peroxisomal disorder [ICD-11: 5C57]</td>\n",
       "      <td>81.39%</td>\n",
       "      <td>85.94%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>Acyl coenzyme A:cholesterol acyltransferase</td>\n",
       "      <td>T76369</td>\n",
       "      <td>Synthesis disorder [ICD-11: 5C52-5C59]</td>\n",
       "      <td>81.39%</td>\n",
       "      <td>85.94%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>Cyclophilin A</td>\n",
       "      <td>T47081</td>\n",
       "      <td>Malnutrition [ICD-11: 5B50-5B71]</td>\n",
       "      <td>80.31%</td>\n",
       "      <td>98.57%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>Glycine receptor subunit alpha-1</td>\n",
       "      <td>T50269</td>\n",
       "      <td>Muscle spasm [ICD-11: MB47.3]</td>\n",
       "      <td>79.44%</td>\n",
       "      <td>90.71%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>Casein kinase II alpha/beta</td>\n",
       "      <td>T51565</td>\n",
       "      <td>Cholangiocarcinoma [ICD-11: 2C12.10]</td>\n",
       "      <td>79.37%</td>\n",
       "      <td>99.23%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>Casein kinase II alpha/beta</td>\n",
       "      <td>T51565</td>\n",
       "      <td>Solid tumour/cancer [ICD-11: 2A00-2F9Z]</td>\n",
       "      <td>79.37%</td>\n",
       "      <td>99.23%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>Cytochrome P450 19A1</td>\n",
       "      <td>T13260</td>\n",
       "      <td>Bladder cancer [ICD-11: 2C94]</td>\n",
       "      <td>78.78%</td>\n",
       "      <td>91.76%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>Cytochrome P450 19A1</td>\n",
       "      <td>T13260</td>\n",
       "      <td>Cushing disease [ICD-11: 5A70]</td>\n",
       "      <td>78.78%</td>\n",
       "      <td>91.76%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>Cytochrome P450 19A1</td>\n",
       "      <td>T13260</td>\n",
       "      <td>Dermatological disease [ICD-11: DA24.Y]</td>\n",
       "      <td>78.78%</td>\n",
       "      <td>91.76%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>Cytochrome P450 19A1</td>\n",
       "      <td>T13260</td>\n",
       "      <td>Diabetic neuropathy [ICD-11: 8C0Z]</td>\n",
       "      <td>78.78%</td>\n",
       "      <td>91.76%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>Cytochrome P450 19A1</td>\n",
       "      <td>T13260</td>\n",
       "      <td>Endometriosis [ICD-11: GA10]</td>\n",
       "      <td>78.78%</td>\n",
       "      <td>91.76%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>Cytochrome P450 19A1</td>\n",
       "      <td>T13260</td>\n",
       "      <td>Hormonally-responsive breast cancer [ICD-11: 2...</td>\n",
       "      <td>78.78%</td>\n",
       "      <td>91.76%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>Cytochrome P450 19A1</td>\n",
       "      <td>T13260</td>\n",
       "      <td>Prostate disease [ICD-11: GA91]</td>\n",
       "      <td>78.78%</td>\n",
       "      <td>91.76%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>Histone deacetylase 10</td>\n",
       "      <td>T94324</td>\n",
       "      <td>Solid tumour/cancer [ICD-11: 2A00-2F9Z]</td>\n",
       "      <td>78.4%</td>\n",
       "      <td>90.08%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>Aminopeptidase N</td>\n",
       "      <td>T67272</td>\n",
       "      <td>Psoriasis vulgaris [ICD-11: EA90]</td>\n",
       "      <td>77.49%</td>\n",
       "      <td>93.31%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>G-protein coupled bile acid receptor 1</td>\n",
       "      <td>T86273</td>\n",
       "      <td>Metabolic disorder [ICD-11: 5C50-5D2Z]</td>\n",
       "      <td>77.18%</td>\n",
       "      <td>93.65%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>G-protein coupled bile acid receptor 1</td>\n",
       "      <td>T86273</td>\n",
       "      <td>Type-2 diabetes [ICD-11: 5A11]</td>\n",
       "      <td>77.18%</td>\n",
       "      <td>93.65%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>Formyl peptide receptor 1</td>\n",
       "      <td>T87831</td>\n",
       "      <td>Inflammation [ICD-11: 1A00-CA43.1]</td>\n",
       "      <td>75.29%</td>\n",
       "      <td>93.56%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>Formyl peptide receptor 1</td>\n",
       "      <td>T87831</td>\n",
       "      <td>Peptic ulcer [ICD-11: DA61]</td>\n",
       "      <td>75.29%</td>\n",
       "      <td>93.56%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>Cathepsin B</td>\n",
       "      <td>T61746</td>\n",
       "      <td>Alzheimer disease [ICD-11: 8A20]</td>\n",
       "      <td>75.23%</td>\n",
       "      <td>93.67%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>Cathepsin B</td>\n",
       "      <td>T61746</td>\n",
       "      <td>Asthma [ICD-11: CA23]</td>\n",
       "      <td>75.23%</td>\n",
       "      <td>93.67%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>Cathepsin B</td>\n",
       "      <td>T61746</td>\n",
       "      <td>Bone cancer [ICD-11: 2B5Z]</td>\n",
       "      <td>75.23%</td>\n",
       "      <td>93.67%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>Cathepsin B</td>\n",
       "      <td>T61746</td>\n",
       "      <td>Cancer related pain [ICD-11: MG30]</td>\n",
       "      <td>75.23%</td>\n",
       "      <td>93.67%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>Cathepsin B</td>\n",
       "      <td>T61746</td>\n",
       "      <td>Cerebral ischemia [ICD-11: 8B11]</td>\n",
       "      <td>75.23%</td>\n",
       "      <td>93.67%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32</th>\n",
       "      <td>Cathepsin B</td>\n",
       "      <td>T61746</td>\n",
       "      <td>Chronic obstructive pulmonary disease [ICD-11:...</td>\n",
       "      <td>75.23%</td>\n",
       "      <td>93.67%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33</th>\n",
       "      <td>Cathepsin B</td>\n",
       "      <td>T61746</td>\n",
       "      <td>Cirrhosis [ICD-11: DB93]</td>\n",
       "      <td>75.23%</td>\n",
       "      <td>93.67%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>34</th>\n",
       "      <td>Cathepsin B</td>\n",
       "      <td>T61746</td>\n",
       "      <td>Gastrointestinal disease [ICD-11: DE2Z]</td>\n",
       "      <td>75.23%</td>\n",
       "      <td>93.67%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>Cathepsin B</td>\n",
       "      <td>T61746</td>\n",
       "      <td>Glioma [ICD-11: 2A00.0]</td>\n",
       "      <td>75.23%</td>\n",
       "      <td>93.67%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36</th>\n",
       "      <td>Cathepsin B</td>\n",
       "      <td>T61746</td>\n",
       "      <td>Hair loss [ICD-11: ED70]</td>\n",
       "      <td>75.23%</td>\n",
       "      <td>93.67%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>37</th>\n",
       "      <td>Cathepsin B</td>\n",
       "      <td>T61746</td>\n",
       "      <td>Hepatic fibrosis [ICD-11: DB93.0]</td>\n",
       "      <td>75.23%</td>\n",
       "      <td>93.67%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>38</th>\n",
       "      <td>Cathepsin B</td>\n",
       "      <td>T61746</td>\n",
       "      <td>Meningioma tumour [ICD-11: 2A01]</td>\n",
       "      <td>75.23%</td>\n",
       "      <td>93.67%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>39</th>\n",
       "      <td>Cathepsin B</td>\n",
       "      <td>T61746</td>\n",
       "      <td>Metastatic cancer [ICD-11: 2D50-2E2Z]</td>\n",
       "      <td>75.23%</td>\n",
       "      <td>93.67%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>40</th>\n",
       "      <td>Cathepsin B</td>\n",
       "      <td>T61746</td>\n",
       "      <td>Multiple sclerosis [ICD-11: 8A40]</td>\n",
       "      <td>75.23%</td>\n",
       "      <td>93.67%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>41</th>\n",
       "      <td>Cathepsin B</td>\n",
       "      <td>T61746</td>\n",
       "      <td>Neurodegenerative disorder [ICD-11: 8A20-8A23]</td>\n",
       "      <td>75.23%</td>\n",
       "      <td>93.67%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>42</th>\n",
       "      <td>Cathepsin B</td>\n",
       "      <td>T61746</td>\n",
       "      <td>Osteoarthritis [ICD-11: FA00-FA05]</td>\n",
       "      <td>75.23%</td>\n",
       "      <td>93.67%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>43</th>\n",
       "      <td>Cathepsin B</td>\n",
       "      <td>T61746</td>\n",
       "      <td>Pancreatitis [ICD-11: DC31-DC34]</td>\n",
       "      <td>75.23%</td>\n",
       "      <td>93.67%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>44</th>\n",
       "      <td>Cathepsin B</td>\n",
       "      <td>T61746</td>\n",
       "      <td>Psoriasis vulgaris [ICD-11: EA90]</td>\n",
       "      <td>75.23%</td>\n",
       "      <td>93.67%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45</th>\n",
       "      <td>Cathepsin B</td>\n",
       "      <td>T61746</td>\n",
       "      <td>Rheumatoid arthritis [ICD-11: FA20]</td>\n",
       "      <td>75.23%</td>\n",
       "      <td>93.67%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>46</th>\n",
       "      <td>Pregnane X receptor</td>\n",
       "      <td>T82702</td>\n",
       "      <td>Arteriosclerosis [ICD-11: BD40]</td>\n",
       "      <td>74.67%</td>\n",
       "      <td>94.73%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>47</th>\n",
       "      <td>Integrin alpha-V/beta-3</td>\n",
       "      <td>T67103</td>\n",
       "      <td>Colorectal cancer [ICD-11: 2B91.Z]</td>\n",
       "      <td>74.27%</td>\n",
       "      <td>95.71%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>48</th>\n",
       "      <td>Integrin alpha-V/beta-3</td>\n",
       "      <td>T67103</td>\n",
       "      <td>Solid tumour/cancer [ICD-11: 2A00-2F9Z]</td>\n",
       "      <td>74.27%</td>\n",
       "      <td>95.71%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49</th>\n",
       "      <td>Voltage-gated N-type calcium channel alpha-1B ...</td>\n",
       "      <td>T38338</td>\n",
       "      <td>Anxiety disorder [ICD-11: 6B00-6B0Z]</td>\n",
       "      <td>73.79%</td>\n",
       "      <td>97.14%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>50</th>\n",
       "      <td>Voltage-gated N-type calcium channel alpha-1B ...</td>\n",
       "      <td>T38338</td>\n",
       "      <td>Cardiac failure [ICD-11: BD10-BD13]</td>\n",
       "      <td>73.79%</td>\n",
       "      <td>97.14%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>51</th>\n",
       "      <td>Voltage-gated N-type calcium channel alpha-1B ...</td>\n",
       "      <td>T38338</td>\n",
       "      <td>High blood pressure [ICD-11: BA00]</td>\n",
       "      <td>73.79%</td>\n",
       "      <td>97.14%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>52</th>\n",
       "      <td>Voltage-gated N-type calcium channel alpha-1B ...</td>\n",
       "      <td>T38338</td>\n",
       "      <td>Migraine [ICD-11: 8A80]</td>\n",
       "      <td>73.79%</td>\n",
       "      <td>97.14%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53</th>\n",
       "      <td>Voltage-gated N-type calcium channel alpha-1B ...</td>\n",
       "      <td>T38338</td>\n",
       "      <td>Neuropathic pain [ICD-11: 8E43.0]</td>\n",
       "      <td>73.79%</td>\n",
       "      <td>97.14%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>54</th>\n",
       "      <td>Voltage-gated N-type calcium channel alpha-1B ...</td>\n",
       "      <td>T38338</td>\n",
       "      <td>Pain [ICD-11: MG30-MG3Z]</td>\n",
       "      <td>73.79%</td>\n",
       "      <td>97.14%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>55</th>\n",
       "      <td>Voltage-gated N-type calcium channel alpha-1B ...</td>\n",
       "      <td>T38338</td>\n",
       "      <td>Reperfusion injury [ICD-11: ND56.Z]</td>\n",
       "      <td>73.79%</td>\n",
       "      <td>97.14%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>56</th>\n",
       "      <td>Voltage-gated N-type calcium channel alpha-1B ...</td>\n",
       "      <td>T38338</td>\n",
       "      <td>Traumatic brain injury [ICD-11: NA07.Z]</td>\n",
       "      <td>73.79%</td>\n",
       "      <td>97.14%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>57</th>\n",
       "      <td>Voltage-gated N-type calcium channel alpha-1B ...</td>\n",
       "      <td>T38338</td>\n",
       "      <td>Vascular purpura [ICD-11: 3B60]</td>\n",
       "      <td>73.79%</td>\n",
       "      <td>97.14%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>58</th>\n",
       "      <td>DNA topoisomerase II alpha</td>\n",
       "      <td>T17048</td>\n",
       "      <td>Solid tumour/cancer [ICD-11: 2A00-2F9Z]</td>\n",
       "      <td>70.97%</td>\n",
       "      <td>89%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>59</th>\n",
       "      <td>PI3-kinase p110-delta subunit</td>\n",
       "      <td>T67849</td>\n",
       "      <td>Arthritis [ICD-11: FA20]</td>\n",
       "      <td>70.35%</td>\n",
       "      <td>96.47%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>60</th>\n",
       "      <td>PI3-kinase p110-delta subunit</td>\n",
       "      <td>T67849</td>\n",
       "      <td>Breast cancer [ICD-11: 2C60-2C65]</td>\n",
       "      <td>70.35%</td>\n",
       "      <td>96.47%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>61</th>\n",
       "      <td>PI3-kinase p110-delta subunit</td>\n",
       "      <td>T67849</td>\n",
       "      <td>Chronic lymphocytic leukaemia [ICD-11: 2A82.0]</td>\n",
       "      <td>70.35%</td>\n",
       "      <td>96.47%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>62</th>\n",
       "      <td>PI3-kinase p110-delta subunit</td>\n",
       "      <td>T67849</td>\n",
       "      <td>Coronavirus Disease 2019 (COVID-19) [ICD-11: 1...</td>\n",
       "      <td>70.35%</td>\n",
       "      <td>96.47%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>63</th>\n",
       "      <td>PI3-kinase p110-delta subunit</td>\n",
       "      <td>T67849</td>\n",
       "      <td>Cutaneous T-cell lymphoma [ICD-11: 2B01]</td>\n",
       "      <td>70.35%</td>\n",
       "      <td>96.47%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>64</th>\n",
       "      <td>PI3-kinase p110-delta subunit</td>\n",
       "      <td>T67849</td>\n",
       "      <td>Diffuse large B-cell lymphoma [ICD-11: 2A81]</td>\n",
       "      <td>70.35%</td>\n",
       "      <td>96.47%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>65</th>\n",
       "      <td>PI3-kinase p110-delta subunit</td>\n",
       "      <td>T67849</td>\n",
       "      <td>Follicular lymphoma [ICD-11: 2A80]</td>\n",
       "      <td>70.35%</td>\n",
       "      <td>96.47%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>66</th>\n",
       "      <td>PI3-kinase p110-delta subunit</td>\n",
       "      <td>T67849</td>\n",
       "      <td>Follicular lymphoma [ICD-11: 2A80]</td>\n",
       "      <td>70.35%</td>\n",
       "      <td>96.47%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>67</th>\n",
       "      <td>PI3-kinase p110-delta subunit</td>\n",
       "      <td>T67849</td>\n",
       "      <td>Hematologic tumour [ICD-11: 2B33.Y]</td>\n",
       "      <td>70.35%</td>\n",
       "      <td>96.47%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>68</th>\n",
       "      <td>PI3-kinase p110-delta subunit</td>\n",
       "      <td>T67849</td>\n",
       "      <td>Lymphoma [ICD-11: 2A80-2A86]</td>\n",
       "      <td>70.35%</td>\n",
       "      <td>96.47%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>69</th>\n",
       "      <td>PI3-kinase p110-delta subunit</td>\n",
       "      <td>T67849</td>\n",
       "      <td>Mantle cell lymphoma [ICD-11: 2A85.5]</td>\n",
       "      <td>70.35%</td>\n",
       "      <td>96.47%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70</th>\n",
       "      <td>PI3-kinase p110-delta subunit</td>\n",
       "      <td>T67849</td>\n",
       "      <td>Marginal zone lymphoma [ICD-11: 2A85.0]</td>\n",
       "      <td>70.35%</td>\n",
       "      <td>96.47%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>71</th>\n",
       "      <td>PI3-kinase p110-delta subunit</td>\n",
       "      <td>T67849</td>\n",
       "      <td>Myeloid leukaemia [ICD-11: 2B33.1]</td>\n",
       "      <td>70.35%</td>\n",
       "      <td>96.47%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>72</th>\n",
       "      <td>PI3-kinase p110-delta subunit</td>\n",
       "      <td>T67849</td>\n",
       "      <td>Non-hodgkin lymphoma [ICD-11: 2B33.5]</td>\n",
       "      <td>70.35%</td>\n",
       "      <td>96.47%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>73</th>\n",
       "      <td>PI3-kinase p110-delta subunit</td>\n",
       "      <td>T67849</td>\n",
       "      <td>Solid tumour/cancer [ICD-11: 2A00-2F9Z]</td>\n",
       "      <td>70.35%</td>\n",
       "      <td>96.47%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>74</th>\n",
       "      <td>Adenosine A2b receptor</td>\n",
       "      <td>T86679</td>\n",
       "      <td>Acute and chronic heart failure [ICD-11: BD1Z]</td>\n",
       "      <td>69.38%</td>\n",
       "      <td>98.59%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>75</th>\n",
       "      <td>Adenosine A2b receptor</td>\n",
       "      <td>T86679</td>\n",
       "      <td>Alzheimer disease [ICD-11: 8A20]</td>\n",
       "      <td>69.38%</td>\n",
       "      <td>98.59%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>76</th>\n",
       "      <td>Adenosine A2b receptor</td>\n",
       "      <td>T86679</td>\n",
       "      <td>Apnea [ICD-11: MD11.0]</td>\n",
       "      <td>69.38%</td>\n",
       "      <td>98.59%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>77</th>\n",
       "      <td>Adenosine A2b receptor</td>\n",
       "      <td>T86679</td>\n",
       "      <td>Asthma [ICD-11: CA23]</td>\n",
       "      <td>69.38%</td>\n",
       "      <td>98.59%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>78</th>\n",
       "      <td>Adenosine A2b receptor</td>\n",
       "      <td>T86679</td>\n",
       "      <td>Herpes simplex virus infection [ICD-11: 1F00]</td>\n",
       "      <td>69.38%</td>\n",
       "      <td>98.59%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>79</th>\n",
       "      <td>Adenosine A2b receptor</td>\n",
       "      <td>T86679</td>\n",
       "      <td>Hypertension [ICD-11: BA00-BA04]</td>\n",
       "      <td>69.38%</td>\n",
       "      <td>98.59%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>80</th>\n",
       "      <td>Adenosine A2b receptor</td>\n",
       "      <td>T86679</td>\n",
       "      <td>Multiple sclerosis [ICD-11: 8A40]</td>\n",
       "      <td>69.38%</td>\n",
       "      <td>98.59%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>81</th>\n",
       "      <td>Adenosine A2b receptor</td>\n",
       "      <td>T86679</td>\n",
       "      <td>Non-insulin dependent diabetes [ICD-11: 5A11]</td>\n",
       "      <td>69.38%</td>\n",
       "      <td>98.59%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>82</th>\n",
       "      <td>Adenosine A2b receptor</td>\n",
       "      <td>T86679</td>\n",
       "      <td>Non-small-cell lung cancer [ICD-11: 2C25.Y]</td>\n",
       "      <td>69.38%</td>\n",
       "      <td>98.59%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>83</th>\n",
       "      <td>Adenosine A2b receptor</td>\n",
       "      <td>T86679</td>\n",
       "      <td>Parkinson disease [ICD-11: 8A00.0]</td>\n",
       "      <td>69.38%</td>\n",
       "      <td>98.59%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>84</th>\n",
       "      <td>Adenosine A2b receptor</td>\n",
       "      <td>T86679</td>\n",
       "      <td>Paroxysmal supraventricular tachycardia [ICD-1...</td>\n",
       "      <td>69.38%</td>\n",
       "      <td>98.59%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>85</th>\n",
       "      <td>Adenosine A2b receptor</td>\n",
       "      <td>T86679</td>\n",
       "      <td>Solid tumour/cancer [ICD-11: 2A00-2F9Z]</td>\n",
       "      <td>69.38%</td>\n",
       "      <td>98.59%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>86</th>\n",
       "      <td>Cystic fibrosis transmembrane conductance regu...</td>\n",
       "      <td>T55654</td>\n",
       "      <td>Acute lung injury [ICD-11: NB32.3]</td>\n",
       "      <td>68.66%</td>\n",
       "      <td>95.71%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>87</th>\n",
       "      <td>Cystic fibrosis transmembrane conductance regu...</td>\n",
       "      <td>T55654</td>\n",
       "      <td>Cystic fibrosis [ICD-11: CA25]</td>\n",
       "      <td>68.66%</td>\n",
       "      <td>95.71%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>88</th>\n",
       "      <td>Cystic fibrosis transmembrane conductance regu...</td>\n",
       "      <td>T55654</td>\n",
       "      <td>Diarrhea [ICD-11: ME05.1]</td>\n",
       "      <td>68.66%</td>\n",
       "      <td>95.71%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>89</th>\n",
       "      <td>Cystic fibrosis transmembrane conductance regu...</td>\n",
       "      <td>T55654</td>\n",
       "      <td>HIV-associated diarrhoea [ICD-11: 1A2Z]</td>\n",
       "      <td>68.66%</td>\n",
       "      <td>95.71%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>90</th>\n",
       "      <td>Toll-like receptor 4</td>\n",
       "      <td>T81443</td>\n",
       "      <td>Allergy [ICD-11: 4A80-4A85]</td>\n",
       "      <td>68.63%</td>\n",
       "      <td>92.5%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>91</th>\n",
       "      <td>Toll-like receptor 4</td>\n",
       "      <td>T81443</td>\n",
       "      <td>Autoimmune diabetes [ICD-11: 5A10]</td>\n",
       "      <td>68.63%</td>\n",
       "      <td>92.5%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>92</th>\n",
       "      <td>Toll-like receptor 4</td>\n",
       "      <td>T81443</td>\n",
       "      <td>Hepatitis virus infection [ICD-11: 1E50-1E51]</td>\n",
       "      <td>68.63%</td>\n",
       "      <td>92.5%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>93</th>\n",
       "      <td>Toll-like receptor 4</td>\n",
       "      <td>T81443</td>\n",
       "      <td>Melanoma [ICD-11: 2C30]</td>\n",
       "      <td>68.63%</td>\n",
       "      <td>92.5%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>94</th>\n",
       "      <td>Toll-like receptor 4</td>\n",
       "      <td>T81443</td>\n",
       "      <td>Non-hodgkin lymphoma [ICD-11: 2B33.5]</td>\n",
       "      <td>68.63%</td>\n",
       "      <td>92.5%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>95</th>\n",
       "      <td>Toll-like receptor 4</td>\n",
       "      <td>T81443</td>\n",
       "      <td>Prostate cancer [ICD-11: 2C82.0]</td>\n",
       "      <td>68.63%</td>\n",
       "      <td>92.5%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>96</th>\n",
       "      <td>Toll-like receptor 4</td>\n",
       "      <td>T81443</td>\n",
       "      <td>Sepsis [ICD-11: 1G40-1G41]</td>\n",
       "      <td>68.63%</td>\n",
       "      <td>92.5%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>97</th>\n",
       "      <td>Toll-like receptor 4</td>\n",
       "      <td>T81443</td>\n",
       "      <td>Solid tumour/cancer [ICD-11: 2A00-2F9Z]</td>\n",
       "      <td>68.63%</td>\n",
       "      <td>92.5%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>98</th>\n",
       "      <td>Sphingosine 1-phosphate receptor Edg-8</td>\n",
       "      <td>T50089</td>\n",
       "      <td>Multiple sclerosis [ICD-11: 8A40]</td>\n",
       "      <td>67.76%</td>\n",
       "      <td>100%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>99</th>\n",
       "      <td>Serine/threonine-protein kinase mTOR</td>\n",
       "      <td>T99685</td>\n",
       "      <td>Advanced/metastatic breast cancer [ICD-11: 2C60]</td>\n",
       "      <td>67.71%</td>\n",
       "      <td>92.78%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>100</th>\n",
       "      <td>Serine/threonine-protein kinase mTOR</td>\n",
       "      <td>T99685</td>\n",
       "      <td>Artery stenosis [ICD-11: BD52]</td>\n",
       "      <td>67.71%</td>\n",
       "      <td>92.78%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>101</th>\n",
       "      <td>Serine/threonine-protein kinase mTOR</td>\n",
       "      <td>T99685</td>\n",
       "      <td>Breast cancer [ICD-11: 2C60-2C65]</td>\n",
       "      <td>67.71%</td>\n",
       "      <td>92.78%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>102</th>\n",
       "      <td>Serine/threonine-protein kinase mTOR</td>\n",
       "      <td>T99685</td>\n",
       "      <td>Breast cancer [ICD-11: 2C60-2C65]</td>\n",
       "      <td>67.71%</td>\n",
       "      <td>92.78%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>103</th>\n",
       "      <td>Serine/threonine-protein kinase mTOR</td>\n",
       "      <td>T99685</td>\n",
       "      <td>Chronic myelomonocytic leukaemia [ICD-11: 2A40]</td>\n",
       "      <td>67.71%</td>\n",
       "      <td>92.78%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>104</th>\n",
       "      <td>Serine/threonine-protein kinase mTOR</td>\n",
       "      <td>T99685</td>\n",
       "      <td>Coronavirus Disease 2019 (COVID-19) [ICD-11: 1...</td>\n",
       "      <td>67.71%</td>\n",
       "      <td>92.78%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>105</th>\n",
       "      <td>Serine/threonine-protein kinase mTOR</td>\n",
       "      <td>T99685</td>\n",
       "      <td>Dutch elm disease [ICD-11: 8D64]</td>\n",
       "      <td>67.71%</td>\n",
       "      <td>92.78%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>106</th>\n",
       "      <td>Serine/threonine-protein kinase mTOR</td>\n",
       "      <td>T99685</td>\n",
       "      <td>Endometrial cancer [ICD-11: 2C76]</td>\n",
       "      <td>67.71%</td>\n",
       "      <td>92.78%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>107</th>\n",
       "      <td>Serine/threonine-protein kinase mTOR</td>\n",
       "      <td>T99685</td>\n",
       "      <td>Head and neck cancer [ICD-11: 2D42]</td>\n",
       "      <td>67.71%</td>\n",
       "      <td>92.78%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>108</th>\n",
       "      <td>Serine/threonine-protein kinase mTOR</td>\n",
       "      <td>T99685</td>\n",
       "      <td>Hepatocellular carcinoma [ICD-11: 2C12.02]</td>\n",
       "      <td>67.71%</td>\n",
       "      <td>92.78%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>109</th>\n",
       "      <td>Serine/threonine-protein kinase mTOR</td>\n",
       "      <td>T99685</td>\n",
       "      <td>Inflammation [ICD-11: 1A00-CA43.1]</td>\n",
       "      <td>67.71%</td>\n",
       "      <td>92.78%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>110</th>\n",
       "      <td>Serine/threonine-protein kinase mTOR</td>\n",
       "      <td>T99685</td>\n",
       "      <td>Kidney cancer [ICD-11: 2C90.0]</td>\n",
       "      <td>67.71%</td>\n",
       "      <td>92.78%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>111</th>\n",
       "      <td>Serine/threonine-protein kinase mTOR</td>\n",
       "      <td>T99685</td>\n",
       "      <td>Lung cancer [ICD-11: 2C25.0]</td>\n",
       "      <td>67.71%</td>\n",
       "      <td>92.78%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>112</th>\n",
       "      <td>Serine/threonine-protein kinase mTOR</td>\n",
       "      <td>T99685</td>\n",
       "      <td>Lymphangioleiomyomatosis [ICD-11: CB07]</td>\n",
       "      <td>67.71%</td>\n",
       "      <td>92.78%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>113</th>\n",
       "      <td>Serine/threonine-protein kinase mTOR</td>\n",
       "      <td>T99685</td>\n",
       "      <td>Lymphangioleiomyomatosis [ICD-11: CB07]</td>\n",
       "      <td>67.71%</td>\n",
       "      <td>92.78%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>114</th>\n",
       "      <td>Serine/threonine-protein kinase mTOR</td>\n",
       "      <td>T99685</td>\n",
       "      <td>Lymphoma [ICD-11: 2A80-2A86]</td>\n",
       "      <td>67.71%</td>\n",
       "      <td>92.78%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>115</th>\n",
       "      <td>Serine/threonine-protein kinase mTOR</td>\n",
       "      <td>T99685</td>\n",
       "      <td>Malignant mesothelioma [ICD-11: 2C26.0]</td>\n",
       "      <td>67.71%</td>\n",
       "      <td>92.78%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>116</th>\n",
       "      <td>Serine/threonine-protein kinase mTOR</td>\n",
       "      <td>T99685</td>\n",
       "      <td>Malignant perivascular epithelioid cell tumour...</td>\n",
       "      <td>67.71%</td>\n",
       "      <td>92.78%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>117</th>\n",
       "      <td>Serine/threonine-protein kinase mTOR</td>\n",
       "      <td>T99685</td>\n",
       "      <td>Middle East Respiratory Syndrome (MERS) [ICD-1...</td>\n",
       "      <td>67.71%</td>\n",
       "      <td>92.78%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>118</th>\n",
       "      <td>Serine/threonine-protein kinase mTOR</td>\n",
       "      <td>T99685</td>\n",
       "      <td>Multiple myeloma [ICD-11: 2A83]</td>\n",
       "      <td>67.71%</td>\n",
       "      <td>92.78%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>119</th>\n",
       "      <td>Serine/threonine-protein kinase mTOR</td>\n",
       "      <td>T99685</td>\n",
       "      <td>Non-hodgkin lymphoma [ICD-11: 2B33.5]</td>\n",
       "      <td>67.71%</td>\n",
       "      <td>92.78%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>120</th>\n",
       "      <td>Serine/threonine-protein kinase mTOR</td>\n",
       "      <td>T99685</td>\n",
       "      <td>Non-muscle invasive bladder cancer [ICD-11: 2C94]</td>\n",
       "      <td>67.71%</td>\n",
       "      <td>92.78%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121</th>\n",
       "      <td>Serine/threonine-protein kinase mTOR</td>\n",
       "      <td>T99685</td>\n",
       "      <td>Non-small-cell lung cancer [ICD-11: 2C25.Y]</td>\n",
       "      <td>67.71%</td>\n",
       "      <td>92.78%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>122</th>\n",
       "      <td>Serine/threonine-protein kinase mTOR</td>\n",
       "      <td>T99685</td>\n",
       "      <td>Organ transplant rejection [ICD-11: NE84]</td>\n",
       "      <td>67.71%</td>\n",
       "      <td>92.78%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>123</th>\n",
       "      <td>Serine/threonine-protein kinase mTOR</td>\n",
       "      <td>T99685</td>\n",
       "      <td>Pain [ICD-11: MG30-MG3Z]</td>\n",
       "      <td>67.71%</td>\n",
       "      <td>92.78%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>124</th>\n",
       "      <td>Serine/threonine-protein kinase mTOR</td>\n",
       "      <td>T99685</td>\n",
       "      <td>Pancreatic cancer [ICD-11: 2C10]</td>\n",
       "      <td>67.71%</td>\n",
       "      <td>92.78%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>125</th>\n",
       "      <td>Serine/threonine-protein kinase mTOR</td>\n",
       "      <td>T99685</td>\n",
       "      <td>Prostate cancer [ICD-11: 2C82.0]</td>\n",
       "      <td>67.71%</td>\n",
       "      <td>92.78%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>126</th>\n",
       "      <td>Serine/threonine-protein kinase mTOR</td>\n",
       "      <td>T99685</td>\n",
       "      <td>Pulmonary arterial hypertension [ICD-11: BB01.0]</td>\n",
       "      <td>67.71%</td>\n",
       "      <td>92.78%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>127</th>\n",
       "      <td>Serine/threonine-protein kinase mTOR</td>\n",
       "      <td>T99685</td>\n",
       "      <td>Renal cell carcinoma [ICD-11: 2C90]</td>\n",
       "      <td>67.71%</td>\n",
       "      <td>92.78%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>128</th>\n",
       "      <td>Serine/threonine-protein kinase mTOR</td>\n",
       "      <td>T99685</td>\n",
       "      <td>Sarcoma [ICD-11: 2A60-2C35]</td>\n",
       "      <td>67.71%</td>\n",
       "      <td>92.78%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>129</th>\n",
       "      <td>Serine/threonine-protein kinase mTOR</td>\n",
       "      <td>T99685</td>\n",
       "      <td>Severe acute respiratory syndrome (SARS) [ICD-...</td>\n",
       "      <td>67.71%</td>\n",
       "      <td>92.78%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>130</th>\n",
       "      <td>Serine/threonine-protein kinase mTOR</td>\n",
       "      <td>T99685</td>\n",
       "      <td>Solid tumour/cancer [ICD-11: 2A00-2F9Z]</td>\n",
       "      <td>67.71%</td>\n",
       "      <td>92.78%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>131</th>\n",
       "      <td>Serine/threonine-protein kinase mTOR</td>\n",
       "      <td>T99685</td>\n",
       "      <td>Ulcerative colitis [ICD-11: DD71]</td>\n",
       "      <td>67.71%</td>\n",
       "      <td>92.78%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>132</th>\n",
       "      <td>C-C chemokine receptor type 1</td>\n",
       "      <td>T16016</td>\n",
       "      <td>Autoimmune diabetes [ICD-11: 5A10]</td>\n",
       "      <td>66.28%</td>\n",
       "      <td>89.5%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>133</th>\n",
       "      <td>C-C chemokine receptor type 1</td>\n",
       "      <td>T16016</td>\n",
       "      <td>Chronic obstructive pulmonary disease [ICD-11:...</td>\n",
       "      <td>66.28%</td>\n",
       "      <td>89.5%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>134</th>\n",
       "      <td>C-C chemokine receptor type 1</td>\n",
       "      <td>T16016</td>\n",
       "      <td>Rheumatoid arthritis [ICD-11: FA20]</td>\n",
       "      <td>66.28%</td>\n",
       "      <td>89.5%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>135</th>\n",
       "      <td>Cyclin-dependent kinase 5/CDK5 activator 1</td>\n",
       "      <td>T20973</td>\n",
       "      <td>Obesity [ICD-11: 5B81]</td>\n",
       "      <td>65.63%</td>\n",
       "      <td>93.03%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>136</th>\n",
       "      <td>Voltage-gated T-type calcium channel alpha-1H ...</td>\n",
       "      <td>T54644</td>\n",
       "      <td>Angina pectoris [ICD-11: BA40]</td>\n",
       "      <td>65.01%</td>\n",
       "      <td>98.57%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>137</th>\n",
       "      <td>Voltage-gated T-type calcium channel alpha-1H ...</td>\n",
       "      <td>T54644</td>\n",
       "      <td>Glioblastoma multiforme [ICD-11: 2A00.0]</td>\n",
       "      <td>65.01%</td>\n",
       "      <td>98.57%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>138</th>\n",
       "      <td>Voltage-gated T-type calcium channel alpha-1H ...</td>\n",
       "      <td>T54644</td>\n",
       "      <td>Insomnia [ICD-11: 7A00-7A0Z]</td>\n",
       "      <td>65.01%</td>\n",
       "      <td>98.57%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>139</th>\n",
       "      <td>Voltage-gated T-type calcium channel alpha-1H ...</td>\n",
       "      <td>T54644</td>\n",
       "      <td>Metabolic acidosis [ICD-11: 5C73]</td>\n",
       "      <td>65.01%</td>\n",
       "      <td>98.57%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>140</th>\n",
       "      <td>Voltage-gated T-type calcium channel alpha-1H ...</td>\n",
       "      <td>T54644</td>\n",
       "      <td>Migraine [ICD-11: 8A80]</td>\n",
       "      <td>65.01%</td>\n",
       "      <td>98.57%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>141</th>\n",
       "      <td>Voltage-gated T-type calcium channel alpha-1H ...</td>\n",
       "      <td>T54644</td>\n",
       "      <td>Ovarian cancer [ICD-11: 2C73]</td>\n",
       "      <td>65.01%</td>\n",
       "      <td>98.57%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>142</th>\n",
       "      <td>Voltage-gated T-type calcium channel alpha-1H ...</td>\n",
       "      <td>T54644</td>\n",
       "      <td>Pain [ICD-11: MG30-MG3Z]</td>\n",
       "      <td>65.01%</td>\n",
       "      <td>98.57%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>143</th>\n",
       "      <td>Voltage-gated T-type calcium channel alpha-1H ...</td>\n",
       "      <td>T54644</td>\n",
       "      <td>Solid tumour/cancer [ICD-11: 2A00-2F9Z]</td>\n",
       "      <td>65.01%</td>\n",
       "      <td>98.57%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>144</th>\n",
       "      <td>Cysteinyl leukotriene receptor 2</td>\n",
       "      <td>T74238</td>\n",
       "      <td>Asthma [ICD-11: CA23]</td>\n",
       "      <td>64.94%</td>\n",
       "      <td>98%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>145</th>\n",
       "      <td>Sodium channel protein type III alpha subunit</td>\n",
       "      <td>T76937</td>\n",
       "      <td>Angina pectoris [ICD-11: BA40]</td>\n",
       "      <td>63.75%</td>\n",
       "      <td>96.9%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>146</th>\n",
       "      <td>Sodium channel protein type III alpha subunit</td>\n",
       "      <td>T76937</td>\n",
       "      <td>Neurological disorder [ICD-11: 6B60]</td>\n",
       "      <td>63.75%</td>\n",
       "      <td>96.9%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>147</th>\n",
       "      <td>Sodium channel protein type III alpha subunit</td>\n",
       "      <td>T76937</td>\n",
       "      <td>Pain [ICD-11: MG30-MG3Z]</td>\n",
       "      <td>63.75%</td>\n",
       "      <td>96.9%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>148</th>\n",
       "      <td>Serotonin 3a (5-HT3a) receptor</td>\n",
       "      <td>T64591</td>\n",
       "      <td>Anaesthesia [ICD-11: 9A78.6]</td>\n",
       "      <td>63.59%</td>\n",
       "      <td>100%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>149</th>\n",
       "      <td>Serotonin 3a (5-HT3a) receptor</td>\n",
       "      <td>T64591</td>\n",
       "      <td>Chemotherapy-induced nausea [ICD-11: MD90]</td>\n",
       "      <td>63.59%</td>\n",
       "      <td>100%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>150</th>\n",
       "      <td>Serotonin 3a (5-HT3a) receptor</td>\n",
       "      <td>T64591</td>\n",
       "      <td>Epilepsy [ICD-11: 8A60-8A68]</td>\n",
       "      <td>63.59%</td>\n",
       "      <td>100%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>151</th>\n",
       "      <td>Serotonin 3a (5-HT3a) receptor</td>\n",
       "      <td>T64591</td>\n",
       "      <td>Fibromyalgia [ICD-11: MG30.01]</td>\n",
       "      <td>63.59%</td>\n",
       "      <td>100%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>152</th>\n",
       "      <td>Serotonin 3a (5-HT3a) receptor</td>\n",
       "      <td>T64591</td>\n",
       "      <td>Gastroesophageal reflux disease [ICD-11: DA22.Z]</td>\n",
       "      <td>63.59%</td>\n",
       "      <td>100%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>153</th>\n",
       "      <td>Serotonin 3a (5-HT3a) receptor</td>\n",
       "      <td>T64591</td>\n",
       "      <td>Irritable bowel syndrome [ICD-11: DD91.0]</td>\n",
       "      <td>63.59%</td>\n",
       "      <td>100%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>154</th>\n",
       "      <td>Serotonin 3a (5-HT3a) receptor</td>\n",
       "      <td>T64591</td>\n",
       "      <td>Schizophrenia [ICD-11: 6A20]</td>\n",
       "      <td>63.59%</td>\n",
       "      <td>100%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>155</th>\n",
       "      <td>Multidrug resistance-associated protein 1</td>\n",
       "      <td>T11288</td>\n",
       "      <td>Gout [ICD-11: FA25]</td>\n",
       "      <td>62.6%</td>\n",
       "      <td>96.37%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>156</th>\n",
       "      <td>Vitamin K-dependent protein C</td>\n",
       "      <td>T24836</td>\n",
       "      <td>Blood forming organ disorder [ICD-11: JB64.1]</td>\n",
       "      <td>62.4%</td>\n",
       "      <td>93.89%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>157</th>\n",
       "      <td>Vitamin K-dependent protein C</td>\n",
       "      <td>T24836</td>\n",
       "      <td>Cardiovascular disease [ICD-11: BA00-BE2Z]</td>\n",
       "      <td>62.4%</td>\n",
       "      <td>93.89%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>158</th>\n",
       "      <td>Vitamin K-dependent protein C</td>\n",
       "      <td>T24836</td>\n",
       "      <td>Cerebrovascular ischaemia [ICD-11: 8B1Z]</td>\n",
       "      <td>62.4%</td>\n",
       "      <td>93.89%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>159</th>\n",
       "      <td>Vitamin K-dependent protein C</td>\n",
       "      <td>T24836</td>\n",
       "      <td>Hemangioma [ICD-11: 2E81-2F2Y]</td>\n",
       "      <td>62.4%</td>\n",
       "      <td>93.89%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>160</th>\n",
       "      <td>Vitamin K-dependent protein C</td>\n",
       "      <td>T24836</td>\n",
       "      <td>Ischemic stroke [ICD-11: 8B11.5Z]</td>\n",
       "      <td>62.4%</td>\n",
       "      <td>93.89%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>161</th>\n",
       "      <td>Vitamin K-dependent protein C</td>\n",
       "      <td>T24836</td>\n",
       "      <td>Varicose and spider veins of leg [ICD-11: BD74.1]</td>\n",
       "      <td>62.4%</td>\n",
       "      <td>93.89%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>162</th>\n",
       "      <td>Sodium/hydrogen exchanger 1</td>\n",
       "      <td>T82028</td>\n",
       "      <td>Angina pectoris [ICD-11: BA40]</td>\n",
       "      <td>61.84%</td>\n",
       "      <td>90.24%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>163</th>\n",
       "      <td>Sodium/hydrogen exchanger 1</td>\n",
       "      <td>T82028</td>\n",
       "      <td>Cardiac arrhythmias [ICD-11: BC9Z]</td>\n",
       "      <td>61.84%</td>\n",
       "      <td>90.24%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>164</th>\n",
       "      <td>Sodium/hydrogen exchanger 1</td>\n",
       "      <td>T82028</td>\n",
       "      <td>Heart arrhythmia [ICD-11: BC65]</td>\n",
       "      <td>61.84%</td>\n",
       "      <td>90.24%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>165</th>\n",
       "      <td>Sodium/hydrogen exchanger 1</td>\n",
       "      <td>T82028</td>\n",
       "      <td>Myocardial infarction [ICD-11: BA41-BA43]</td>\n",
       "      <td>61.84%</td>\n",
       "      <td>90.24%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>166</th>\n",
       "      <td>PRMT5/MEP50 complex</td>\n",
       "      <td>T82665</td>\n",
       "      <td>Non-hodgkin lymphoma [ICD-11: 2B33.5]</td>\n",
       "      <td>61.53%</td>\n",
       "      <td>100%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>167</th>\n",
       "      <td>PRMT5/MEP50 complex</td>\n",
       "      <td>T82665</td>\n",
       "      <td>Solid tumour/cancer [ICD-11: 2A00-2F9Z]</td>\n",
       "      <td>61.53%</td>\n",
       "      <td>100%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>168</th>\n",
       "      <td>Protein-tyrosine phosphatase 2C</td>\n",
       "      <td>T13057</td>\n",
       "      <td>Solid tumour/cancer [ICD-11: 2A00-2F9Z]</td>\n",
       "      <td>61.2%</td>\n",
       "      <td>94.42%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>169</th>\n",
       "      <td>Acyl-CoA desaturase</td>\n",
       "      <td>T10897</td>\n",
       "      <td>Bacterial infection [ICD-11: 1A00-1C4Z]</td>\n",
       "      <td>60.11%</td>\n",
       "      <td>97.5%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>170</th>\n",
       "      <td>Acyl-CoA desaturase</td>\n",
       "      <td>T10897</td>\n",
       "      <td>Diabetic complication [ICD-11: 5A2Y]</td>\n",
       "      <td>60.11%</td>\n",
       "      <td>97.5%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>171</th>\n",
       "      <td>Acyl-CoA desaturase</td>\n",
       "      <td>T10897</td>\n",
       "      <td>Lipid metabolism disorder [ICD-11: 5C52.Z]</td>\n",
       "      <td>60.11%</td>\n",
       "      <td>97.5%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>172</th>\n",
       "      <td>Acyl-CoA desaturase</td>\n",
       "      <td>T10897</td>\n",
       "      <td>Type-2 diabetes [ICD-11: 5A11]</td>\n",
       "      <td>60.11%</td>\n",
       "      <td>97.5%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>173</th>\n",
       "      <td>P2X purinoceptor 7</td>\n",
       "      <td>T63414</td>\n",
       "      <td>Alzheimer disease [ICD-11: 8A20]</td>\n",
       "      <td>58.78%</td>\n",
       "      <td>97.5%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>174</th>\n",
       "      <td>P2X purinoceptor 7</td>\n",
       "      <td>T63414</td>\n",
       "      <td>Anhedonia [ICD-11: MB24.2]</td>\n",
       "      <td>58.78%</td>\n",
       "      <td>97.5%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>175</th>\n",
       "      <td>P2X purinoceptor 7</td>\n",
       "      <td>T63414</td>\n",
       "      <td>Arthralgia [ICD-11: ME82]</td>\n",
       "      <td>58.78%</td>\n",
       "      <td>97.5%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>176</th>\n",
       "      <td>P2X purinoceptor 7</td>\n",
       "      <td>T63414</td>\n",
       "      <td>Autoimmune diabetes [ICD-11: 5A10]</td>\n",
       "      <td>58.78%</td>\n",
       "      <td>97.5%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>177</th>\n",
       "      <td>P2X purinoceptor 7</td>\n",
       "      <td>T63414</td>\n",
       "      <td>Chronic obstructive pulmonary disease [ICD-11:...</td>\n",
       "      <td>58.78%</td>\n",
       "      <td>97.5%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>178</th>\n",
       "      <td>P2X purinoceptor 7</td>\n",
       "      <td>T63414</td>\n",
       "      <td>Inflammation [ICD-11: 1A00-CA43.1]</td>\n",
       "      <td>58.78%</td>\n",
       "      <td>97.5%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>179</th>\n",
       "      <td>P2X purinoceptor 7</td>\n",
       "      <td>T63414</td>\n",
       "      <td>Inflammatory bowel disease [ICD-11: DD72]</td>\n",
       "      <td>58.78%</td>\n",
       "      <td>97.5%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>180</th>\n",
       "      <td>P2X purinoceptor 7</td>\n",
       "      <td>T63414</td>\n",
       "      <td>Major depressive disorder [ICD-11: 6A70.3]</td>\n",
       "      <td>58.78%</td>\n",
       "      <td>97.5%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>181</th>\n",
       "      <td>P2X purinoceptor 7</td>\n",
       "      <td>T63414</td>\n",
       "      <td>Mood disorder [ICD-11: 6A60-6E23]</td>\n",
       "      <td>58.78%</td>\n",
       "      <td>97.5%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>182</th>\n",
       "      <td>P2X purinoceptor 7</td>\n",
       "      <td>T63414</td>\n",
       "      <td>Neuroinflammation [ICD-11: 1D0Y]</td>\n",
       "      <td>58.78%</td>\n",
       "      <td>97.5%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>183</th>\n",
       "      <td>P2X purinoceptor 7</td>\n",
       "      <td>T63414</td>\n",
       "      <td>Pain [ICD-11: MG30-MG3Z]</td>\n",
       "      <td>58.78%</td>\n",
       "      <td>97.5%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>184</th>\n",
       "      <td>P2X purinoceptor 7</td>\n",
       "      <td>T63414</td>\n",
       "      <td>Rheumatoid arthritis [ICD-11: FA20]</td>\n",
       "      <td>58.78%</td>\n",
       "      <td>97.5%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>185</th>\n",
       "      <td>P2X purinoceptor 7</td>\n",
       "      <td>T63414</td>\n",
       "      <td>Solid tumour/cancer [ICD-11: 2A00-2F9Z]</td>\n",
       "      <td>58.78%</td>\n",
       "      <td>97.5%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>186</th>\n",
       "      <td>C5a anaphylatoxin chemotactic receptor</td>\n",
       "      <td>T15439</td>\n",
       "      <td>Atopic dermatitis [ICD-11: EA80]</td>\n",
       "      <td>58.71%</td>\n",
       "      <td>92.62%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>187</th>\n",
       "      <td>C5a anaphylatoxin chemotactic receptor</td>\n",
       "      <td>T15439</td>\n",
       "      <td>Eosinophilic granulomatosis with polyangiitis ...</td>\n",
       "      <td>58.71%</td>\n",
       "      <td>92.62%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>188</th>\n",
       "      <td>C5a anaphylatoxin chemotactic receptor</td>\n",
       "      <td>T15439</td>\n",
       "      <td>Hereditary haemolytic anemia [ICD-11: 3A10.3]</td>\n",
       "      <td>58.71%</td>\n",
       "      <td>92.62%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>189</th>\n",
       "      <td>C5a anaphylatoxin chemotactic receptor</td>\n",
       "      <td>T15439</td>\n",
       "      <td>Inflammation [ICD-11: 1A00-CA43.1]</td>\n",
       "      <td>58.71%</td>\n",
       "      <td>92.62%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>190</th>\n",
       "      <td>C5a anaphylatoxin chemotactic receptor</td>\n",
       "      <td>T15439</td>\n",
       "      <td>Rheumatoid arthritis [ICD-11: FA20]</td>\n",
       "      <td>58.71%</td>\n",
       "      <td>92.62%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>191</th>\n",
       "      <td>C5a anaphylatoxin chemotactic receptor</td>\n",
       "      <td>T15439</td>\n",
       "      <td>Vasculitis [ICD-11: 4A44]</td>\n",
       "      <td>58.71%</td>\n",
       "      <td>92.62%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>192</th>\n",
       "      <td>Cyclin-dependent kinase 5</td>\n",
       "      <td>T20973</td>\n",
       "      <td>Obesity [ICD-11: 5B81]</td>\n",
       "      <td>58.13%</td>\n",
       "      <td>79.09%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>193</th>\n",
       "      <td>ADAM10</td>\n",
       "      <td>T31902</td>\n",
       "      <td>Breast cancer [ICD-11: 2C60-2C65]</td>\n",
       "      <td>57.77%</td>\n",
       "      <td>97.5%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>194</th>\n",
       "      <td>ADAM10</td>\n",
       "      <td>T31902</td>\n",
       "      <td>Solid tumour/cancer [ICD-11: 2A00-2F9Z]</td>\n",
       "      <td>57.77%</td>\n",
       "      <td>97.5%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>195</th>\n",
       "      <td>Ghrelin receptor</td>\n",
       "      <td>T59604</td>\n",
       "      <td>Alcohol dependence [ICD-11: 6C40.2]</td>\n",
       "      <td>57.7%</td>\n",
       "      <td>92%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>196</th>\n",
       "      <td>Ghrelin receptor</td>\n",
       "      <td>T59604</td>\n",
       "      <td>Anorexia nervosa cachexia [ICD-11: 6B80]</td>\n",
       "      <td>57.7%</td>\n",
       "      <td>92%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>197</th>\n",
       "      <td>Ghrelin receptor</td>\n",
       "      <td>T59604</td>\n",
       "      <td>Cachexia [ICD-11: MG20]</td>\n",
       "      <td>57.7%</td>\n",
       "      <td>92%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>198</th>\n",
       "      <td>Ghrelin receptor</td>\n",
       "      <td>T59604</td>\n",
       "      <td>Carbohydrate metabolism disorder [ICD-11: 5C51.Z]</td>\n",
       "      <td>57.7%</td>\n",
       "      <td>92%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>199</th>\n",
       "      <td>Ghrelin receptor</td>\n",
       "      <td>T59604</td>\n",
       "      <td>Fibromyalgia [ICD-11: MG30.01]</td>\n",
       "      <td>57.7%</td>\n",
       "      <td>92%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>200</th>\n",
       "      <td>Ghrelin receptor</td>\n",
       "      <td>T59604</td>\n",
       "      <td>Frailty [ICD-11: MG2A]</td>\n",
       "      <td>57.7%</td>\n",
       "      <td>92%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>201</th>\n",
       "      <td>Ghrelin receptor</td>\n",
       "      <td>T59604</td>\n",
       "      <td>Functional bowel disorder [ICD-11: DD91]</td>\n",
       "      <td>57.7%</td>\n",
       "      <td>92%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>202</th>\n",
       "      <td>Ghrelin receptor</td>\n",
       "      <td>T59604</td>\n",
       "      <td>Gastric motility disorder [ICD-11: DA21]</td>\n",
       "      <td>57.7%</td>\n",
       "      <td>92%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>203</th>\n",
       "      <td>Ghrelin receptor</td>\n",
       "      <td>T59604</td>\n",
       "      <td>Gastrointestinal disease [ICD-11: DE2Z]</td>\n",
       "      <td>57.7%</td>\n",
       "      <td>92%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>204</th>\n",
       "      <td>Ghrelin receptor</td>\n",
       "      <td>T59604</td>\n",
       "      <td>Gastroparesis [ICD-11: DA41.00]</td>\n",
       "      <td>57.7%</td>\n",
       "      <td>92%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>205</th>\n",
       "      <td>Ghrelin receptor</td>\n",
       "      <td>T59604</td>\n",
       "      <td>Growth hormone deficiency [ICD-11: 5A61.3]</td>\n",
       "      <td>57.7%</td>\n",
       "      <td>92%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>206</th>\n",
       "      <td>Ghrelin receptor</td>\n",
       "      <td>T59604</td>\n",
       "      <td>Ileus [ICD-11: DA93.0]</td>\n",
       "      <td>57.7%</td>\n",
       "      <td>92%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>207</th>\n",
       "      <td>Ghrelin receptor</td>\n",
       "      <td>T59604</td>\n",
       "      <td>Metabolic disorder [ICD-11: 5C50-5D2Z]</td>\n",
       "      <td>57.7%</td>\n",
       "      <td>92%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>208</th>\n",
       "      <td>Ghrelin receptor</td>\n",
       "      <td>T59604</td>\n",
       "      <td>Obesity [ICD-11: 5B81]</td>\n",
       "      <td>57.7%</td>\n",
       "      <td>92%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>209</th>\n",
       "      <td>Ghrelin receptor</td>\n",
       "      <td>T59604</td>\n",
       "      <td>Postoperative ileus [ICD-11: DA91-DB30]</td>\n",
       "      <td>57.7%</td>\n",
       "      <td>92%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>210</th>\n",
       "      <td>Ghrelin receptor</td>\n",
       "      <td>T59604</td>\n",
       "      <td>Solid tumour/cancer [ICD-11: 2A00-2F9Z]</td>\n",
       "      <td>57.7%</td>\n",
       "      <td>92%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>211</th>\n",
       "      <td>Ghrelin receptor</td>\n",
       "      <td>T59604</td>\n",
       "      <td>Somatotropin deficiency [ICD-11: 5A61.0]</td>\n",
       "      <td>57.7%</td>\n",
       "      <td>92%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>212</th>\n",
       "      <td>Ghrelin receptor</td>\n",
       "      <td>T59604</td>\n",
       "      <td>Type-2 diabetes [ICD-11: 5A11]</td>\n",
       "      <td>57.7%</td>\n",
       "      <td>92%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>213</th>\n",
       "      <td>Ras-related protein Rab-9A</td>\n",
       "      <td>T66350</td>\n",
       "      <td>Fungal infection [ICD-11: 1F29-1F2F]</td>\n",
       "      <td>57.22%</td>\n",
       "      <td>87.67%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>214</th>\n",
       "      <td>Cytochrome P450 3A4</td>\n",
       "      <td>T37848</td>\n",
       "      <td>Atopic dermatitis [ICD-11: EA80]</td>\n",
       "      <td>57.14%</td>\n",
       "      <td>91.19%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>215</th>\n",
       "      <td>Cytochrome P450 3A4</td>\n",
       "      <td>T37848</td>\n",
       "      <td>Solid tumour/cancer [ICD-11: 2A00-2F9Z]</td>\n",
       "      <td>57.14%</td>\n",
       "      <td>91.19%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>216</th>\n",
       "      <td>Neuronal acetylcholine receptor protein alpha-...</td>\n",
       "      <td>T34429</td>\n",
       "      <td>Alzheimer disease [ICD-11: 8A20]</td>\n",
       "      <td>57.1%</td>\n",
       "      <td>88.42%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>217</th>\n",
       "      <td>Neuronal acetylcholine receptor protein alpha-...</td>\n",
       "      <td>T34429</td>\n",
       "      <td>Anaesthesia [ICD-11: 9A78.6]</td>\n",
       "      <td>57.1%</td>\n",
       "      <td>88.42%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218</th>\n",
       "      <td>Neuronal acetylcholine receptor protein alpha-...</td>\n",
       "      <td>T34429</td>\n",
       "      <td>Asthma [ICD-11: CA23]</td>\n",
       "      <td>57.1%</td>\n",
       "      <td>88.42%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>219</th>\n",
       "      <td>Neuronal acetylcholine receptor protein alpha-...</td>\n",
       "      <td>T34429</td>\n",
       "      <td>Attention deficit hyperactivity disorder [ICD-...</td>\n",
       "      <td>57.1%</td>\n",
       "      <td>88.42%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>220</th>\n",
       "      <td>Neuronal acetylcholine receptor protein alpha-...</td>\n",
       "      <td>T34429</td>\n",
       "      <td>Breast cancer [ICD-11: 2C60-2C65]</td>\n",
       "      <td>57.1%</td>\n",
       "      <td>88.42%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>221</th>\n",
       "      <td>Neuronal acetylcholine receptor protein alpha-...</td>\n",
       "      <td>T34429</td>\n",
       "      <td>Central nervous system disease [ICD-11: 8A04-8...</td>\n",
       "      <td>57.1%</td>\n",
       "      <td>88.42%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>222</th>\n",
       "      <td>Neuronal acetylcholine receptor protein alpha-...</td>\n",
       "      <td>T34429</td>\n",
       "      <td>Cognitive impairment [ICD-11: 6D71]</td>\n",
       "      <td>57.1%</td>\n",
       "      <td>88.42%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>223</th>\n",
       "      <td>Neuronal acetylcholine receptor protein alpha-...</td>\n",
       "      <td>T34429</td>\n",
       "      <td>Complete androgen insensitivity syndrome [ICD-...</td>\n",
       "      <td>57.1%</td>\n",
       "      <td>88.42%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>224</th>\n",
       "      <td>Neuronal acetylcholine receptor protein alpha-...</td>\n",
       "      <td>T34429</td>\n",
       "      <td>Depression [ICD-11: 6A70-6A7Z]</td>\n",
       "      <td>57.1%</td>\n",
       "      <td>88.42%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>225</th>\n",
       "      <td>Neuronal acetylcholine receptor protein alpha-...</td>\n",
       "      <td>T34429</td>\n",
       "      <td>Immune dysregulation [ICD-11: 4A01.2]</td>\n",
       "      <td>57.1%</td>\n",
       "      <td>88.42%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>226</th>\n",
       "      <td>Neuronal acetylcholine receptor protein alpha-...</td>\n",
       "      <td>T34429</td>\n",
       "      <td>Neurological disorder [ICD-11: 6B60]</td>\n",
       "      <td>57.1%</td>\n",
       "      <td>88.42%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>227</th>\n",
       "      <td>Neuronal acetylcholine receptor protein alpha-...</td>\n",
       "      <td>T34429</td>\n",
       "      <td>Neuropathic pain [ICD-11: 8E43.0]</td>\n",
       "      <td>57.1%</td>\n",
       "      <td>88.42%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>228</th>\n",
       "      <td>Neuronal acetylcholine receptor protein alpha-...</td>\n",
       "      <td>T34429</td>\n",
       "      <td>Parkinson disease [ICD-11: 8A00.0]</td>\n",
       "      <td>57.1%</td>\n",
       "      <td>88.42%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>229</th>\n",
       "      <td>Neuronal acetylcholine receptor protein alpha-...</td>\n",
       "      <td>T34429</td>\n",
       "      <td>Psychiatric disorder [ICD-11: 6E8Z]</td>\n",
       "      <td>57.1%</td>\n",
       "      <td>88.42%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>230</th>\n",
       "      <td>Neuronal acetylcholine receptor protein alpha-...</td>\n",
       "      <td>T34429</td>\n",
       "      <td>Schizophrenia [ICD-11: 6A20]</td>\n",
       "      <td>57.1%</td>\n",
       "      <td>88.42%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>231</th>\n",
       "      <td>Neuronal acetylcholine receptor protein alpha-...</td>\n",
       "      <td>T34429</td>\n",
       "      <td>Sexual dysfunction [ICD-11: HA00-HA01]</td>\n",
       "      <td>57.1%</td>\n",
       "      <td>88.42%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>232</th>\n",
       "      <td>Neuronal acetylcholine receptor protein alpha-...</td>\n",
       "      <td>T34429</td>\n",
       "      <td>Thrombosis [ICD-11: DB61-GB90]</td>\n",
       "      <td>57.1%</td>\n",
       "      <td>88.42%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>233</th>\n",
       "      <td>Neuronal acetylcholine receptor protein alpha-...</td>\n",
       "      <td>T34429</td>\n",
       "      <td>Tobacco dependence [ICD-11: 6C4A.2]</td>\n",
       "      <td>57.1%</td>\n",
       "      <td>88.42%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>234</th>\n",
       "      <td>Histone-lysine N-methyltransferase EZH2</td>\n",
       "      <td>T25265</td>\n",
       "      <td>Acute lymphoblastic leukaemia [ICD-11: 2A85]</td>\n",
       "      <td>56.86%</td>\n",
       "      <td>97.5%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>235</th>\n",
       "      <td>Histone-lysine N-methyltransferase EZH2</td>\n",
       "      <td>T25265</td>\n",
       "      <td>Acute myeloid leukaemia [ICD-11: 2A60]</td>\n",
       "      <td>56.86%</td>\n",
       "      <td>97.5%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>236</th>\n",
       "      <td>Histone-lysine N-methyltransferase EZH2</td>\n",
       "      <td>T25265</td>\n",
       "      <td>B-cell lymphoma [ICD-11: 2A86]</td>\n",
       "      <td>56.86%</td>\n",
       "      <td>97.5%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>237</th>\n",
       "      <td>Histone-lysine N-methyltransferase EZH2</td>\n",
       "      <td>T25265</td>\n",
       "      <td>Brain and central nervous system tumour [ICD-1...</td>\n",
       "      <td>56.86%</td>\n",
       "      <td>97.5%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>238</th>\n",
       "      <td>Histone-lysine N-methyltransferase EZH2</td>\n",
       "      <td>T25265</td>\n",
       "      <td>Diffuse large B-cell lymphoma [ICD-11: 2A81]</td>\n",
       "      <td>56.86%</td>\n",
       "      <td>97.5%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>239</th>\n",
       "      <td>Histone-lysine N-methyltransferase EZH2</td>\n",
       "      <td>T25265</td>\n",
       "      <td>Malignant rhabdoid tumour [ICD-11: 2A00.1Y]</td>\n",
       "      <td>56.86%</td>\n",
       "      <td>97.5%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>240</th>\n",
       "      <td>Histone-lysine N-methyltransferase EZH2</td>\n",
       "      <td>T25265</td>\n",
       "      <td>Mesothelioma [ICD-11: 2C51.2]</td>\n",
       "      <td>56.86%</td>\n",
       "      <td>97.5%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>241</th>\n",
       "      <td>Histone-lysine N-methyltransferase EZH2</td>\n",
       "      <td>T25265</td>\n",
       "      <td>Prostate cancer [ICD-11: 2C82.0]</td>\n",
       "      <td>56.86%</td>\n",
       "      <td>97.5%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>242</th>\n",
       "      <td>Histone-lysine N-methyltransferase EZH2</td>\n",
       "      <td>T25265</td>\n",
       "      <td>Solid tumour/cancer [ICD-11: 2A00-2F9Z]</td>\n",
       "      <td>56.86%</td>\n",
       "      <td>97.5%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>243</th>\n",
       "      <td>Histone-lysine N-methyltransferase EZH2</td>\n",
       "      <td>T25265</td>\n",
       "      <td>Synovial sarcoma [ICD-11: 2B5A]</td>\n",
       "      <td>56.86%</td>\n",
       "      <td>97.5%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>244</th>\n",
       "      <td>Melanocortin receptor 3</td>\n",
       "      <td>T76846</td>\n",
       "      <td>Female sexual arousal dysfunction [ICD-11: HA0...</td>\n",
       "      <td>56.76%</td>\n",
       "      <td>99.52%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>245</th>\n",
       "      <td>Melanocortin receptor 3</td>\n",
       "      <td>T76846</td>\n",
       "      <td>Obesity [ICD-11: 5B81]</td>\n",
       "      <td>56.76%</td>\n",
       "      <td>99.52%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>246</th>\n",
       "      <td>Melanocortin receptor 3</td>\n",
       "      <td>T76846</td>\n",
       "      <td>Sexual dysfunction [ICD-11: HA00-HA01]</td>\n",
       "      <td>56.76%</td>\n",
       "      <td>99.52%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>247</th>\n",
       "      <td>Melanocortin receptor 3</td>\n",
       "      <td>T76846</td>\n",
       "      <td>Type-2 diabetes [ICD-11: 5A11]</td>\n",
       "      <td>56.76%</td>\n",
       "      <td>99.52%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>248</th>\n",
       "      <td>Androgen Receptor</td>\n",
       "      <td>T11211</td>\n",
       "      <td>Acne vulgaris [ICD-11: ED80]</td>\n",
       "      <td>56.55%</td>\n",
       "      <td>96.43%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>249</th>\n",
       "      <td>Androgen Receptor</td>\n",
       "      <td>T11211</td>\n",
       "      <td>Acute myeloid leukaemia [ICD-11: 2A60]</td>\n",
       "      <td>56.55%</td>\n",
       "      <td>96.43%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>250</th>\n",
       "      <td>Androgen Receptor</td>\n",
       "      <td>T11211</td>\n",
       "      <td>Alcoholic hepatitis [ICD-11: DB94.1]</td>\n",
       "      <td>56.55%</td>\n",
       "      <td>96.43%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>251</th>\n",
       "      <td>Androgen Receptor</td>\n",
       "      <td>T11211</td>\n",
       "      <td>Alopecia [ICD-11: ED70]</td>\n",
       "      <td>56.55%</td>\n",
       "      <td>96.43%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>252</th>\n",
       "      <td>Androgen Receptor</td>\n",
       "      <td>T11211</td>\n",
       "      <td>Bladder cancer [ICD-11: 2C94]</td>\n",
       "      <td>56.55%</td>\n",
       "      <td>96.43%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>253</th>\n",
       "      <td>Androgen Receptor</td>\n",
       "      <td>T11211</td>\n",
       "      <td>Breast cancer [ICD-11: 2C60-2C65]</td>\n",
       "      <td>56.55%</td>\n",
       "      <td>96.43%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>254</th>\n",
       "      <td>Androgen Receptor</td>\n",
       "      <td>T11211</td>\n",
       "      <td>Cachexia [ICD-11: MG20]</td>\n",
       "      <td>56.55%</td>\n",
       "      <td>96.43%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>255</th>\n",
       "      <td>Androgen Receptor</td>\n",
       "      <td>T11211</td>\n",
       "      <td>Cardiovascular disease [ICD-11: BA00-BE2Z]</td>\n",
       "      <td>56.55%</td>\n",
       "      <td>96.43%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>256</th>\n",
       "      <td>Androgen Receptor</td>\n",
       "      <td>T11211</td>\n",
       "      <td>Cerebral salt-wasting syndrome [ICD-11: 5C72]</td>\n",
       "      <td>56.55%</td>\n",
       "      <td>96.43%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>257</th>\n",
       "      <td>Androgen Receptor</td>\n",
       "      <td>T11211</td>\n",
       "      <td>Chronic obstructive pulmonary disease [ICD-11:...</td>\n",
       "      <td>56.55%</td>\n",
       "      <td>96.43%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>258</th>\n",
       "      <td>Androgen Receptor</td>\n",
       "      <td>T11211</td>\n",
       "      <td>Contraception [ICD-11: QA21]</td>\n",
       "      <td>56.55%</td>\n",
       "      <td>96.43%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>259</th>\n",
       "      <td>Androgen Receptor</td>\n",
       "      <td>T11211</td>\n",
       "      <td>Cystic fibrosis [ICD-11: CA25]</td>\n",
       "      <td>56.55%</td>\n",
       "      <td>96.43%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>260</th>\n",
       "      <td>Androgen Receptor</td>\n",
       "      <td>T11211</td>\n",
       "      <td>Dermatological disease [ICD-11: DA24.Y]</td>\n",
       "      <td>56.55%</td>\n",
       "      <td>96.43%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>261</th>\n",
       "      <td>Androgen Receptor</td>\n",
       "      <td>T11211</td>\n",
       "      <td>Duchenne dystrophy [ICD-11: 8C70]</td>\n",
       "      <td>56.55%</td>\n",
       "      <td>96.43%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>262</th>\n",
       "      <td>Androgen Receptor</td>\n",
       "      <td>T11211</td>\n",
       "      <td>Dysmenorrhea [ICD-11: GA34.3]</td>\n",
       "      <td>56.55%</td>\n",
       "      <td>96.43%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>263</th>\n",
       "      <td>Androgen Receptor</td>\n",
       "      <td>T11211</td>\n",
       "      <td>Endocrine disease [ICD-11: 5B3Z]</td>\n",
       "      <td>56.55%</td>\n",
       "      <td>96.43%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>264</th>\n",
       "      <td>Androgen Receptor</td>\n",
       "      <td>T11211</td>\n",
       "      <td>Heart failure [ICD-11: BD10-BD13]</td>\n",
       "      <td>56.55%</td>\n",
       "      <td>96.43%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>265</th>\n",
       "      <td>Androgen Receptor</td>\n",
       "      <td>T11211</td>\n",
       "      <td>Hormone deficiency [ICD-11: 5A61.1]</td>\n",
       "      <td>56.55%</td>\n",
       "      <td>96.43%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>266</th>\n",
       "      <td>Androgen Receptor</td>\n",
       "      <td>T11211</td>\n",
       "      <td>Hypogonadism [ICD-11: 5A61.0]</td>\n",
       "      <td>56.55%</td>\n",
       "      <td>96.43%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>267</th>\n",
       "      <td>Androgen Receptor</td>\n",
       "      <td>T11211</td>\n",
       "      <td>Male hormonal deficiency [ICD-11: 5A81]</td>\n",
       "      <td>56.55%</td>\n",
       "      <td>96.43%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>268</th>\n",
       "      <td>Androgen Receptor</td>\n",
       "      <td>T11211</td>\n",
       "      <td>Mammary tumour [ICD-11: 2C60-2C6Z]</td>\n",
       "      <td>56.55%</td>\n",
       "      <td>96.43%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>269</th>\n",
       "      <td>Androgen Receptor</td>\n",
       "      <td>T11211</td>\n",
       "      <td>Muscle atrophy [ICD-11: FB32.Y]</td>\n",
       "      <td>56.55%</td>\n",
       "      <td>96.43%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>270</th>\n",
       "      <td>Androgen Receptor</td>\n",
       "      <td>T11211</td>\n",
       "      <td>Neurological disorder [ICD-11: 6B60]</td>\n",
       "      <td>56.55%</td>\n",
       "      <td>96.43%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>271</th>\n",
       "      <td>Androgen Receptor</td>\n",
       "      <td>T11211</td>\n",
       "      <td>Osteoporosis [ICD-11: FB83.0]</td>\n",
       "      <td>56.55%</td>\n",
       "      <td>96.43%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>272</th>\n",
       "      <td>Androgen Receptor</td>\n",
       "      <td>T11211</td>\n",
       "      <td>Pain [ICD-11: MG30-MG3Z]</td>\n",
       "      <td>56.55%</td>\n",
       "      <td>96.43%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>273</th>\n",
       "      <td>Androgen Receptor</td>\n",
       "      <td>T11211</td>\n",
       "      <td>Prostate cancer [ICD-11: 2C82.0]</td>\n",
       "      <td>56.55%</td>\n",
       "      <td>96.43%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>274</th>\n",
       "      <td>Androgen Receptor</td>\n",
       "      <td>T11211</td>\n",
       "      <td>Prostate hyperplasia [ICD-11: GA90]</td>\n",
       "      <td>56.55%</td>\n",
       "      <td>96.43%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>275</th>\n",
       "      <td>Androgen Receptor</td>\n",
       "      <td>T11211</td>\n",
       "      <td>Solid tumour/cancer [ICD-11: 2A00-2F9Z]</td>\n",
       "      <td>56.55%</td>\n",
       "      <td>96.43%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>276</th>\n",
       "      <td>Androgen Receptor</td>\n",
       "      <td>T11211</td>\n",
       "      <td>Testosterone deficiency [ICD-11: 5A81.1]</td>\n",
       "      <td>56.55%</td>\n",
       "      <td>96.43%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>277</th>\n",
       "      <td>Platelet-derived growth factor receptor</td>\n",
       "      <td>T53524</td>\n",
       "      <td>Acute myelogenous leukaemia [ICD-11: 2A41]</td>\n",
       "      <td>55.66%</td>\n",
       "      <td>71.67%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>278</th>\n",
       "      <td>Platelet-derived growth factor receptor</td>\n",
       "      <td>T53524</td>\n",
       "      <td>Acute myeloid leukaemia [ICD-11: 2A60]</td>\n",
       "      <td>55.66%</td>\n",
       "      <td>71.67%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>279</th>\n",
       "      <td>Platelet-derived growth factor receptor</td>\n",
       "      <td>T53524</td>\n",
       "      <td>Alzheimer disease [ICD-11: 8A20]</td>\n",
       "      <td>55.66%</td>\n",
       "      <td>71.67%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>280</th>\n",
       "      <td>Platelet-derived growth factor receptor</td>\n",
       "      <td>T53524</td>\n",
       "      <td>Brain injury [ICD-11: NA07.Z]</td>\n",
       "      <td>55.66%</td>\n",
       "      <td>71.67%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>281</th>\n",
       "      <td>Platelet-derived growth factor receptor</td>\n",
       "      <td>T53524</td>\n",
       "      <td>Breast cancer [ICD-11: 2C60-2C65]</td>\n",
       "      <td>55.66%</td>\n",
       "      <td>71.67%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>282</th>\n",
       "      <td>Platelet-derived growth factor receptor</td>\n",
       "      <td>T53524</td>\n",
       "      <td>Colon cancer [ICD-11: 2B90.Z]</td>\n",
       "      <td>55.66%</td>\n",
       "      <td>71.67%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>283</th>\n",
       "      <td>Platelet-derived growth factor receptor</td>\n",
       "      <td>T53524</td>\n",
       "      <td>Colorectal cancer [ICD-11: 2B91.Z]</td>\n",
       "      <td>55.66%</td>\n",
       "      <td>71.67%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>284</th>\n",
       "      <td>Platelet-derived growth factor receptor</td>\n",
       "      <td>T53524</td>\n",
       "      <td>Diabetic complication [ICD-11: 5A2Y]</td>\n",
       "      <td>55.66%</td>\n",
       "      <td>71.67%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>285</th>\n",
       "      <td>Platelet-derived growth factor receptor</td>\n",
       "      <td>T53524</td>\n",
       "      <td>Gastric adenocarcinoma [ICD-11: 2B72]</td>\n",
       "      <td>55.66%</td>\n",
       "      <td>71.67%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>286</th>\n",
       "      <td>Platelet-derived growth factor receptor</td>\n",
       "      <td>T53524</td>\n",
       "      <td>Gastrointestinal cancer [ICD-11: 2C11]</td>\n",
       "      <td>55.66%</td>\n",
       "      <td>71.67%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>287</th>\n",
       "      <td>Platelet-derived growth factor receptor</td>\n",
       "      <td>T53524</td>\n",
       "      <td>Gastrointestinal stromal tumour [ICD-11: 2B5B]</td>\n",
       "      <td>55.66%</td>\n",
       "      <td>71.67%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>288</th>\n",
       "      <td>Platelet-derived growth factor receptor</td>\n",
       "      <td>T53524</td>\n",
       "      <td>Glioblastoma multiforme [ICD-11: 2A00.0]</td>\n",
       "      <td>55.66%</td>\n",
       "      <td>71.67%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>289</th>\n",
       "      <td>Platelet-derived growth factor receptor</td>\n",
       "      <td>T53524</td>\n",
       "      <td>Gram-positive bacterial infection [ICD-11: 1B7...</td>\n",
       "      <td>55.66%</td>\n",
       "      <td>71.67%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>290</th>\n",
       "      <td>Platelet-derived growth factor receptor</td>\n",
       "      <td>T53524</td>\n",
       "      <td>Gram-positive bacterial infection [ICD-11: 1B7...</td>\n",
       "      <td>55.66%</td>\n",
       "      <td>71.67%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>291</th>\n",
       "      <td>Platelet-derived growth factor receptor</td>\n",
       "      <td>T53524</td>\n",
       "      <td>Hepatocellular carcinoma [ICD-11: 2C12.02]</td>\n",
       "      <td>55.66%</td>\n",
       "      <td>71.67%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>292</th>\n",
       "      <td>Platelet-derived growth factor receptor</td>\n",
       "      <td>T53524</td>\n",
       "      <td>Lung cancer [ICD-11: 2C25.0]</td>\n",
       "      <td>55.66%</td>\n",
       "      <td>71.67%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>293</th>\n",
       "      <td>Platelet-derived growth factor receptor</td>\n",
       "      <td>T53524</td>\n",
       "      <td>Mast cell leukaemia [ICD-11: 2A21.00]</td>\n",
       "      <td>55.66%</td>\n",
       "      <td>71.67%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>294</th>\n",
       "      <td>Platelet-derived growth factor receptor</td>\n",
       "      <td>T53524</td>\n",
       "      <td>Multiple myeloma [ICD-11: 2A83]</td>\n",
       "      <td>55.66%</td>\n",
       "      <td>71.67%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>295</th>\n",
       "      <td>Platelet-derived growth factor receptor</td>\n",
       "      <td>T53524</td>\n",
       "      <td>Multiple myeloma [ICD-11: 2A83]</td>\n",
       "      <td>55.66%</td>\n",
       "      <td>71.67%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>296</th>\n",
       "      <td>Platelet-derived growth factor receptor</td>\n",
       "      <td>T53524</td>\n",
       "      <td>Myelodysplastic syndrome [ICD-11: 2A37]</td>\n",
       "      <td>55.66%</td>\n",
       "      <td>71.67%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>297</th>\n",
       "      <td>Platelet-derived growth factor receptor</td>\n",
       "      <td>T53524</td>\n",
       "      <td>Myelodysplastic syndrome [ICD-11: 2A37]</td>\n",
       "      <td>55.66%</td>\n",
       "      <td>71.67%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>298</th>\n",
       "      <td>Platelet-derived growth factor receptor</td>\n",
       "      <td>T53524</td>\n",
       "      <td>Non-small-cell lung cancer [ICD-11: 2C25.Y]</td>\n",
       "      <td>55.66%</td>\n",
       "      <td>71.67%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>299</th>\n",
       "      <td>Platelet-derived growth factor receptor</td>\n",
       "      <td>T53524</td>\n",
       "      <td>Non-small-cell lung cancer [ICD-11: 2C25.Y]</td>\n",
       "      <td>55.66%</td>\n",
       "      <td>71.67%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>300</th>\n",
       "      <td>Platelet-derived growth factor receptor</td>\n",
       "      <td>T53524</td>\n",
       "      <td>Pancreatic cancer [ICD-11: 2C10]</td>\n",
       "      <td>55.66%</td>\n",
       "      <td>71.67%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>301</th>\n",
       "      <td>Platelet-derived growth factor receptor</td>\n",
       "      <td>T53524</td>\n",
       "      <td>Prostate cancer [ICD-11: 2C82.0]</td>\n",
       "      <td>55.66%</td>\n",
       "      <td>71.67%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>302</th>\n",
       "      <td>Platelet-derived growth factor receptor</td>\n",
       "      <td>T53524</td>\n",
       "      <td>Recurrent glioblastoma [ICD-11: 2A00.00]</td>\n",
       "      <td>55.66%</td>\n",
       "      <td>71.67%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>303</th>\n",
       "      <td>Platelet-derived growth factor receptor</td>\n",
       "      <td>T53524</td>\n",
       "      <td>Renal cell carcinoma [ICD-11: 2C90]</td>\n",
       "      <td>55.66%</td>\n",
       "      <td>71.67%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>304</th>\n",
       "      <td>Platelet-derived growth factor receptor</td>\n",
       "      <td>T53524</td>\n",
       "      <td>Soft tissue sarcoma [ICD-11: 2B57]</td>\n",
       "      <td>55.66%</td>\n",
       "      <td>71.67%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>305</th>\n",
       "      <td>Platelet-derived growth factor receptor</td>\n",
       "      <td>T53524</td>\n",
       "      <td>Solid tumour/cancer [ICD-11: 2A00-2F9Z]</td>\n",
       "      <td>55.66%</td>\n",
       "      <td>71.67%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>306</th>\n",
       "      <td>Platelet-derived growth factor receptor</td>\n",
       "      <td>T53524</td>\n",
       "      <td>Solid tumour/cancer [ICD-11: 2A00-2F9Z]</td>\n",
       "      <td>55.66%</td>\n",
       "      <td>71.67%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>307</th>\n",
       "      <td>Platelet-derived growth factor receptor</td>\n",
       "      <td>T53524</td>\n",
       "      <td>Systemic mastocytosis [ICD-11: 2A21.0]</td>\n",
       "      <td>55.66%</td>\n",
       "      <td>71.67%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>308</th>\n",
       "      <td>Platelet-derived growth factor receptor</td>\n",
       "      <td>T53524</td>\n",
       "      <td>Thrombocytopenia [ICD-11: 3B64]</td>\n",
       "      <td>55.66%</td>\n",
       "      <td>71.67%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>309</th>\n",
       "      <td>Platelet-derived growth factor receptor</td>\n",
       "      <td>T53524</td>\n",
       "      <td>Thrombocytopenia [ICD-11: 3B64]</td>\n",
       "      <td>55.66%</td>\n",
       "      <td>71.67%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>310</th>\n",
       "      <td>Galectin-3</td>\n",
       "      <td>T72038</td>\n",
       "      <td>Melanoma [ICD-11: 2C30]</td>\n",
       "      <td>54.97%</td>\n",
       "      <td>96.9%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>311</th>\n",
       "      <td>Galectin-3</td>\n",
       "      <td>T72038</td>\n",
       "      <td>Plaque psoriasis [ICD-11: EA90.0]</td>\n",
       "      <td>54.97%</td>\n",
       "      <td>96.9%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>312</th>\n",
       "      <td>Melanocortin receptor 5</td>\n",
       "      <td>T95302</td>\n",
       "      <td>Acne vulgaris [ICD-11: ED80]</td>\n",
       "      <td>54.78%</td>\n",
       "      <td>97%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>313</th>\n",
       "      <td>Melanocortin receptor 5</td>\n",
       "      <td>T95302</td>\n",
       "      <td>Female sexual arousal dysfunction [ICD-11: HA0...</td>\n",
       "      <td>54.78%</td>\n",
       "      <td>97%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>314</th>\n",
       "      <td>Melanocortin receptor 5</td>\n",
       "      <td>T95302</td>\n",
       "      <td>Seborrhea [ICD-11: ED91.2]</td>\n",
       "      <td>54.78%</td>\n",
       "      <td>97%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>315</th>\n",
       "      <td>Solute carrier family 40 member 1</td>\n",
       "      <td>T86264</td>\n",
       "      <td>Anemia [ICD-11: 3A00-3A9Z]</td>\n",
       "      <td>54.49%</td>\n",
       "      <td>95%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>316</th>\n",
       "      <td>Trypsin I</td>\n",
       "      <td>T27602</td>\n",
       "      <td>Asthma [ICD-11: CA23]</td>\n",
       "      <td>54.48%</td>\n",
       "      <td>90%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>317</th>\n",
       "      <td>Trypsin I</td>\n",
       "      <td>T27602</td>\n",
       "      <td>Atopic dermatitis [ICD-11: EA80]</td>\n",
       "      <td>54.48%</td>\n",
       "      <td>90%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>318</th>\n",
       "      <td>Trypsin I</td>\n",
       "      <td>T27602</td>\n",
       "      <td>Bacillus anthracis infection [ICD-11: 1G40]</td>\n",
       "      <td>54.48%</td>\n",
       "      <td>90%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>319</th>\n",
       "      <td>Trypsin I</td>\n",
       "      <td>T27602</td>\n",
       "      <td>Coagulation defect [ICD-11: 3B10.0]</td>\n",
       "      <td>54.48%</td>\n",
       "      <td>90%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>320</th>\n",
       "      <td>Trypsin I</td>\n",
       "      <td>T27602</td>\n",
       "      <td>Hypotension [ICD-11: BA20-BA21]</td>\n",
       "      <td>54.48%</td>\n",
       "      <td>90%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>321</th>\n",
       "      <td>Trypsin I</td>\n",
       "      <td>T27602</td>\n",
       "      <td>Multiple myeloma [ICD-11: 2A83]</td>\n",
       "      <td>54.48%</td>\n",
       "      <td>90%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>322</th>\n",
       "      <td>Trypsin I</td>\n",
       "      <td>T27602</td>\n",
       "      <td>Non-hodgkin lymphoma [ICD-11: 2B33.5]</td>\n",
       "      <td>54.48%</td>\n",
       "      <td>90%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>323</th>\n",
       "      <td>Trypsin I</td>\n",
       "      <td>T27602</td>\n",
       "      <td>Premature labour [ICD-11: JB00]</td>\n",
       "      <td>54.48%</td>\n",
       "      <td>90%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>324</th>\n",
       "      <td>Trypsin I</td>\n",
       "      <td>T27602</td>\n",
       "      <td>Solid tumour/cancer [ICD-11: 2A00-2F9Z]</td>\n",
       "      <td>54.48%</td>\n",
       "      <td>90%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>325</th>\n",
       "      <td>Platelet-derived growth factor receptor alpha</td>\n",
       "      <td>T53524</td>\n",
       "      <td>Acute myelogenous leukaemia [ICD-11: 2A41]</td>\n",
       "      <td>54.17%</td>\n",
       "      <td>91.07%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>326</th>\n",
       "      <td>Platelet-derived growth factor receptor alpha</td>\n",
       "      <td>T53524</td>\n",
       "      <td>Acute myeloid leukaemia [ICD-11: 2A60]</td>\n",
       "      <td>54.17%</td>\n",
       "      <td>91.07%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>327</th>\n",
       "      <td>Platelet-derived growth factor receptor alpha</td>\n",
       "      <td>T53524</td>\n",
       "      <td>Breast cancer [ICD-11: 2C60-2C65]</td>\n",
       "      <td>54.17%</td>\n",
       "      <td>91.07%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>328</th>\n",
       "      <td>Platelet-derived growth factor receptor alpha</td>\n",
       "      <td>T53524</td>\n",
       "      <td>Colon cancer [ICD-11: 2B90.Z]</td>\n",
       "      <td>54.17%</td>\n",
       "      <td>91.07%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>329</th>\n",
       "      <td>Platelet-derived growth factor receptor alpha</td>\n",
       "      <td>T53524</td>\n",
       "      <td>Colorectal cancer [ICD-11: 2B91.Z]</td>\n",
       "      <td>54.17%</td>\n",
       "      <td>91.07%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>330</th>\n",
       "      <td>Platelet-derived growth factor receptor alpha</td>\n",
       "      <td>T53524</td>\n",
       "      <td>Gastric adenocarcinoma [ICD-11: 2B72]</td>\n",
       "      <td>54.17%</td>\n",
       "      <td>91.07%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>331</th>\n",
       "      <td>Platelet-derived growth factor receptor alpha</td>\n",
       "      <td>T53524</td>\n",
       "      <td>Gastrointestinal cancer [ICD-11: 2C11]</td>\n",
       "      <td>54.17%</td>\n",
       "      <td>91.07%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>332</th>\n",
       "      <td>Platelet-derived growth factor receptor alpha</td>\n",
       "      <td>T53524</td>\n",
       "      <td>Gastrointestinal stromal tumour [ICD-11: 2B5B]</td>\n",
       "      <td>54.17%</td>\n",
       "      <td>91.07%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>333</th>\n",
       "      <td>Platelet-derived growth factor receptor alpha</td>\n",
       "      <td>T53524</td>\n",
       "      <td>Glioblastoma multiforme [ICD-11: 2A00.0]</td>\n",
       "      <td>54.17%</td>\n",
       "      <td>91.07%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>334</th>\n",
       "      <td>Platelet-derived growth factor receptor alpha</td>\n",
       "      <td>T53524</td>\n",
       "      <td>Gram-positive bacterial infection [ICD-11: 1B7...</td>\n",
       "      <td>54.17%</td>\n",
       "      <td>91.07%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>335</th>\n",
       "      <td>Platelet-derived growth factor receptor alpha</td>\n",
       "      <td>T53524</td>\n",
       "      <td>Lung cancer [ICD-11: 2C25.0]</td>\n",
       "      <td>54.17%</td>\n",
       "      <td>91.07%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>336</th>\n",
       "      <td>Platelet-derived growth factor receptor alpha</td>\n",
       "      <td>T53524</td>\n",
       "      <td>Mast cell leukaemia [ICD-11: 2A21.00]</td>\n",
       "      <td>54.17%</td>\n",
       "      <td>91.07%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>337</th>\n",
       "      <td>Platelet-derived growth factor receptor alpha</td>\n",
       "      <td>T53524</td>\n",
       "      <td>Multiple myeloma [ICD-11: 2A83]</td>\n",
       "      <td>54.17%</td>\n",
       "      <td>91.07%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>338</th>\n",
       "      <td>Platelet-derived growth factor receptor alpha</td>\n",
       "      <td>T53524</td>\n",
       "      <td>Myelodysplastic syndrome [ICD-11: 2A37]</td>\n",
       "      <td>54.17%</td>\n",
       "      <td>91.07%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>339</th>\n",
       "      <td>Platelet-derived growth factor receptor alpha</td>\n",
       "      <td>T53524</td>\n",
       "      <td>Non-small-cell lung cancer [ICD-11: 2C25.Y]</td>\n",
       "      <td>54.17%</td>\n",
       "      <td>91.07%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>340</th>\n",
       "      <td>Platelet-derived growth factor receptor alpha</td>\n",
       "      <td>T53524</td>\n",
       "      <td>Pancreatic cancer [ICD-11: 2C10]</td>\n",
       "      <td>54.17%</td>\n",
       "      <td>91.07%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>341</th>\n",
       "      <td>Platelet-derived growth factor receptor alpha</td>\n",
       "      <td>T53524</td>\n",
       "      <td>Prostate cancer [ICD-11: 2C82.0]</td>\n",
       "      <td>54.17%</td>\n",
       "      <td>91.07%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>342</th>\n",
       "      <td>Platelet-derived growth factor receptor alpha</td>\n",
       "      <td>T53524</td>\n",
       "      <td>Recurrent glioblastoma [ICD-11: 2A00.00]</td>\n",
       "      <td>54.17%</td>\n",
       "      <td>91.07%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>343</th>\n",
       "      <td>Platelet-derived growth factor receptor alpha</td>\n",
       "      <td>T53524</td>\n",
       "      <td>Soft tissue sarcoma [ICD-11: 2B57]</td>\n",
       "      <td>54.17%</td>\n",
       "      <td>91.07%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>344</th>\n",
       "      <td>Platelet-derived growth factor receptor alpha</td>\n",
       "      <td>T53524</td>\n",
       "      <td>Solid tumour/cancer [ICD-11: 2A00-2F9Z]</td>\n",
       "      <td>54.17%</td>\n",
       "      <td>91.07%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>345</th>\n",
       "      <td>Platelet-derived growth factor receptor alpha</td>\n",
       "      <td>T53524</td>\n",
       "      <td>Systemic mastocytosis [ICD-11: 2A21.0]</td>\n",
       "      <td>54.17%</td>\n",
       "      <td>91.07%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>346</th>\n",
       "      <td>Platelet-derived growth factor receptor alpha</td>\n",
       "      <td>T53524</td>\n",
       "      <td>Thrombocytopenia [ICD-11: 3B64]</td>\n",
       "      <td>54.17%</td>\n",
       "      <td>91.07%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>347</th>\n",
       "      <td>C-C chemokine receptor type 2</td>\n",
       "      <td>T89988</td>\n",
       "      <td>Alzheimer disease [ICD-11: 8A20]</td>\n",
       "      <td>54.1%</td>\n",
       "      <td>98.57%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>348</th>\n",
       "      <td>C-C chemokine receptor type 2</td>\n",
       "      <td>T89988</td>\n",
       "      <td>Arteriosclerosis [ICD-11: BD40]</td>\n",
       "      <td>54.1%</td>\n",
       "      <td>98.57%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>349</th>\n",
       "      <td>C-C chemokine receptor type 2</td>\n",
       "      <td>T89988</td>\n",
       "      <td>Arthritis [ICD-11: FA20]</td>\n",
       "      <td>54.1%</td>\n",
       "      <td>98.57%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>350</th>\n",
       "      <td>C-C chemokine receptor type 2</td>\n",
       "      <td>T89988</td>\n",
       "      <td>Chronic obstructive pulmonary disease [ICD-11:...</td>\n",
       "      <td>54.1%</td>\n",
       "      <td>98.57%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>351</th>\n",
       "      <td>C-C chemokine receptor type 2</td>\n",
       "      <td>T89988</td>\n",
       "      <td>Diabetic nephropathy [ICD-11: GB61.Z]</td>\n",
       "      <td>54.1%</td>\n",
       "      <td>98.57%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>352</th>\n",
       "      <td>C-C chemokine receptor type 2</td>\n",
       "      <td>T89988</td>\n",
       "      <td>Diabetic retinopathy [ICD-11: 9B71.0]</td>\n",
       "      <td>54.1%</td>\n",
       "      <td>98.57%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>353</th>\n",
       "      <td>C-C chemokine receptor type 2</td>\n",
       "      <td>T89988</td>\n",
       "      <td>Human immunodeficiency virus infection [ICD-11...</td>\n",
       "      <td>54.1%</td>\n",
       "      <td>98.57%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>354</th>\n",
       "      <td>C-C chemokine receptor type 2</td>\n",
       "      <td>T89988</td>\n",
       "      <td>Inflammation [ICD-11: 1A00-CA43.1]</td>\n",
       "      <td>54.1%</td>\n",
       "      <td>98.57%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>355</th>\n",
       "      <td>C-C chemokine receptor type 2</td>\n",
       "      <td>T89988</td>\n",
       "      <td>Inflammatory pain [ICD-11: MG30.42]</td>\n",
       "      <td>54.1%</td>\n",
       "      <td>98.57%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>356</th>\n",
       "      <td>C-C chemokine receptor type 2</td>\n",
       "      <td>T89988</td>\n",
       "      <td>Insulin-resistant disorder [ICD-11: 5A44]</td>\n",
       "      <td>54.1%</td>\n",
       "      <td>98.57%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>357</th>\n",
       "      <td>C-C chemokine receptor type 2</td>\n",
       "      <td>T89988</td>\n",
       "      <td>Melanoma [ICD-11: 2C30]</td>\n",
       "      <td>54.1%</td>\n",
       "      <td>98.57%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>358</th>\n",
       "      <td>C-C chemokine receptor type 2</td>\n",
       "      <td>T89988</td>\n",
       "      <td>Metastatic cancer [ICD-11: 2D50-2E2Z]</td>\n",
       "      <td>54.1%</td>\n",
       "      <td>98.57%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>359</th>\n",
       "      <td>C-C chemokine receptor type 2</td>\n",
       "      <td>T89988</td>\n",
       "      <td>Multiple sclerosis [ICD-11: 8A40]</td>\n",
       "      <td>54.1%</td>\n",
       "      <td>98.57%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>360</th>\n",
       "      <td>C-C chemokine receptor type 2</td>\n",
       "      <td>T89988</td>\n",
       "      <td>Neuropathic pain [ICD-11: 8E43.0]</td>\n",
       "      <td>54.1%</td>\n",
       "      <td>98.57%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>361</th>\n",
       "      <td>C-C chemokine receptor type 2</td>\n",
       "      <td>T89988</td>\n",
       "      <td>Pancreatic tumour [ICD-11: 2C10]</td>\n",
       "      <td>54.1%</td>\n",
       "      <td>98.57%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>362</th>\n",
       "      <td>C-C chemokine receptor type 2</td>\n",
       "      <td>T89988</td>\n",
       "      <td>Respiratory syncytial virus infection [ICD-11:...</td>\n",
       "      <td>54.1%</td>\n",
       "      <td>98.57%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>363</th>\n",
       "      <td>C-C chemokine receptor type 2</td>\n",
       "      <td>T89988</td>\n",
       "      <td>Solid tumour/cancer [ICD-11: 2A00-2F9Z]</td>\n",
       "      <td>54.1%</td>\n",
       "      <td>98.57%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>364</th>\n",
       "      <td>ALK tyrosine kinase receptor</td>\n",
       "      <td>T56418</td>\n",
       "      <td>Anaplastic large cell lymphoma [ICD-11: 2A90.A]</td>\n",
       "      <td>53.89%</td>\n",
       "      <td>96.86%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>365</th>\n",
       "      <td>ALK tyrosine kinase receptor</td>\n",
       "      <td>T56418</td>\n",
       "      <td>Brain metastases [ICD-11: 2D50]</td>\n",
       "      <td>53.89%</td>\n",
       "      <td>96.86%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>366</th>\n",
       "      <td>ALK tyrosine kinase receptor</td>\n",
       "      <td>T56418</td>\n",
       "      <td>Colorectal cancer [ICD-11: 2B91.Z]</td>\n",
       "      <td>53.89%</td>\n",
       "      <td>96.86%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>367</th>\n",
       "      <td>ALK tyrosine kinase receptor</td>\n",
       "      <td>T56418</td>\n",
       "      <td>Diffuse large B-cell lymphoma [ICD-11: 2A81]</td>\n",
       "      <td>53.89%</td>\n",
       "      <td>96.86%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>368</th>\n",
       "      <td>ALK tyrosine kinase receptor</td>\n",
       "      <td>T56418</td>\n",
       "      <td>Lung cancer [ICD-11: 2C25.0]</td>\n",
       "      <td>53.89%</td>\n",
       "      <td>96.86%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>369</th>\n",
       "      <td>ALK tyrosine kinase receptor</td>\n",
       "      <td>T56418</td>\n",
       "      <td>Lymphoma [ICD-11: 2A80-2A86]</td>\n",
       "      <td>53.89%</td>\n",
       "      <td>96.86%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>370</th>\n",
       "      <td>ALK tyrosine kinase receptor</td>\n",
       "      <td>T56418</td>\n",
       "      <td>Neuroblastoma [ICD-11: 2D11.2]</td>\n",
       "      <td>53.89%</td>\n",
       "      <td>96.86%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>371</th>\n",
       "      <td>ALK tyrosine kinase receptor</td>\n",
       "      <td>T56418</td>\n",
       "      <td>Non-small-cell lung cancer [ICD-11: 2C25.Y]</td>\n",
       "      <td>53.89%</td>\n",
       "      <td>96.86%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>372</th>\n",
       "      <td>ALK tyrosine kinase receptor</td>\n",
       "      <td>T56418</td>\n",
       "      <td>Solid tumour/cancer [ICD-11: 2A00-2F9Z]</td>\n",
       "      <td>53.89%</td>\n",
       "      <td>96.86%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>373</th>\n",
       "      <td>Cyclin-dependent kinase 1/cyclin B1</td>\n",
       "      <td>T49898</td>\n",
       "      <td>Acute lymphoblastic leukaemia [ICD-11: 2A85]</td>\n",
       "      <td>53.87%</td>\n",
       "      <td>91.24%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>374</th>\n",
       "      <td>Cyclin-dependent kinase 1/cyclin B1</td>\n",
       "      <td>T49898</td>\n",
       "      <td>Allergic inflammation [ICD-11: 4A80-4A85]</td>\n",
       "      <td>53.87%</td>\n",
       "      <td>91.24%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>375</th>\n",
       "      <td>Cyclin-dependent kinase 1/cyclin B1</td>\n",
       "      <td>T49898</td>\n",
       "      <td>Breast cancer [ICD-11: 2C60-2C65]</td>\n",
       "      <td>53.87%</td>\n",
       "      <td>91.24%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>376</th>\n",
       "      <td>Cyclin-dependent kinase 1/cyclin B1</td>\n",
       "      <td>T49898</td>\n",
       "      <td>Graft rejection [ICD-11: NE84]</td>\n",
       "      <td>53.87%</td>\n",
       "      <td>91.24%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>377</th>\n",
       "      <td>Cyclin-dependent kinase 1/cyclin B1</td>\n",
       "      <td>T49898</td>\n",
       "      <td>Haematological malignancy [ICD-11: 2B33.Y]</td>\n",
       "      <td>53.87%</td>\n",
       "      <td>91.24%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>378</th>\n",
       "      <td>Cyclin-dependent kinase 1/cyclin B1</td>\n",
       "      <td>T49898</td>\n",
       "      <td>Mantle cell lymphoma [ICD-11: 2A85.5]</td>\n",
       "      <td>53.87%</td>\n",
       "      <td>91.24%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>379</th>\n",
       "      <td>Cyclin-dependent kinase 1/cyclin B1</td>\n",
       "      <td>T49898</td>\n",
       "      <td>Nasopharyngeal carcinoma [ICD-11: 2B6B]</td>\n",
       "      <td>53.87%</td>\n",
       "      <td>91.24%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>380</th>\n",
       "      <td>Cyclin-dependent kinase 1/cyclin B1</td>\n",
       "      <td>T49898</td>\n",
       "      <td>Non-small-cell lung cancer [ICD-11: 2C25.Y]</td>\n",
       "      <td>53.87%</td>\n",
       "      <td>91.24%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>381</th>\n",
       "      <td>Cyclin-dependent kinase 1/cyclin B1</td>\n",
       "      <td>T49898</td>\n",
       "      <td>Obesity [ICD-11: 5B81]</td>\n",
       "      <td>53.87%</td>\n",
       "      <td>91.24%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>382</th>\n",
       "      <td>Cyclin-dependent kinase 1/cyclin B1</td>\n",
       "      <td>T49898</td>\n",
       "      <td>Pain [ICD-11: MG30-MG3Z]</td>\n",
       "      <td>53.87%</td>\n",
       "      <td>91.24%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>383</th>\n",
       "      <td>Cyclin-dependent kinase 1/cyclin B1</td>\n",
       "      <td>T49898</td>\n",
       "      <td>Solid tumour/cancer [ICD-11: 2A00-2F9Z]</td>\n",
       "      <td>53.87%</td>\n",
       "      <td>91.24%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>384</th>\n",
       "      <td>Histone deacetylase 2</td>\n",
       "      <td>T51191</td>\n",
       "      <td>Dermatitis [ICD-11: EA80-EA89]</td>\n",
       "      <td>53.52%</td>\n",
       "      <td>94.75%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>385</th>\n",
       "      <td>Histone deacetylase 2</td>\n",
       "      <td>T51191</td>\n",
       "      <td>Solid tumour/cancer [ICD-11: 2A00-2F9Z]</td>\n",
       "      <td>53.52%</td>\n",
       "      <td>94.75%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>386</th>\n",
       "      <td>Plasminogen activator inhibitor-1</td>\n",
       "      <td>T15556</td>\n",
       "      <td>Asthma [ICD-11: CA23]</td>\n",
       "      <td>52.87%</td>\n",
       "      <td>83%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>387</th>\n",
       "      <td>Plasminogen activator inhibitor-1</td>\n",
       "      <td>T15556</td>\n",
       "      <td>Solid tumour/cancer [ICD-11: 2A00-2F9Z]</td>\n",
       "      <td>52.87%</td>\n",
       "      <td>83%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>388</th>\n",
       "      <td>Plasminogen activator inhibitor-1</td>\n",
       "      <td>T15556</td>\n",
       "      <td>Thrombosis [ICD-11: DB61-GB90]</td>\n",
       "      <td>52.87%</td>\n",
       "      <td>83%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>389</th>\n",
       "      <td>3-phosphoinositide dependent protein kinase-1</td>\n",
       "      <td>T20891</td>\n",
       "      <td>Lymphoma [ICD-11: 2A80-2A86]</td>\n",
       "      <td>52.44%</td>\n",
       "      <td>95.36%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>390</th>\n",
       "      <td>3-phosphoinositide dependent protein kinase-1</td>\n",
       "      <td>T20891</td>\n",
       "      <td>Solid tumour/cancer [ICD-11: 2A00-2F9Z]</td>\n",
       "      <td>52.44%</td>\n",
       "      <td>95.36%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>391</th>\n",
       "      <td>Cathepsin L</td>\n",
       "      <td>T41141</td>\n",
       "      <td>Abdominal aortic aneurysm [ICD-11: BD50.4]</td>\n",
       "      <td>52.05%</td>\n",
       "      <td>96.61%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>392</th>\n",
       "      <td>Cathepsin L</td>\n",
       "      <td>T41141</td>\n",
       "      <td>Asthma [ICD-11: CA23]</td>\n",
       "      <td>52.05%</td>\n",
       "      <td>96.61%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>393</th>\n",
       "      <td>Cathepsin L</td>\n",
       "      <td>T41141</td>\n",
       "      <td>Bone cancer [ICD-11: 2B5Z]</td>\n",
       "      <td>52.05%</td>\n",
       "      <td>96.61%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>394</th>\n",
       "      <td>Cathepsin L</td>\n",
       "      <td>T41141</td>\n",
       "      <td>Cancer related pain [ICD-11: MG30]</td>\n",
       "      <td>52.05%</td>\n",
       "      <td>96.61%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>395</th>\n",
       "      <td>Cathepsin L</td>\n",
       "      <td>T41141</td>\n",
       "      <td>Chronic obstructive pulmonary disease [ICD-11:...</td>\n",
       "      <td>52.05%</td>\n",
       "      <td>96.61%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>396</th>\n",
       "      <td>Cathepsin L</td>\n",
       "      <td>T41141</td>\n",
       "      <td>Cirrhosis [ICD-11: DB93]</td>\n",
       "      <td>52.05%</td>\n",
       "      <td>96.61%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>397</th>\n",
       "      <td>Cathepsin L</td>\n",
       "      <td>T41141</td>\n",
       "      <td>Coagulation defect [ICD-11: 3B10.0]</td>\n",
       "      <td>52.05%</td>\n",
       "      <td>96.61%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>398</th>\n",
       "      <td>Cathepsin L</td>\n",
       "      <td>T41141</td>\n",
       "      <td>Coronavirus infection [ICD-11: 1D92]</td>\n",
       "      <td>52.05%</td>\n",
       "      <td>96.61%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>399</th>\n",
       "      <td>Cathepsin L</td>\n",
       "      <td>T41141</td>\n",
       "      <td>Gastrointestinal disease [ICD-11: DE2Z]</td>\n",
       "      <td>52.05%</td>\n",
       "      <td>96.61%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>400</th>\n",
       "      <td>Cathepsin L</td>\n",
       "      <td>T41141</td>\n",
       "      <td>Glioma [ICD-11: 2A00.0]</td>\n",
       "      <td>52.05%</td>\n",
       "      <td>96.61%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>401</th>\n",
       "      <td>Cathepsin L</td>\n",
       "      <td>T41141</td>\n",
       "      <td>Hair loss [ICD-11: ED70]</td>\n",
       "      <td>52.05%</td>\n",
       "      <td>96.61%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>402</th>\n",
       "      <td>Cathepsin L</td>\n",
       "      <td>T41141</td>\n",
       "      <td>Henipavirus Encephalitis [ICD-11: 1D63]</td>\n",
       "      <td>52.05%</td>\n",
       "      <td>96.61%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>403</th>\n",
       "      <td>Cathepsin L</td>\n",
       "      <td>T41141</td>\n",
       "      <td>Middle East Respiratory Syndrome (MERS) [ICD-1...</td>\n",
       "      <td>52.05%</td>\n",
       "      <td>96.61%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>404</th>\n",
       "      <td>Cathepsin L</td>\n",
       "      <td>T41141</td>\n",
       "      <td>Multiple sclerosis [ICD-11: 8A40]</td>\n",
       "      <td>52.05%</td>\n",
       "      <td>96.61%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>405</th>\n",
       "      <td>Cathepsin L</td>\n",
       "      <td>T41141</td>\n",
       "      <td>Psoriasis vulgaris [ICD-11: EA90]</td>\n",
       "      <td>52.05%</td>\n",
       "      <td>96.61%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>406</th>\n",
       "      <td>Cathepsin L</td>\n",
       "      <td>T41141</td>\n",
       "      <td>Rheumatoid arthritis [ICD-11: FA20]</td>\n",
       "      <td>52.05%</td>\n",
       "      <td>96.61%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>407</th>\n",
       "      <td>Cathepsin L</td>\n",
       "      <td>T41141</td>\n",
       "      <td>Severe acute respiratory syndrome (SARS) [ICD-...</td>\n",
       "      <td>52.05%</td>\n",
       "      <td>96.61%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>408</th>\n",
       "      <td>Cathepsin L</td>\n",
       "      <td>T41141</td>\n",
       "      <td>Solid tumour/cancer [ICD-11: 2A00-2F9Z]</td>\n",
       "      <td>52.05%</td>\n",
       "      <td>96.61%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>409</th>\n",
       "      <td>Isocitrate dehydrogenase [NADP] cytoplasmic</td>\n",
       "      <td>T69563</td>\n",
       "      <td>Acute myeloid leukaemia [ICD-11: 2A60]</td>\n",
       "      <td>51.93%</td>\n",
       "      <td>99%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>410</th>\n",
       "      <td>Isocitrate dehydrogenase [NADP] cytoplasmic</td>\n",
       "      <td>T69563</td>\n",
       "      <td>Advanced malignancy [ICD-11: 2A00-2F9Z]</td>\n",
       "      <td>51.93%</td>\n",
       "      <td>99%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>411</th>\n",
       "      <td>Isocitrate dehydrogenase [NADP] cytoplasmic</td>\n",
       "      <td>T69563</td>\n",
       "      <td>Haematological malignancy [ICD-11: 2B33.Y]</td>\n",
       "      <td>51.93%</td>\n",
       "      <td>99%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>412</th>\n",
       "      <td>Glutamate receptor ionotropic, AMPA 2</td>\n",
       "      <td>T42392</td>\n",
       "      <td>Diabetic neuropathy [ICD-11: 8C0Z]</td>\n",
       "      <td>51.89%</td>\n",
       "      <td>86.92%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>413</th>\n",
       "      <td>Glutamate receptor ionotropic, AMPA 2</td>\n",
       "      <td>T42392</td>\n",
       "      <td>Parkinson disease [ICD-11: 8A00.0]</td>\n",
       "      <td>51.89%</td>\n",
       "      <td>86.92%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>414</th>\n",
       "      <td>Tyrosine-protein kinase ITK/TSK</td>\n",
       "      <td>T91761</td>\n",
       "      <td>Allergy [ICD-11: 4A80-4A85]</td>\n",
       "      <td>51.87%</td>\n",
       "      <td>95%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>415</th>\n",
       "      <td>Tyrosine-protein kinase ITK/TSK</td>\n",
       "      <td>T91761</td>\n",
       "      <td>Inflammation [ICD-11: 1A00-CA43.1]</td>\n",
       "      <td>51.87%</td>\n",
       "      <td>95%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>416</th>\n",
       "      <td>Tyrosine-protein kinase ITK/TSK</td>\n",
       "      <td>T91761</td>\n",
       "      <td>Plaque psoriasis [ICD-11: EA90.0]</td>\n",
       "      <td>51.87%</td>\n",
       "      <td>95%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>417</th>\n",
       "      <td>Neuronal acetylcholine receptor; alpha4/beta4</td>\n",
       "      <td>T73724</td>\n",
       "      <td>Alzheimer disease [ICD-11: 8A20]</td>\n",
       "      <td>51.48%</td>\n",
       "      <td>100%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>418</th>\n",
       "      <td>Neuronal acetylcholine receptor; alpha4/beta4</td>\n",
       "      <td>T73724</td>\n",
       "      <td>Alzheimer disease [ICD-11: 8A20]</td>\n",
       "      <td>51.48%</td>\n",
       "      <td>100%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>419</th>\n",
       "      <td>Neuronal acetylcholine receptor; alpha4/beta4</td>\n",
       "      <td>T73724</td>\n",
       "      <td>Aneurysm [ICD-11: BD51.Z]</td>\n",
       "      <td>51.48%</td>\n",
       "      <td>100%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>420</th>\n",
       "      <td>Neuronal acetylcholine receptor; alpha4/beta4</td>\n",
       "      <td>T73724</td>\n",
       "      <td>Hypertensive emergency [ICD-11: BA03]</td>\n",
       "      <td>51.48%</td>\n",
       "      <td>100%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>421</th>\n",
       "      <td>Neuronal acetylcholine receptor; alpha4/beta4</td>\n",
       "      <td>T73724</td>\n",
       "      <td>Hypotension [ICD-11: BA20-BA21]</td>\n",
       "      <td>51.48%</td>\n",
       "      <td>100%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>422</th>\n",
       "      <td>Neuronal acetylcholine receptor; alpha4/beta4</td>\n",
       "      <td>T73724</td>\n",
       "      <td>Tobacco dependence [ICD-11: 6C4A.2]</td>\n",
       "      <td>51.48%</td>\n",
       "      <td>100%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>423</th>\n",
       "      <td>Neuronal acetylcholine receptor; alpha4/beta4</td>\n",
       "      <td>T73724</td>\n",
       "      <td>Tobacco dependence [ICD-11: 6C4A.2]</td>\n",
       "      <td>51.48%</td>\n",
       "      <td>100%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>424</th>\n",
       "      <td>Indoleamine 2,3-dioxygenase</td>\n",
       "      <td>T89697</td>\n",
       "      <td>Acute myeloid leukaemia [ICD-11: 2A60]</td>\n",
       "      <td>51.37%</td>\n",
       "      <td>96.38%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>425</th>\n",
       "      <td>Indoleamine 2,3-dioxygenase</td>\n",
       "      <td>T89697</td>\n",
       "      <td>B-cell lymphoma [ICD-11: 2A86]</td>\n",
       "      <td>51.37%</td>\n",
       "      <td>96.38%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>426</th>\n",
       "      <td>Indoleamine 2,3-dioxygenase</td>\n",
       "      <td>T89697</td>\n",
       "      <td>Brain cancer [ICD-11: 2A00]</td>\n",
       "      <td>51.37%</td>\n",
       "      <td>96.38%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>427</th>\n",
       "      <td>Indoleamine 2,3-dioxygenase</td>\n",
       "      <td>T89697</td>\n",
       "      <td>Colorectal cancer [ICD-11: 2B91.Z]</td>\n",
       "      <td>51.37%</td>\n",
       "      <td>96.38%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>428</th>\n",
       "      <td>Indoleamine 2,3-dioxygenase</td>\n",
       "      <td>T89697</td>\n",
       "      <td>Depression [ICD-11: 6A70-6A7Z]</td>\n",
       "      <td>51.37%</td>\n",
       "      <td>96.38%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>429</th>\n",
       "      <td>Indoleamine 2,3-dioxygenase</td>\n",
       "      <td>T89697</td>\n",
       "      <td>Gastric adenocarcinoma [ICD-11: 2B72]</td>\n",
       "      <td>51.37%</td>\n",
       "      <td>96.38%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>430</th>\n",
       "      <td>Indoleamine 2,3-dioxygenase</td>\n",
       "      <td>T89697</td>\n",
       "      <td>Glioma [ICD-11: 2A00.0]</td>\n",
       "      <td>51.37%</td>\n",
       "      <td>96.38%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>431</th>\n",
       "      <td>Indoleamine 2,3-dioxygenase</td>\n",
       "      <td>T89697</td>\n",
       "      <td>Head and neck cancer [ICD-11: 2D42]</td>\n",
       "      <td>51.37%</td>\n",
       "      <td>96.38%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>432</th>\n",
       "      <td>Indoleamine 2,3-dioxygenase</td>\n",
       "      <td>T89697</td>\n",
       "      <td>Lung cancer [ICD-11: 2C25.0]</td>\n",
       "      <td>51.37%</td>\n",
       "      <td>96.38%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>433</th>\n",
       "      <td>Indoleamine 2,3-dioxygenase</td>\n",
       "      <td>T89697</td>\n",
       "      <td>Lymphoma [ICD-11: 2A80-2A86]</td>\n",
       "      <td>51.37%</td>\n",
       "      <td>96.38%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>434</th>\n",
       "      <td>Indoleamine 2,3-dioxygenase</td>\n",
       "      <td>T89697</td>\n",
       "      <td>Melanoma [ICD-11: 2C30]</td>\n",
       "      <td>51.37%</td>\n",
       "      <td>96.38%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>435</th>\n",
       "      <td>Indoleamine 2,3-dioxygenase</td>\n",
       "      <td>T89697</td>\n",
       "      <td>Merkel cell carcinoma [ICD-11: 2C34]</td>\n",
       "      <td>51.37%</td>\n",
       "      <td>96.38%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>436</th>\n",
       "      <td>Indoleamine 2,3-dioxygenase</td>\n",
       "      <td>T89697</td>\n",
       "      <td>Nasopharyngeal carcinoma [ICD-11: 2B6B]</td>\n",
       "      <td>51.37%</td>\n",
       "      <td>96.38%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>437</th>\n",
       "      <td>Indoleamine 2,3-dioxygenase</td>\n",
       "      <td>T89697</td>\n",
       "      <td>Non-small-cell lung cancer [ICD-11: 2C25.Y]</td>\n",
       "      <td>51.37%</td>\n",
       "      <td>96.38%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>438</th>\n",
       "      <td>Indoleamine 2,3-dioxygenase</td>\n",
       "      <td>T89697</td>\n",
       "      <td>Ovarian cancer [ICD-11: 2C73]</td>\n",
       "      <td>51.37%</td>\n",
       "      <td>96.38%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>439</th>\n",
       "      <td>Indoleamine 2,3-dioxygenase</td>\n",
       "      <td>T89697</td>\n",
       "      <td>Pancreatic cancer [ICD-11: 2C10]</td>\n",
       "      <td>51.37%</td>\n",
       "      <td>96.38%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>440</th>\n",
       "      <td>Indoleamine 2,3-dioxygenase</td>\n",
       "      <td>T89697</td>\n",
       "      <td>Prostate cancer [ICD-11: 2C82.0]</td>\n",
       "      <td>51.37%</td>\n",
       "      <td>96.38%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>441</th>\n",
       "      <td>Indoleamine 2,3-dioxygenase</td>\n",
       "      <td>T89697</td>\n",
       "      <td>Recurrent glioblastoma [ICD-11: 2A00.00]</td>\n",
       "      <td>51.37%</td>\n",
       "      <td>96.38%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>442</th>\n",
       "      <td>Indoleamine 2,3-dioxygenase</td>\n",
       "      <td>T89697</td>\n",
       "      <td>Renal cell carcinoma [ICD-11: 2C90]</td>\n",
       "      <td>51.37%</td>\n",
       "      <td>96.38%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>443</th>\n",
       "      <td>Indoleamine 2,3-dioxygenase</td>\n",
       "      <td>T89697</td>\n",
       "      <td>Solid tumour/cancer [ICD-11: 2A00-2F9Z]</td>\n",
       "      <td>51.37%</td>\n",
       "      <td>96.38%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>444</th>\n",
       "      <td>Macrophage migration inhibitory factor</td>\n",
       "      <td>T39977</td>\n",
       "      <td>Autoimmune diabetes [ICD-11: 5A10]</td>\n",
       "      <td>50.95%</td>\n",
       "      <td>80.78%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>445</th>\n",
       "      <td>Macrophage migration inhibitory factor</td>\n",
       "      <td>T39977</td>\n",
       "      <td>Autoimmune disease [ICD-11: 4A40-4A45]</td>\n",
       "      <td>50.95%</td>\n",
       "      <td>80.78%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>446</th>\n",
       "      <td>Macrophage migration inhibitory factor</td>\n",
       "      <td>T39977</td>\n",
       "      <td>Inflammation [ICD-11: 1A00-CA43.1]</td>\n",
       "      <td>50.95%</td>\n",
       "      <td>80.78%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>447</th>\n",
       "      <td>PI3-kinase p110-alpha/p85-alpha</td>\n",
       "      <td>T80276</td>\n",
       "      <td>Breast cancer [ICD-11: 2C60-2C65]</td>\n",
       "      <td>50.89%</td>\n",
       "      <td>94.33%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>448</th>\n",
       "      <td>PI3-kinase p110-alpha/p85-alpha</td>\n",
       "      <td>T80276</td>\n",
       "      <td>Follicular lymphoma [ICD-11: 2A80]</td>\n",
       "      <td>50.89%</td>\n",
       "      <td>94.33%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>449</th>\n",
       "      <td>PI3-kinase p110-alpha/p85-alpha</td>\n",
       "      <td>T80276</td>\n",
       "      <td>Non-hodgkin lymphoma [ICD-11: 2B33.5]</td>\n",
       "      <td>50.89%</td>\n",
       "      <td>94.33%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>450</th>\n",
       "      <td>PI3-kinase p110-alpha/p85-alpha</td>\n",
       "      <td>T80276</td>\n",
       "      <td>Prostate cancer [ICD-11: 2C82.0]</td>\n",
       "      <td>50.89%</td>\n",
       "      <td>94.33%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>451</th>\n",
       "      <td>PI3-kinase p110-alpha/p85-alpha</td>\n",
       "      <td>T80276</td>\n",
       "      <td>Solid tumour/cancer [ICD-11: 2A00-2F9Z]</td>\n",
       "      <td>50.89%</td>\n",
       "      <td>94.33%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>452</th>\n",
       "      <td>11-beta-hydroxysteroid dehydrogenase 2</td>\n",
       "      <td>T43721</td>\n",
       "      <td>Type-2 diabetes [ICD-11: 5A11]</td>\n",
       "      <td>50.73%</td>\n",
       "      <td>94.78%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>453</th>\n",
       "      <td>Relaxin receptor 1</td>\n",
       "      <td>T73696</td>\n",
       "      <td>Acute heart failure [ICD-11: BD10-BD13]</td>\n",
       "      <td>50.5%</td>\n",
       "      <td>82.5%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>454</th>\n",
       "      <td>Protein kinase C alpha</td>\n",
       "      <td>T12808</td>\n",
       "      <td>Human immunodeficiency virus infection [ICD-11...</td>\n",
       "      <td>50.38%</td>\n",
       "      <td>98.03%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>455</th>\n",
       "      <td>Protein kinase C alpha</td>\n",
       "      <td>T12808</td>\n",
       "      <td>Renal transplantation [ICD-11: NE84]</td>\n",
       "      <td>50.38%</td>\n",
       "      <td>98.03%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>456</th>\n",
       "      <td>Protein kinase C alpha</td>\n",
       "      <td>T12808</td>\n",
       "      <td>Spinal muscular atrophy [ICD-11: 8B61]</td>\n",
       "      <td>50.38%</td>\n",
       "      <td>98.03%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>457</th>\n",
       "      <td>Hexokinase type IV</td>\n",
       "      <td>T87166</td>\n",
       "      <td>Diabetic complication [ICD-11: 5A2Y]</td>\n",
       "      <td>50.33%</td>\n",
       "      <td>91.96%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>458</th>\n",
       "      <td>Hexokinase type IV</td>\n",
       "      <td>T87166</td>\n",
       "      <td>Obesity [ICD-11: 5B81]</td>\n",
       "      <td>50.33%</td>\n",
       "      <td>91.96%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>459</th>\n",
       "      <td>Hexokinase type IV</td>\n",
       "      <td>T87166</td>\n",
       "      <td>Type-2 diabetes [ICD-11: 5A11]</td>\n",
       "      <td>50.33%</td>\n",
       "      <td>91.96%</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                           Target Name ChEMBL-ID  \\\n",
       "0                                          Cathepsin D    T67102   \n",
       "1                                          Cathepsin D    T67102   \n",
       "2                        G-protein coupled receptor 55    T87670   \n",
       "3          Acyl coenzyme A:cholesterol acyltransferase    T76369   \n",
       "4          Acyl coenzyme A:cholesterol acyltransferase    T76369   \n",
       "5          Acyl coenzyme A:cholesterol acyltransferase    T76369   \n",
       "6          Acyl coenzyme A:cholesterol acyltransferase    T76369   \n",
       "7          Acyl coenzyme A:cholesterol acyltransferase    T76369   \n",
       "8          Acyl coenzyme A:cholesterol acyltransferase    T76369   \n",
       "9          Acyl coenzyme A:cholesterol acyltransferase    T76369   \n",
       "10                                       Cyclophilin A    T47081   \n",
       "11                    Glycine receptor subunit alpha-1    T50269   \n",
       "12                         Casein kinase II alpha/beta    T51565   \n",
       "13                         Casein kinase II alpha/beta    T51565   \n",
       "14                                Cytochrome P450 19A1    T13260   \n",
       "15                                Cytochrome P450 19A1    T13260   \n",
       "16                                Cytochrome P450 19A1    T13260   \n",
       "17                                Cytochrome P450 19A1    T13260   \n",
       "18                                Cytochrome P450 19A1    T13260   \n",
       "19                                Cytochrome P450 19A1    T13260   \n",
       "20                                Cytochrome P450 19A1    T13260   \n",
       "21                              Histone deacetylase 10    T94324   \n",
       "22                                    Aminopeptidase N    T67272   \n",
       "23              G-protein coupled bile acid receptor 1    T86273   \n",
       "24              G-protein coupled bile acid receptor 1    T86273   \n",
       "25                           Formyl peptide receptor 1    T87831   \n",
       "26                           Formyl peptide receptor 1    T87831   \n",
       "27                                         Cathepsin B    T61746   \n",
       "28                                         Cathepsin B    T61746   \n",
       "29                                         Cathepsin B    T61746   \n",
       "30                                         Cathepsin B    T61746   \n",
       "31                                         Cathepsin B    T61746   \n",
       "32                                         Cathepsin B    T61746   \n",
       "33                                         Cathepsin B    T61746   \n",
       "34                                         Cathepsin B    T61746   \n",
       "35                                         Cathepsin B    T61746   \n",
       "36                                         Cathepsin B    T61746   \n",
       "37                                         Cathepsin B    T61746   \n",
       "38                                         Cathepsin B    T61746   \n",
       "39                                         Cathepsin B    T61746   \n",
       "40                                         Cathepsin B    T61746   \n",
       "41                                         Cathepsin B    T61746   \n",
       "42                                         Cathepsin B    T61746   \n",
       "43                                         Cathepsin B    T61746   \n",
       "44                                         Cathepsin B    T61746   \n",
       "45                                         Cathepsin B    T61746   \n",
       "46                                 Pregnane X receptor    T82702   \n",
       "47                             Integrin alpha-V/beta-3    T67103   \n",
       "48                             Integrin alpha-V/beta-3    T67103   \n",
       "49   Voltage-gated N-type calcium channel alpha-1B ...    T38338   \n",
       "50   Voltage-gated N-type calcium channel alpha-1B ...    T38338   \n",
       "51   Voltage-gated N-type calcium channel alpha-1B ...    T38338   \n",
       "52   Voltage-gated N-type calcium channel alpha-1B ...    T38338   \n",
       "53   Voltage-gated N-type calcium channel alpha-1B ...    T38338   \n",
       "54   Voltage-gated N-type calcium channel alpha-1B ...    T38338   \n",
       "55   Voltage-gated N-type calcium channel alpha-1B ...    T38338   \n",
       "56   Voltage-gated N-type calcium channel alpha-1B ...    T38338   \n",
       "57   Voltage-gated N-type calcium channel alpha-1B ...    T38338   \n",
       "58                          DNA topoisomerase II alpha    T17048   \n",
       "59                       PI3-kinase p110-delta subunit    T67849   \n",
       "60                       PI3-kinase p110-delta subunit    T67849   \n",
       "61                       PI3-kinase p110-delta subunit    T67849   \n",
       "62                       PI3-kinase p110-delta subunit    T67849   \n",
       "63                       PI3-kinase p110-delta subunit    T67849   \n",
       "64                       PI3-kinase p110-delta subunit    T67849   \n",
       "65                       PI3-kinase p110-delta subunit    T67849   \n",
       "66                       PI3-kinase p110-delta subunit    T67849   \n",
       "67                       PI3-kinase p110-delta subunit    T67849   \n",
       "68                       PI3-kinase p110-delta subunit    T67849   \n",
       "69                       PI3-kinase p110-delta subunit    T67849   \n",
       "70                       PI3-kinase p110-delta subunit    T67849   \n",
       "71                       PI3-kinase p110-delta subunit    T67849   \n",
       "72                       PI3-kinase p110-delta subunit    T67849   \n",
       "73                       PI3-kinase p110-delta subunit    T67849   \n",
       "74                              Adenosine A2b receptor    T86679   \n",
       "75                              Adenosine A2b receptor    T86679   \n",
       "76                              Adenosine A2b receptor    T86679   \n",
       "77                              Adenosine A2b receptor    T86679   \n",
       "78                              Adenosine A2b receptor    T86679   \n",
       "79                              Adenosine A2b receptor    T86679   \n",
       "80                              Adenosine A2b receptor    T86679   \n",
       "81                              Adenosine A2b receptor    T86679   \n",
       "82                              Adenosine A2b receptor    T86679   \n",
       "83                              Adenosine A2b receptor    T86679   \n",
       "84                              Adenosine A2b receptor    T86679   \n",
       "85                              Adenosine A2b receptor    T86679   \n",
       "86   Cystic fibrosis transmembrane conductance regu...    T55654   \n",
       "87   Cystic fibrosis transmembrane conductance regu...    T55654   \n",
       "88   Cystic fibrosis transmembrane conductance regu...    T55654   \n",
       "89   Cystic fibrosis transmembrane conductance regu...    T55654   \n",
       "90                                Toll-like receptor 4    T81443   \n",
       "91                                Toll-like receptor 4    T81443   \n",
       "92                                Toll-like receptor 4    T81443   \n",
       "93                                Toll-like receptor 4    T81443   \n",
       "94                                Toll-like receptor 4    T81443   \n",
       "95                                Toll-like receptor 4    T81443   \n",
       "96                                Toll-like receptor 4    T81443   \n",
       "97                                Toll-like receptor 4    T81443   \n",
       "98              Sphingosine 1-phosphate receptor Edg-8    T50089   \n",
       "99                Serine/threonine-protein kinase mTOR    T99685   \n",
       "100               Serine/threonine-protein kinase mTOR    T99685   \n",
       "101               Serine/threonine-protein kinase mTOR    T99685   \n",
       "102               Serine/threonine-protein kinase mTOR    T99685   \n",
       "103               Serine/threonine-protein kinase mTOR    T99685   \n",
       "104               Serine/threonine-protein kinase mTOR    T99685   \n",
       "105               Serine/threonine-protein kinase mTOR    T99685   \n",
       "106               Serine/threonine-protein kinase mTOR    T99685   \n",
       "107               Serine/threonine-protein kinase mTOR    T99685   \n",
       "108               Serine/threonine-protein kinase mTOR    T99685   \n",
       "109               Serine/threonine-protein kinase mTOR    T99685   \n",
       "110               Serine/threonine-protein kinase mTOR    T99685   \n",
       "111               Serine/threonine-protein kinase mTOR    T99685   \n",
       "112               Serine/threonine-protein kinase mTOR    T99685   \n",
       "113               Serine/threonine-protein kinase mTOR    T99685   \n",
       "114               Serine/threonine-protein kinase mTOR    T99685   \n",
       "115               Serine/threonine-protein kinase mTOR    T99685   \n",
       "116               Serine/threonine-protein kinase mTOR    T99685   \n",
       "117               Serine/threonine-protein kinase mTOR    T99685   \n",
       "118               Serine/threonine-protein kinase mTOR    T99685   \n",
       "119               Serine/threonine-protein kinase mTOR    T99685   \n",
       "120               Serine/threonine-protein kinase mTOR    T99685   \n",
       "121               Serine/threonine-protein kinase mTOR    T99685   \n",
       "122               Serine/threonine-protein kinase mTOR    T99685   \n",
       "123               Serine/threonine-protein kinase mTOR    T99685   \n",
       "124               Serine/threonine-protein kinase mTOR    T99685   \n",
       "125               Serine/threonine-protein kinase mTOR    T99685   \n",
       "126               Serine/threonine-protein kinase mTOR    T99685   \n",
       "127               Serine/threonine-protein kinase mTOR    T99685   \n",
       "128               Serine/threonine-protein kinase mTOR    T99685   \n",
       "129               Serine/threonine-protein kinase mTOR    T99685   \n",
       "130               Serine/threonine-protein kinase mTOR    T99685   \n",
       "131               Serine/threonine-protein kinase mTOR    T99685   \n",
       "132                      C-C chemokine receptor type 1    T16016   \n",
       "133                      C-C chemokine receptor type 1    T16016   \n",
       "134                      C-C chemokine receptor type 1    T16016   \n",
       "135         Cyclin-dependent kinase 5/CDK5 activator 1    T20973   \n",
       "136  Voltage-gated T-type calcium channel alpha-1H ...    T54644   \n",
       "137  Voltage-gated T-type calcium channel alpha-1H ...    T54644   \n",
       "138  Voltage-gated T-type calcium channel alpha-1H ...    T54644   \n",
       "139  Voltage-gated T-type calcium channel alpha-1H ...    T54644   \n",
       "140  Voltage-gated T-type calcium channel alpha-1H ...    T54644   \n",
       "141  Voltage-gated T-type calcium channel alpha-1H ...    T54644   \n",
       "142  Voltage-gated T-type calcium channel alpha-1H ...    T54644   \n",
       "143  Voltage-gated T-type calcium channel alpha-1H ...    T54644   \n",
       "144                   Cysteinyl leukotriene receptor 2    T74238   \n",
       "145      Sodium channel protein type III alpha subunit    T76937   \n",
       "146      Sodium channel protein type III alpha subunit    T76937   \n",
       "147      Sodium channel protein type III alpha subunit    T76937   \n",
       "148                     Serotonin 3a (5-HT3a) receptor    T64591   \n",
       "149                     Serotonin 3a (5-HT3a) receptor    T64591   \n",
       "150                     Serotonin 3a (5-HT3a) receptor    T64591   \n",
       "151                     Serotonin 3a (5-HT3a) receptor    T64591   \n",
       "152                     Serotonin 3a (5-HT3a) receptor    T64591   \n",
       "153                     Serotonin 3a (5-HT3a) receptor    T64591   \n",
       "154                     Serotonin 3a (5-HT3a) receptor    T64591   \n",
       "155          Multidrug resistance-associated protein 1    T11288   \n",
       "156                      Vitamin K-dependent protein C    T24836   \n",
       "157                      Vitamin K-dependent protein C    T24836   \n",
       "158                      Vitamin K-dependent protein C    T24836   \n",
       "159                      Vitamin K-dependent protein C    T24836   \n",
       "160                      Vitamin K-dependent protein C    T24836   \n",
       "161                      Vitamin K-dependent protein C    T24836   \n",
       "162                        Sodium/hydrogen exchanger 1    T82028   \n",
       "163                        Sodium/hydrogen exchanger 1    T82028   \n",
       "164                        Sodium/hydrogen exchanger 1    T82028   \n",
       "165                        Sodium/hydrogen exchanger 1    T82028   \n",
       "166                                PRMT5/MEP50 complex    T82665   \n",
       "167                                PRMT5/MEP50 complex    T82665   \n",
       "168                    Protein-tyrosine phosphatase 2C    T13057   \n",
       "169                                Acyl-CoA desaturase    T10897   \n",
       "170                                Acyl-CoA desaturase    T10897   \n",
       "171                                Acyl-CoA desaturase    T10897   \n",
       "172                                Acyl-CoA desaturase    T10897   \n",
       "173                                 P2X purinoceptor 7    T63414   \n",
       "174                                 P2X purinoceptor 7    T63414   \n",
       "175                                 P2X purinoceptor 7    T63414   \n",
       "176                                 P2X purinoceptor 7    T63414   \n",
       "177                                 P2X purinoceptor 7    T63414   \n",
       "178                                 P2X purinoceptor 7    T63414   \n",
       "179                                 P2X purinoceptor 7    T63414   \n",
       "180                                 P2X purinoceptor 7    T63414   \n",
       "181                                 P2X purinoceptor 7    T63414   \n",
       "182                                 P2X purinoceptor 7    T63414   \n",
       "183                                 P2X purinoceptor 7    T63414   \n",
       "184                                 P2X purinoceptor 7    T63414   \n",
       "185                                 P2X purinoceptor 7    T63414   \n",
       "186             C5a anaphylatoxin chemotactic receptor    T15439   \n",
       "187             C5a anaphylatoxin chemotactic receptor    T15439   \n",
       "188             C5a anaphylatoxin chemotactic receptor    T15439   \n",
       "189             C5a anaphylatoxin chemotactic receptor    T15439   \n",
       "190             C5a anaphylatoxin chemotactic receptor    T15439   \n",
       "191             C5a anaphylatoxin chemotactic receptor    T15439   \n",
       "192                          Cyclin-dependent kinase 5    T20973   \n",
       "193                                             ADAM10    T31902   \n",
       "194                                             ADAM10    T31902   \n",
       "195                                   Ghrelin receptor    T59604   \n",
       "196                                   Ghrelin receptor    T59604   \n",
       "197                                   Ghrelin receptor    T59604   \n",
       "198                                   Ghrelin receptor    T59604   \n",
       "199                                   Ghrelin receptor    T59604   \n",
       "200                                   Ghrelin receptor    T59604   \n",
       "201                                   Ghrelin receptor    T59604   \n",
       "202                                   Ghrelin receptor    T59604   \n",
       "203                                   Ghrelin receptor    T59604   \n",
       "204                                   Ghrelin receptor    T59604   \n",
       "205                                   Ghrelin receptor    T59604   \n",
       "206                                   Ghrelin receptor    T59604   \n",
       "207                                   Ghrelin receptor    T59604   \n",
       "208                                   Ghrelin receptor    T59604   \n",
       "209                                   Ghrelin receptor    T59604   \n",
       "210                                   Ghrelin receptor    T59604   \n",
       "211                                   Ghrelin receptor    T59604   \n",
       "212                                   Ghrelin receptor    T59604   \n",
       "213                         Ras-related protein Rab-9A    T66350   \n",
       "214                                Cytochrome P450 3A4    T37848   \n",
       "215                                Cytochrome P450 3A4    T37848   \n",
       "216  Neuronal acetylcholine receptor protein alpha-...    T34429   \n",
       "217  Neuronal acetylcholine receptor protein alpha-...    T34429   \n",
       "218  Neuronal acetylcholine receptor protein alpha-...    T34429   \n",
       "219  Neuronal acetylcholine receptor protein alpha-...    T34429   \n",
       "220  Neuronal acetylcholine receptor protein alpha-...    T34429   \n",
       "221  Neuronal acetylcholine receptor protein alpha-...    T34429   \n",
       "222  Neuronal acetylcholine receptor protein alpha-...    T34429   \n",
       "223  Neuronal acetylcholine receptor protein alpha-...    T34429   \n",
       "224  Neuronal acetylcholine receptor protein alpha-...    T34429   \n",
       "225  Neuronal acetylcholine receptor protein alpha-...    T34429   \n",
       "226  Neuronal acetylcholine receptor protein alpha-...    T34429   \n",
       "227  Neuronal acetylcholine receptor protein alpha-...    T34429   \n",
       "228  Neuronal acetylcholine receptor protein alpha-...    T34429   \n",
       "229  Neuronal acetylcholine receptor protein alpha-...    T34429   \n",
       "230  Neuronal acetylcholine receptor protein alpha-...    T34429   \n",
       "231  Neuronal acetylcholine receptor protein alpha-...    T34429   \n",
       "232  Neuronal acetylcholine receptor protein alpha-...    T34429   \n",
       "233  Neuronal acetylcholine receptor protein alpha-...    T34429   \n",
       "234            Histone-lysine N-methyltransferase EZH2    T25265   \n",
       "235            Histone-lysine N-methyltransferase EZH2    T25265   \n",
       "236            Histone-lysine N-methyltransferase EZH2    T25265   \n",
       "237            Histone-lysine N-methyltransferase EZH2    T25265   \n",
       "238            Histone-lysine N-methyltransferase EZH2    T25265   \n",
       "239            Histone-lysine N-methyltransferase EZH2    T25265   \n",
       "240            Histone-lysine N-methyltransferase EZH2    T25265   \n",
       "241            Histone-lysine N-methyltransferase EZH2    T25265   \n",
       "242            Histone-lysine N-methyltransferase EZH2    T25265   \n",
       "243            Histone-lysine N-methyltransferase EZH2    T25265   \n",
       "244                            Melanocortin receptor 3    T76846   \n",
       "245                            Melanocortin receptor 3    T76846   \n",
       "246                            Melanocortin receptor 3    T76846   \n",
       "247                            Melanocortin receptor 3    T76846   \n",
       "248                                  Androgen Receptor    T11211   \n",
       "249                                  Androgen Receptor    T11211   \n",
       "250                                  Androgen Receptor    T11211   \n",
       "251                                  Androgen Receptor    T11211   \n",
       "252                                  Androgen Receptor    T11211   \n",
       "253                                  Androgen Receptor    T11211   \n",
       "254                                  Androgen Receptor    T11211   \n",
       "255                                  Androgen Receptor    T11211   \n",
       "256                                  Androgen Receptor    T11211   \n",
       "257                                  Androgen Receptor    T11211   \n",
       "258                                  Androgen Receptor    T11211   \n",
       "259                                  Androgen Receptor    T11211   \n",
       "260                                  Androgen Receptor    T11211   \n",
       "261                                  Androgen Receptor    T11211   \n",
       "262                                  Androgen Receptor    T11211   \n",
       "263                                  Androgen Receptor    T11211   \n",
       "264                                  Androgen Receptor    T11211   \n",
       "265                                  Androgen Receptor    T11211   \n",
       "266                                  Androgen Receptor    T11211   \n",
       "267                                  Androgen Receptor    T11211   \n",
       "268                                  Androgen Receptor    T11211   \n",
       "269                                  Androgen Receptor    T11211   \n",
       "270                                  Androgen Receptor    T11211   \n",
       "271                                  Androgen Receptor    T11211   \n",
       "272                                  Androgen Receptor    T11211   \n",
       "273                                  Androgen Receptor    T11211   \n",
       "274                                  Androgen Receptor    T11211   \n",
       "275                                  Androgen Receptor    T11211   \n",
       "276                                  Androgen Receptor    T11211   \n",
       "277            Platelet-derived growth factor receptor    T53524   \n",
       "278            Platelet-derived growth factor receptor    T53524   \n",
       "279            Platelet-derived growth factor receptor    T53524   \n",
       "280            Platelet-derived growth factor receptor    T53524   \n",
       "281            Platelet-derived growth factor receptor    T53524   \n",
       "282            Platelet-derived growth factor receptor    T53524   \n",
       "283            Platelet-derived growth factor receptor    T53524   \n",
       "284            Platelet-derived growth factor receptor    T53524   \n",
       "285            Platelet-derived growth factor receptor    T53524   \n",
       "286            Platelet-derived growth factor receptor    T53524   \n",
       "287            Platelet-derived growth factor receptor    T53524   \n",
       "288            Platelet-derived growth factor receptor    T53524   \n",
       "289            Platelet-derived growth factor receptor    T53524   \n",
       "290            Platelet-derived growth factor receptor    T53524   \n",
       "291            Platelet-derived growth factor receptor    T53524   \n",
       "292            Platelet-derived growth factor receptor    T53524   \n",
       "293            Platelet-derived growth factor receptor    T53524   \n",
       "294            Platelet-derived growth factor receptor    T53524   \n",
       "295            Platelet-derived growth factor receptor    T53524   \n",
       "296            Platelet-derived growth factor receptor    T53524   \n",
       "297            Platelet-derived growth factor receptor    T53524   \n",
       "298            Platelet-derived growth factor receptor    T53524   \n",
       "299            Platelet-derived growth factor receptor    T53524   \n",
       "300            Platelet-derived growth factor receptor    T53524   \n",
       "301            Platelet-derived growth factor receptor    T53524   \n",
       "302            Platelet-derived growth factor receptor    T53524   \n",
       "303            Platelet-derived growth factor receptor    T53524   \n",
       "304            Platelet-derived growth factor receptor    T53524   \n",
       "305            Platelet-derived growth factor receptor    T53524   \n",
       "306            Platelet-derived growth factor receptor    T53524   \n",
       "307            Platelet-derived growth factor receptor    T53524   \n",
       "308            Platelet-derived growth factor receptor    T53524   \n",
       "309            Platelet-derived growth factor receptor    T53524   \n",
       "310                                         Galectin-3    T72038   \n",
       "311                                         Galectin-3    T72038   \n",
       "312                            Melanocortin receptor 5    T95302   \n",
       "313                            Melanocortin receptor 5    T95302   \n",
       "314                            Melanocortin receptor 5    T95302   \n",
       "315                  Solute carrier family 40 member 1    T86264   \n",
       "316                                          Trypsin I    T27602   \n",
       "317                                          Trypsin I    T27602   \n",
       "318                                          Trypsin I    T27602   \n",
       "319                                          Trypsin I    T27602   \n",
       "320                                          Trypsin I    T27602   \n",
       "321                                          Trypsin I    T27602   \n",
       "322                                          Trypsin I    T27602   \n",
       "323                                          Trypsin I    T27602   \n",
       "324                                          Trypsin I    T27602   \n",
       "325      Platelet-derived growth factor receptor alpha    T53524   \n",
       "326      Platelet-derived growth factor receptor alpha    T53524   \n",
       "327      Platelet-derived growth factor receptor alpha    T53524   \n",
       "328      Platelet-derived growth factor receptor alpha    T53524   \n",
       "329      Platelet-derived growth factor receptor alpha    T53524   \n",
       "330      Platelet-derived growth factor receptor alpha    T53524   \n",
       "331      Platelet-derived growth factor receptor alpha    T53524   \n",
       "332      Platelet-derived growth factor receptor alpha    T53524   \n",
       "333      Platelet-derived growth factor receptor alpha    T53524   \n",
       "334      Platelet-derived growth factor receptor alpha    T53524   \n",
       "335      Platelet-derived growth factor receptor alpha    T53524   \n",
       "336      Platelet-derived growth factor receptor alpha    T53524   \n",
       "337      Platelet-derived growth factor receptor alpha    T53524   \n",
       "338      Platelet-derived growth factor receptor alpha    T53524   \n",
       "339      Platelet-derived growth factor receptor alpha    T53524   \n",
       "340      Platelet-derived growth factor receptor alpha    T53524   \n",
       "341      Platelet-derived growth factor receptor alpha    T53524   \n",
       "342      Platelet-derived growth factor receptor alpha    T53524   \n",
       "343      Platelet-derived growth factor receptor alpha    T53524   \n",
       "344      Platelet-derived growth factor receptor alpha    T53524   \n",
       "345      Platelet-derived growth factor receptor alpha    T53524   \n",
       "346      Platelet-derived growth factor receptor alpha    T53524   \n",
       "347                      C-C chemokine receptor type 2    T89988   \n",
       "348                      C-C chemokine receptor type 2    T89988   \n",
       "349                      C-C chemokine receptor type 2    T89988   \n",
       "350                      C-C chemokine receptor type 2    T89988   \n",
       "351                      C-C chemokine receptor type 2    T89988   \n",
       "352                      C-C chemokine receptor type 2    T89988   \n",
       "353                      C-C chemokine receptor type 2    T89988   \n",
       "354                      C-C chemokine receptor type 2    T89988   \n",
       "355                      C-C chemokine receptor type 2    T89988   \n",
       "356                      C-C chemokine receptor type 2    T89988   \n",
       "357                      C-C chemokine receptor type 2    T89988   \n",
       "358                      C-C chemokine receptor type 2    T89988   \n",
       "359                      C-C chemokine receptor type 2    T89988   \n",
       "360                      C-C chemokine receptor type 2    T89988   \n",
       "361                      C-C chemokine receptor type 2    T89988   \n",
       "362                      C-C chemokine receptor type 2    T89988   \n",
       "363                      C-C chemokine receptor type 2    T89988   \n",
       "364                       ALK tyrosine kinase receptor    T56418   \n",
       "365                       ALK tyrosine kinase receptor    T56418   \n",
       "366                       ALK tyrosine kinase receptor    T56418   \n",
       "367                       ALK tyrosine kinase receptor    T56418   \n",
       "368                       ALK tyrosine kinase receptor    T56418   \n",
       "369                       ALK tyrosine kinase receptor    T56418   \n",
       "370                       ALK tyrosine kinase receptor    T56418   \n",
       "371                       ALK tyrosine kinase receptor    T56418   \n",
       "372                       ALK tyrosine kinase receptor    T56418   \n",
       "373                Cyclin-dependent kinase 1/cyclin B1    T49898   \n",
       "374                Cyclin-dependent kinase 1/cyclin B1    T49898   \n",
       "375                Cyclin-dependent kinase 1/cyclin B1    T49898   \n",
       "376                Cyclin-dependent kinase 1/cyclin B1    T49898   \n",
       "377                Cyclin-dependent kinase 1/cyclin B1    T49898   \n",
       "378                Cyclin-dependent kinase 1/cyclin B1    T49898   \n",
       "379                Cyclin-dependent kinase 1/cyclin B1    T49898   \n",
       "380                Cyclin-dependent kinase 1/cyclin B1    T49898   \n",
       "381                Cyclin-dependent kinase 1/cyclin B1    T49898   \n",
       "382                Cyclin-dependent kinase 1/cyclin B1    T49898   \n",
       "383                Cyclin-dependent kinase 1/cyclin B1    T49898   \n",
       "384                              Histone deacetylase 2    T51191   \n",
       "385                              Histone deacetylase 2    T51191   \n",
       "386                  Plasminogen activator inhibitor-1    T15556   \n",
       "387                  Plasminogen activator inhibitor-1    T15556   \n",
       "388                  Plasminogen activator inhibitor-1    T15556   \n",
       "389      3-phosphoinositide dependent protein kinase-1    T20891   \n",
       "390      3-phosphoinositide dependent protein kinase-1    T20891   \n",
       "391                                        Cathepsin L    T41141   \n",
       "392                                        Cathepsin L    T41141   \n",
       "393                                        Cathepsin L    T41141   \n",
       "394                                        Cathepsin L    T41141   \n",
       "395                                        Cathepsin L    T41141   \n",
       "396                                        Cathepsin L    T41141   \n",
       "397                                        Cathepsin L    T41141   \n",
       "398                                        Cathepsin L    T41141   \n",
       "399                                        Cathepsin L    T41141   \n",
       "400                                        Cathepsin L    T41141   \n",
       "401                                        Cathepsin L    T41141   \n",
       "402                                        Cathepsin L    T41141   \n",
       "403                                        Cathepsin L    T41141   \n",
       "404                                        Cathepsin L    T41141   \n",
       "405                                        Cathepsin L    T41141   \n",
       "406                                        Cathepsin L    T41141   \n",
       "407                                        Cathepsin L    T41141   \n",
       "408                                        Cathepsin L    T41141   \n",
       "409        Isocitrate dehydrogenase [NADP] cytoplasmic    T69563   \n",
       "410        Isocitrate dehydrogenase [NADP] cytoplasmic    T69563   \n",
       "411        Isocitrate dehydrogenase [NADP] cytoplasmic    T69563   \n",
       "412              Glutamate receptor ionotropic, AMPA 2    T42392   \n",
       "413              Glutamate receptor ionotropic, AMPA 2    T42392   \n",
       "414                    Tyrosine-protein kinase ITK/TSK    T91761   \n",
       "415                    Tyrosine-protein kinase ITK/TSK    T91761   \n",
       "416                    Tyrosine-protein kinase ITK/TSK    T91761   \n",
       "417      Neuronal acetylcholine receptor; alpha4/beta4    T73724   \n",
       "418      Neuronal acetylcholine receptor; alpha4/beta4    T73724   \n",
       "419      Neuronal acetylcholine receptor; alpha4/beta4    T73724   \n",
       "420      Neuronal acetylcholine receptor; alpha4/beta4    T73724   \n",
       "421      Neuronal acetylcholine receptor; alpha4/beta4    T73724   \n",
       "422      Neuronal acetylcholine receptor; alpha4/beta4    T73724   \n",
       "423      Neuronal acetylcholine receptor; alpha4/beta4    T73724   \n",
       "424                        Indoleamine 2,3-dioxygenase    T89697   \n",
       "425                        Indoleamine 2,3-dioxygenase    T89697   \n",
       "426                        Indoleamine 2,3-dioxygenase    T89697   \n",
       "427                        Indoleamine 2,3-dioxygenase    T89697   \n",
       "428                        Indoleamine 2,3-dioxygenase    T89697   \n",
       "429                        Indoleamine 2,3-dioxygenase    T89697   \n",
       "430                        Indoleamine 2,3-dioxygenase    T89697   \n",
       "431                        Indoleamine 2,3-dioxygenase    T89697   \n",
       "432                        Indoleamine 2,3-dioxygenase    T89697   \n",
       "433                        Indoleamine 2,3-dioxygenase    T89697   \n",
       "434                        Indoleamine 2,3-dioxygenase    T89697   \n",
       "435                        Indoleamine 2,3-dioxygenase    T89697   \n",
       "436                        Indoleamine 2,3-dioxygenase    T89697   \n",
       "437                        Indoleamine 2,3-dioxygenase    T89697   \n",
       "438                        Indoleamine 2,3-dioxygenase    T89697   \n",
       "439                        Indoleamine 2,3-dioxygenase    T89697   \n",
       "440                        Indoleamine 2,3-dioxygenase    T89697   \n",
       "441                        Indoleamine 2,3-dioxygenase    T89697   \n",
       "442                        Indoleamine 2,3-dioxygenase    T89697   \n",
       "443                        Indoleamine 2,3-dioxygenase    T89697   \n",
       "444             Macrophage migration inhibitory factor    T39977   \n",
       "445             Macrophage migration inhibitory factor    T39977   \n",
       "446             Macrophage migration inhibitory factor    T39977   \n",
       "447                    PI3-kinase p110-alpha/p85-alpha    T80276   \n",
       "448                    PI3-kinase p110-alpha/p85-alpha    T80276   \n",
       "449                    PI3-kinase p110-alpha/p85-alpha    T80276   \n",
       "450                    PI3-kinase p110-alpha/p85-alpha    T80276   \n",
       "451                    PI3-kinase p110-alpha/p85-alpha    T80276   \n",
       "452             11-beta-hydroxysteroid dehydrogenase 2    T43721   \n",
       "453                                 Relaxin receptor 1    T73696   \n",
       "454                             Protein kinase C alpha    T12808   \n",
       "455                             Protein kinase C alpha    T12808   \n",
       "456                             Protein kinase C alpha    T12808   \n",
       "457                                 Hexokinase type IV    T87166   \n",
       "458                                 Hexokinase type IV    T87166   \n",
       "459                                 Hexokinase type IV    T87166   \n",
       "\n",
       "                                            Indication Probability  \\\n",
       "0                     Hypertension [ICD-11: BA00-BA04]      91.51%   \n",
       "1                    Multiple sclerosis [ICD-11: 8A40]      91.51%   \n",
       "2    Attention deficit hyperactivity disorder [ICD-...      88.35%   \n",
       "3         Acute lymphoblastic leukaemia [ICD-11: 2A85]      81.39%   \n",
       "4                      Arteriosclerosis [ICD-11: BD40]      81.39%   \n",
       "5               Hypercholesterolaemia [ICD-11: 5C80.0]      81.39%   \n",
       "6                       Hyperlipidaemia [ICD-11: 5C80]      81.39%   \n",
       "7           Peripheral vascular disease [ICD-11: BD4Z]      81.39%   \n",
       "8                  Peroxisomal disorder [ICD-11: 5C57]      81.39%   \n",
       "9               Synthesis disorder [ICD-11: 5C52-5C59]      81.39%   \n",
       "10                    Malnutrition [ICD-11: 5B50-5B71]      80.31%   \n",
       "11                       Muscle spasm [ICD-11: MB47.3]      79.44%   \n",
       "12                Cholangiocarcinoma [ICD-11: 2C12.10]      79.37%   \n",
       "13             Solid tumour/cancer [ICD-11: 2A00-2F9Z]      79.37%   \n",
       "14                       Bladder cancer [ICD-11: 2C94]      78.78%   \n",
       "15                      Cushing disease [ICD-11: 5A70]      78.78%   \n",
       "16             Dermatological disease [ICD-11: DA24.Y]      78.78%   \n",
       "17                  Diabetic neuropathy [ICD-11: 8C0Z]      78.78%   \n",
       "18                        Endometriosis [ICD-11: GA10]      78.78%   \n",
       "19   Hormonally-responsive breast cancer [ICD-11: 2...      78.78%   \n",
       "20                     Prostate disease [ICD-11: GA91]      78.78%   \n",
       "21             Solid tumour/cancer [ICD-11: 2A00-2F9Z]       78.4%   \n",
       "22                   Psoriasis vulgaris [ICD-11: EA90]      77.49%   \n",
       "23              Metabolic disorder [ICD-11: 5C50-5D2Z]      77.18%   \n",
       "24                      Type-2 diabetes [ICD-11: 5A11]      77.18%   \n",
       "25                  Inflammation [ICD-11: 1A00-CA43.1]      75.29%   \n",
       "26                         Peptic ulcer [ICD-11: DA61]      75.29%   \n",
       "27                    Alzheimer disease [ICD-11: 8A20]      75.23%   \n",
       "28                               Asthma [ICD-11: CA23]      75.23%   \n",
       "29                          Bone cancer [ICD-11: 2B5Z]      75.23%   \n",
       "30                  Cancer related pain [ICD-11: MG30]      75.23%   \n",
       "31                    Cerebral ischemia [ICD-11: 8B11]      75.23%   \n",
       "32   Chronic obstructive pulmonary disease [ICD-11:...      75.23%   \n",
       "33                            Cirrhosis [ICD-11: DB93]      75.23%   \n",
       "34             Gastrointestinal disease [ICD-11: DE2Z]      75.23%   \n",
       "35                             Glioma [ICD-11: 2A00.0]      75.23%   \n",
       "36                            Hair loss [ICD-11: ED70]      75.23%   \n",
       "37                   Hepatic fibrosis [ICD-11: DB93.0]      75.23%   \n",
       "38                    Meningioma tumour [ICD-11: 2A01]      75.23%   \n",
       "39               Metastatic cancer [ICD-11: 2D50-2E2Z]      75.23%   \n",
       "40                   Multiple sclerosis [ICD-11: 8A40]      75.23%   \n",
       "41      Neurodegenerative disorder [ICD-11: 8A20-8A23]      75.23%   \n",
       "42                  Osteoarthritis [ICD-11: FA00-FA05]      75.23%   \n",
       "43                    Pancreatitis [ICD-11: DC31-DC34]      75.23%   \n",
       "44                   Psoriasis vulgaris [ICD-11: EA90]      75.23%   \n",
       "45                 Rheumatoid arthritis [ICD-11: FA20]      75.23%   \n",
       "46                     Arteriosclerosis [ICD-11: BD40]      74.67%   \n",
       "47                  Colorectal cancer [ICD-11: 2B91.Z]      74.27%   \n",
       "48             Solid tumour/cancer [ICD-11: 2A00-2F9Z]      74.27%   \n",
       "49                Anxiety disorder [ICD-11: 6B00-6B0Z]      73.79%   \n",
       "50                 Cardiac failure [ICD-11: BD10-BD13]      73.79%   \n",
       "51                  High blood pressure [ICD-11: BA00]      73.79%   \n",
       "52                             Migraine [ICD-11: 8A80]      73.79%   \n",
       "53                   Neuropathic pain [ICD-11: 8E43.0]      73.79%   \n",
       "54                            Pain [ICD-11: MG30-MG3Z]      73.79%   \n",
       "55                 Reperfusion injury [ICD-11: ND56.Z]      73.79%   \n",
       "56             Traumatic brain injury [ICD-11: NA07.Z]      73.79%   \n",
       "57                     Vascular purpura [ICD-11: 3B60]      73.79%   \n",
       "58             Solid tumour/cancer [ICD-11: 2A00-2F9Z]      70.97%   \n",
       "59                            Arthritis [ICD-11: FA20]      70.35%   \n",
       "60                   Breast cancer [ICD-11: 2C60-2C65]      70.35%   \n",
       "61      Chronic lymphocytic leukaemia [ICD-11: 2A82.0]      70.35%   \n",
       "62   Coronavirus Disease 2019 (COVID-19) [ICD-11: 1...      70.35%   \n",
       "63            Cutaneous T-cell lymphoma [ICD-11: 2B01]      70.35%   \n",
       "64        Diffuse large B-cell lymphoma [ICD-11: 2A81]      70.35%   \n",
       "65                  Follicular lymphoma [ICD-11: 2A80]      70.35%   \n",
       "66                  Follicular lymphoma [ICD-11: 2A80]      70.35%   \n",
       "67                 Hematologic tumour [ICD-11: 2B33.Y]      70.35%   \n",
       "68                        Lymphoma [ICD-11: 2A80-2A86]      70.35%   \n",
       "69               Mantle cell lymphoma [ICD-11: 2A85.5]      70.35%   \n",
       "70             Marginal zone lymphoma [ICD-11: 2A85.0]      70.35%   \n",
       "71                  Myeloid leukaemia [ICD-11: 2B33.1]      70.35%   \n",
       "72               Non-hodgkin lymphoma [ICD-11: 2B33.5]      70.35%   \n",
       "73             Solid tumour/cancer [ICD-11: 2A00-2F9Z]      70.35%   \n",
       "74      Acute and chronic heart failure [ICD-11: BD1Z]      69.38%   \n",
       "75                    Alzheimer disease [ICD-11: 8A20]      69.38%   \n",
       "76                              Apnea [ICD-11: MD11.0]      69.38%   \n",
       "77                               Asthma [ICD-11: CA23]      69.38%   \n",
       "78       Herpes simplex virus infection [ICD-11: 1F00]      69.38%   \n",
       "79                    Hypertension [ICD-11: BA00-BA04]      69.38%   \n",
       "80                   Multiple sclerosis [ICD-11: 8A40]      69.38%   \n",
       "81       Non-insulin dependent diabetes [ICD-11: 5A11]      69.38%   \n",
       "82         Non-small-cell lung cancer [ICD-11: 2C25.Y]      69.38%   \n",
       "83                  Parkinson disease [ICD-11: 8A00.0]      69.38%   \n",
       "84   Paroxysmal supraventricular tachycardia [ICD-1...      69.38%   \n",
       "85             Solid tumour/cancer [ICD-11: 2A00-2F9Z]      69.38%   \n",
       "86                  Acute lung injury [ICD-11: NB32.3]      68.66%   \n",
       "87                      Cystic fibrosis [ICD-11: CA25]      68.66%   \n",
       "88                           Diarrhea [ICD-11: ME05.1]      68.66%   \n",
       "89             HIV-associated diarrhoea [ICD-11: 1A2Z]      68.66%   \n",
       "90                         Allergy [ICD-11: 4A80-4A85]      68.63%   \n",
       "91                  Autoimmune diabetes [ICD-11: 5A10]      68.63%   \n",
       "92       Hepatitis virus infection [ICD-11: 1E50-1E51]      68.63%   \n",
       "93                             Melanoma [ICD-11: 2C30]      68.63%   \n",
       "94               Non-hodgkin lymphoma [ICD-11: 2B33.5]      68.63%   \n",
       "95                    Prostate cancer [ICD-11: 2C82.0]      68.63%   \n",
       "96                          Sepsis [ICD-11: 1G40-1G41]      68.63%   \n",
       "97             Solid tumour/cancer [ICD-11: 2A00-2F9Z]      68.63%   \n",
       "98                   Multiple sclerosis [ICD-11: 8A40]      67.76%   \n",
       "99    Advanced/metastatic breast cancer [ICD-11: 2C60]      67.71%   \n",
       "100                     Artery stenosis [ICD-11: BD52]      67.71%   \n",
       "101                  Breast cancer [ICD-11: 2C60-2C65]      67.71%   \n",
       "102                  Breast cancer [ICD-11: 2C60-2C65]      67.71%   \n",
       "103    Chronic myelomonocytic leukaemia [ICD-11: 2A40]      67.71%   \n",
       "104  Coronavirus Disease 2019 (COVID-19) [ICD-11: 1...      67.71%   \n",
       "105                   Dutch elm disease [ICD-11: 8D64]      67.71%   \n",
       "106                  Endometrial cancer [ICD-11: 2C76]      67.71%   \n",
       "107                Head and neck cancer [ICD-11: 2D42]      67.71%   \n",
       "108         Hepatocellular carcinoma [ICD-11: 2C12.02]      67.71%   \n",
       "109                 Inflammation [ICD-11: 1A00-CA43.1]      67.71%   \n",
       "110                     Kidney cancer [ICD-11: 2C90.0]      67.71%   \n",
       "111                       Lung cancer [ICD-11: 2C25.0]      67.71%   \n",
       "112            Lymphangioleiomyomatosis [ICD-11: CB07]      67.71%   \n",
       "113            Lymphangioleiomyomatosis [ICD-11: CB07]      67.71%   \n",
       "114                       Lymphoma [ICD-11: 2A80-2A86]      67.71%   \n",
       "115            Malignant mesothelioma [ICD-11: 2C26.0]      67.71%   \n",
       "116  Malignant perivascular epithelioid cell tumour...      67.71%   \n",
       "117  Middle East Respiratory Syndrome (MERS) [ICD-1...      67.71%   \n",
       "118                    Multiple myeloma [ICD-11: 2A83]      67.71%   \n",
       "119              Non-hodgkin lymphoma [ICD-11: 2B33.5]      67.71%   \n",
       "120  Non-muscle invasive bladder cancer [ICD-11: 2C94]      67.71%   \n",
       "121        Non-small-cell lung cancer [ICD-11: 2C25.Y]      67.71%   \n",
       "122          Organ transplant rejection [ICD-11: NE84]      67.71%   \n",
       "123                           Pain [ICD-11: MG30-MG3Z]      67.71%   \n",
       "124                   Pancreatic cancer [ICD-11: 2C10]      67.71%   \n",
       "125                   Prostate cancer [ICD-11: 2C82.0]      67.71%   \n",
       "126   Pulmonary arterial hypertension [ICD-11: BB01.0]      67.71%   \n",
       "127                Renal cell carcinoma [ICD-11: 2C90]      67.71%   \n",
       "128                        Sarcoma [ICD-11: 2A60-2C35]      67.71%   \n",
       "129  Severe acute respiratory syndrome (SARS) [ICD-...      67.71%   \n",
       "130            Solid tumour/cancer [ICD-11: 2A00-2F9Z]      67.71%   \n",
       "131                  Ulcerative colitis [ICD-11: DD71]      67.71%   \n",
       "132                 Autoimmune diabetes [ICD-11: 5A10]      66.28%   \n",
       "133  Chronic obstructive pulmonary disease [ICD-11:...      66.28%   \n",
       "134                Rheumatoid arthritis [ICD-11: FA20]      66.28%   \n",
       "135                             Obesity [ICD-11: 5B81]      65.63%   \n",
       "136                     Angina pectoris [ICD-11: BA40]      65.01%   \n",
       "137           Glioblastoma multiforme [ICD-11: 2A00.0]      65.01%   \n",
       "138                       Insomnia [ICD-11: 7A00-7A0Z]      65.01%   \n",
       "139                  Metabolic acidosis [ICD-11: 5C73]      65.01%   \n",
       "140                            Migraine [ICD-11: 8A80]      65.01%   \n",
       "141                      Ovarian cancer [ICD-11: 2C73]      65.01%   \n",
       "142                           Pain [ICD-11: MG30-MG3Z]      65.01%   \n",
       "143            Solid tumour/cancer [ICD-11: 2A00-2F9Z]      65.01%   \n",
       "144                              Asthma [ICD-11: CA23]      64.94%   \n",
       "145                     Angina pectoris [ICD-11: BA40]      63.75%   \n",
       "146               Neurological disorder [ICD-11: 6B60]      63.75%   \n",
       "147                           Pain [ICD-11: MG30-MG3Z]      63.75%   \n",
       "148                       Anaesthesia [ICD-11: 9A78.6]      63.59%   \n",
       "149         Chemotherapy-induced nausea [ICD-11: MD90]      63.59%   \n",
       "150                       Epilepsy [ICD-11: 8A60-8A68]      63.59%   \n",
       "151                     Fibromyalgia [ICD-11: MG30.01]      63.59%   \n",
       "152   Gastroesophageal reflux disease [ICD-11: DA22.Z]      63.59%   \n",
       "153          Irritable bowel syndrome [ICD-11: DD91.0]      63.59%   \n",
       "154                       Schizophrenia [ICD-11: 6A20]      63.59%   \n",
       "155                                Gout [ICD-11: FA25]       62.6%   \n",
       "156      Blood forming organ disorder [ICD-11: JB64.1]       62.4%   \n",
       "157         Cardiovascular disease [ICD-11: BA00-BE2Z]       62.4%   \n",
       "158           Cerebrovascular ischaemia [ICD-11: 8B1Z]       62.4%   \n",
       "159                     Hemangioma [ICD-11: 2E81-2F2Y]       62.4%   \n",
       "160                  Ischemic stroke [ICD-11: 8B11.5Z]       62.4%   \n",
       "161  Varicose and spider veins of leg [ICD-11: BD74.1]       62.4%   \n",
       "162                     Angina pectoris [ICD-11: BA40]      61.84%   \n",
       "163                 Cardiac arrhythmias [ICD-11: BC9Z]      61.84%   \n",
       "164                    Heart arrhythmia [ICD-11: BC65]      61.84%   \n",
       "165          Myocardial infarction [ICD-11: BA41-BA43]      61.84%   \n",
       "166              Non-hodgkin lymphoma [ICD-11: 2B33.5]      61.53%   \n",
       "167            Solid tumour/cancer [ICD-11: 2A00-2F9Z]      61.53%   \n",
       "168            Solid tumour/cancer [ICD-11: 2A00-2F9Z]       61.2%   \n",
       "169            Bacterial infection [ICD-11: 1A00-1C4Z]      60.11%   \n",
       "170               Diabetic complication [ICD-11: 5A2Y]      60.11%   \n",
       "171         Lipid metabolism disorder [ICD-11: 5C52.Z]      60.11%   \n",
       "172                     Type-2 diabetes [ICD-11: 5A11]      60.11%   \n",
       "173                   Alzheimer disease [ICD-11: 8A20]      58.78%   \n",
       "174                         Anhedonia [ICD-11: MB24.2]      58.78%   \n",
       "175                          Arthralgia [ICD-11: ME82]      58.78%   \n",
       "176                 Autoimmune diabetes [ICD-11: 5A10]      58.78%   \n",
       "177  Chronic obstructive pulmonary disease [ICD-11:...      58.78%   \n",
       "178                 Inflammation [ICD-11: 1A00-CA43.1]      58.78%   \n",
       "179          Inflammatory bowel disease [ICD-11: DD72]      58.78%   \n",
       "180         Major depressive disorder [ICD-11: 6A70.3]      58.78%   \n",
       "181                  Mood disorder [ICD-11: 6A60-6E23]      58.78%   \n",
       "182                   Neuroinflammation [ICD-11: 1D0Y]      58.78%   \n",
       "183                           Pain [ICD-11: MG30-MG3Z]      58.78%   \n",
       "184                Rheumatoid arthritis [ICD-11: FA20]      58.78%   \n",
       "185            Solid tumour/cancer [ICD-11: 2A00-2F9Z]      58.78%   \n",
       "186                   Atopic dermatitis [ICD-11: EA80]      58.71%   \n",
       "187  Eosinophilic granulomatosis with polyangiitis ...      58.71%   \n",
       "188      Hereditary haemolytic anemia [ICD-11: 3A10.3]      58.71%   \n",
       "189                 Inflammation [ICD-11: 1A00-CA43.1]      58.71%   \n",
       "190                Rheumatoid arthritis [ICD-11: FA20]      58.71%   \n",
       "191                          Vasculitis [ICD-11: 4A44]      58.71%   \n",
       "192                             Obesity [ICD-11: 5B81]      58.13%   \n",
       "193                  Breast cancer [ICD-11: 2C60-2C65]      57.77%   \n",
       "194            Solid tumour/cancer [ICD-11: 2A00-2F9Z]      57.77%   \n",
       "195                Alcohol dependence [ICD-11: 6C40.2]       57.7%   \n",
       "196           Anorexia nervosa cachexia [ICD-11: 6B80]       57.7%   \n",
       "197                            Cachexia [ICD-11: MG20]       57.7%   \n",
       "198  Carbohydrate metabolism disorder [ICD-11: 5C51.Z]       57.7%   \n",
       "199                     Fibromyalgia [ICD-11: MG30.01]       57.7%   \n",
       "200                             Frailty [ICD-11: MG2A]       57.7%   \n",
       "201           Functional bowel disorder [ICD-11: DD91]       57.7%   \n",
       "202           Gastric motility disorder [ICD-11: DA21]       57.7%   \n",
       "203            Gastrointestinal disease [ICD-11: DE2Z]       57.7%   \n",
       "204                    Gastroparesis [ICD-11: DA41.00]       57.7%   \n",
       "205         Growth hormone deficiency [ICD-11: 5A61.3]       57.7%   \n",
       "206                             Ileus [ICD-11: DA93.0]       57.7%   \n",
       "207             Metabolic disorder [ICD-11: 5C50-5D2Z]       57.7%   \n",
       "208                             Obesity [ICD-11: 5B81]       57.7%   \n",
       "209            Postoperative ileus [ICD-11: DA91-DB30]       57.7%   \n",
       "210            Solid tumour/cancer [ICD-11: 2A00-2F9Z]       57.7%   \n",
       "211           Somatotropin deficiency [ICD-11: 5A61.0]       57.7%   \n",
       "212                     Type-2 diabetes [ICD-11: 5A11]       57.7%   \n",
       "213               Fungal infection [ICD-11: 1F29-1F2F]      57.22%   \n",
       "214                   Atopic dermatitis [ICD-11: EA80]      57.14%   \n",
       "215            Solid tumour/cancer [ICD-11: 2A00-2F9Z]      57.14%   \n",
       "216                   Alzheimer disease [ICD-11: 8A20]       57.1%   \n",
       "217                       Anaesthesia [ICD-11: 9A78.6]       57.1%   \n",
       "218                              Asthma [ICD-11: CA23]       57.1%   \n",
       "219  Attention deficit hyperactivity disorder [ICD-...       57.1%   \n",
       "220                  Breast cancer [ICD-11: 2C60-2C65]       57.1%   \n",
       "221  Central nervous system disease [ICD-11: 8A04-8...       57.1%   \n",
       "222                Cognitive impairment [ICD-11: 6D71]       57.1%   \n",
       "223  Complete androgen insensitivity syndrome [ICD-...       57.1%   \n",
       "224                     Depression [ICD-11: 6A70-6A7Z]       57.1%   \n",
       "225              Immune dysregulation [ICD-11: 4A01.2]       57.1%   \n",
       "226               Neurological disorder [ICD-11: 6B60]       57.1%   \n",
       "227                  Neuropathic pain [ICD-11: 8E43.0]       57.1%   \n",
       "228                 Parkinson disease [ICD-11: 8A00.0]       57.1%   \n",
       "229                Psychiatric disorder [ICD-11: 6E8Z]       57.1%   \n",
       "230                       Schizophrenia [ICD-11: 6A20]       57.1%   \n",
       "231             Sexual dysfunction [ICD-11: HA00-HA01]       57.1%   \n",
       "232                     Thrombosis [ICD-11: DB61-GB90]       57.1%   \n",
       "233                Tobacco dependence [ICD-11: 6C4A.2]       57.1%   \n",
       "234       Acute lymphoblastic leukaemia [ICD-11: 2A85]      56.86%   \n",
       "235             Acute myeloid leukaemia [ICD-11: 2A60]      56.86%   \n",
       "236                     B-cell lymphoma [ICD-11: 2A86]      56.86%   \n",
       "237  Brain and central nervous system tumour [ICD-1...      56.86%   \n",
       "238       Diffuse large B-cell lymphoma [ICD-11: 2A81]      56.86%   \n",
       "239        Malignant rhabdoid tumour [ICD-11: 2A00.1Y]      56.86%   \n",
       "240                      Mesothelioma [ICD-11: 2C51.2]      56.86%   \n",
       "241                   Prostate cancer [ICD-11: 2C82.0]      56.86%   \n",
       "242            Solid tumour/cancer [ICD-11: 2A00-2F9Z]      56.86%   \n",
       "243                    Synovial sarcoma [ICD-11: 2B5A]      56.86%   \n",
       "244  Female sexual arousal dysfunction [ICD-11: HA0...      56.76%   \n",
       "245                             Obesity [ICD-11: 5B81]      56.76%   \n",
       "246             Sexual dysfunction [ICD-11: HA00-HA01]      56.76%   \n",
       "247                     Type-2 diabetes [ICD-11: 5A11]      56.76%   \n",
       "248                       Acne vulgaris [ICD-11: ED80]      56.55%   \n",
       "249             Acute myeloid leukaemia [ICD-11: 2A60]      56.55%   \n",
       "250               Alcoholic hepatitis [ICD-11: DB94.1]      56.55%   \n",
       "251                            Alopecia [ICD-11: ED70]      56.55%   \n",
       "252                      Bladder cancer [ICD-11: 2C94]      56.55%   \n",
       "253                  Breast cancer [ICD-11: 2C60-2C65]      56.55%   \n",
       "254                            Cachexia [ICD-11: MG20]      56.55%   \n",
       "255         Cardiovascular disease [ICD-11: BA00-BE2Z]      56.55%   \n",
       "256      Cerebral salt-wasting syndrome [ICD-11: 5C72]      56.55%   \n",
       "257  Chronic obstructive pulmonary disease [ICD-11:...      56.55%   \n",
       "258                       Contraception [ICD-11: QA21]      56.55%   \n",
       "259                     Cystic fibrosis [ICD-11: CA25]      56.55%   \n",
       "260            Dermatological disease [ICD-11: DA24.Y]      56.55%   \n",
       "261                  Duchenne dystrophy [ICD-11: 8C70]      56.55%   \n",
       "262                      Dysmenorrhea [ICD-11: GA34.3]      56.55%   \n",
       "263                   Endocrine disease [ICD-11: 5B3Z]      56.55%   \n",
       "264                  Heart failure [ICD-11: BD10-BD13]      56.55%   \n",
       "265                Hormone deficiency [ICD-11: 5A61.1]      56.55%   \n",
       "266                      Hypogonadism [ICD-11: 5A61.0]      56.55%   \n",
       "267            Male hormonal deficiency [ICD-11: 5A81]      56.55%   \n",
       "268                 Mammary tumour [ICD-11: 2C60-2C6Z]      56.55%   \n",
       "269                    Muscle atrophy [ICD-11: FB32.Y]      56.55%   \n",
       "270               Neurological disorder [ICD-11: 6B60]      56.55%   \n",
       "271                      Osteoporosis [ICD-11: FB83.0]      56.55%   \n",
       "272                           Pain [ICD-11: MG30-MG3Z]      56.55%   \n",
       "273                   Prostate cancer [ICD-11: 2C82.0]      56.55%   \n",
       "274                Prostate hyperplasia [ICD-11: GA90]      56.55%   \n",
       "275            Solid tumour/cancer [ICD-11: 2A00-2F9Z]      56.55%   \n",
       "276           Testosterone deficiency [ICD-11: 5A81.1]      56.55%   \n",
       "277         Acute myelogenous leukaemia [ICD-11: 2A41]      55.66%   \n",
       "278             Acute myeloid leukaemia [ICD-11: 2A60]      55.66%   \n",
       "279                   Alzheimer disease [ICD-11: 8A20]      55.66%   \n",
       "280                      Brain injury [ICD-11: NA07.Z]      55.66%   \n",
       "281                  Breast cancer [ICD-11: 2C60-2C65]      55.66%   \n",
       "282                      Colon cancer [ICD-11: 2B90.Z]      55.66%   \n",
       "283                 Colorectal cancer [ICD-11: 2B91.Z]      55.66%   \n",
       "284               Diabetic complication [ICD-11: 5A2Y]      55.66%   \n",
       "285              Gastric adenocarcinoma [ICD-11: 2B72]      55.66%   \n",
       "286             Gastrointestinal cancer [ICD-11: 2C11]      55.66%   \n",
       "287     Gastrointestinal stromal tumour [ICD-11: 2B5B]      55.66%   \n",
       "288           Glioblastoma multiforme [ICD-11: 2A00.0]      55.66%   \n",
       "289  Gram-positive bacterial infection [ICD-11: 1B7...      55.66%   \n",
       "290  Gram-positive bacterial infection [ICD-11: 1B7...      55.66%   \n",
       "291         Hepatocellular carcinoma [ICD-11: 2C12.02]      55.66%   \n",
       "292                       Lung cancer [ICD-11: 2C25.0]      55.66%   \n",
       "293              Mast cell leukaemia [ICD-11: 2A21.00]      55.66%   \n",
       "294                    Multiple myeloma [ICD-11: 2A83]      55.66%   \n",
       "295                    Multiple myeloma [ICD-11: 2A83]      55.66%   \n",
       "296            Myelodysplastic syndrome [ICD-11: 2A37]      55.66%   \n",
       "297            Myelodysplastic syndrome [ICD-11: 2A37]      55.66%   \n",
       "298        Non-small-cell lung cancer [ICD-11: 2C25.Y]      55.66%   \n",
       "299        Non-small-cell lung cancer [ICD-11: 2C25.Y]      55.66%   \n",
       "300                   Pancreatic cancer [ICD-11: 2C10]      55.66%   \n",
       "301                   Prostate cancer [ICD-11: 2C82.0]      55.66%   \n",
       "302           Recurrent glioblastoma [ICD-11: 2A00.00]      55.66%   \n",
       "303                Renal cell carcinoma [ICD-11: 2C90]      55.66%   \n",
       "304                 Soft tissue sarcoma [ICD-11: 2B57]      55.66%   \n",
       "305            Solid tumour/cancer [ICD-11: 2A00-2F9Z]      55.66%   \n",
       "306            Solid tumour/cancer [ICD-11: 2A00-2F9Z]      55.66%   \n",
       "307             Systemic mastocytosis [ICD-11: 2A21.0]      55.66%   \n",
       "308                    Thrombocytopenia [ICD-11: 3B64]      55.66%   \n",
       "309                    Thrombocytopenia [ICD-11: 3B64]      55.66%   \n",
       "310                            Melanoma [ICD-11: 2C30]      54.97%   \n",
       "311                  Plaque psoriasis [ICD-11: EA90.0]      54.97%   \n",
       "312                       Acne vulgaris [ICD-11: ED80]      54.78%   \n",
       "313  Female sexual arousal dysfunction [ICD-11: HA0...      54.78%   \n",
       "314                         Seborrhea [ICD-11: ED91.2]      54.78%   \n",
       "315                         Anemia [ICD-11: 3A00-3A9Z]      54.49%   \n",
       "316                              Asthma [ICD-11: CA23]      54.48%   \n",
       "317                   Atopic dermatitis [ICD-11: EA80]      54.48%   \n",
       "318        Bacillus anthracis infection [ICD-11: 1G40]      54.48%   \n",
       "319                Coagulation defect [ICD-11: 3B10.0]      54.48%   \n",
       "320                    Hypotension [ICD-11: BA20-BA21]      54.48%   \n",
       "321                    Multiple myeloma [ICD-11: 2A83]      54.48%   \n",
       "322              Non-hodgkin lymphoma [ICD-11: 2B33.5]      54.48%   \n",
       "323                    Premature labour [ICD-11: JB00]      54.48%   \n",
       "324            Solid tumour/cancer [ICD-11: 2A00-2F9Z]      54.48%   \n",
       "325         Acute myelogenous leukaemia [ICD-11: 2A41]      54.17%   \n",
       "326             Acute myeloid leukaemia [ICD-11: 2A60]      54.17%   \n",
       "327                  Breast cancer [ICD-11: 2C60-2C65]      54.17%   \n",
       "328                      Colon cancer [ICD-11: 2B90.Z]      54.17%   \n",
       "329                 Colorectal cancer [ICD-11: 2B91.Z]      54.17%   \n",
       "330              Gastric adenocarcinoma [ICD-11: 2B72]      54.17%   \n",
       "331             Gastrointestinal cancer [ICD-11: 2C11]      54.17%   \n",
       "332     Gastrointestinal stromal tumour [ICD-11: 2B5B]      54.17%   \n",
       "333           Glioblastoma multiforme [ICD-11: 2A00.0]      54.17%   \n",
       "334  Gram-positive bacterial infection [ICD-11: 1B7...      54.17%   \n",
       "335                       Lung cancer [ICD-11: 2C25.0]      54.17%   \n",
       "336              Mast cell leukaemia [ICD-11: 2A21.00]      54.17%   \n",
       "337                    Multiple myeloma [ICD-11: 2A83]      54.17%   \n",
       "338            Myelodysplastic syndrome [ICD-11: 2A37]      54.17%   \n",
       "339        Non-small-cell lung cancer [ICD-11: 2C25.Y]      54.17%   \n",
       "340                   Pancreatic cancer [ICD-11: 2C10]      54.17%   \n",
       "341                   Prostate cancer [ICD-11: 2C82.0]      54.17%   \n",
       "342           Recurrent glioblastoma [ICD-11: 2A00.00]      54.17%   \n",
       "343                 Soft tissue sarcoma [ICD-11: 2B57]      54.17%   \n",
       "344            Solid tumour/cancer [ICD-11: 2A00-2F9Z]      54.17%   \n",
       "345             Systemic mastocytosis [ICD-11: 2A21.0]      54.17%   \n",
       "346                    Thrombocytopenia [ICD-11: 3B64]      54.17%   \n",
       "347                   Alzheimer disease [ICD-11: 8A20]       54.1%   \n",
       "348                    Arteriosclerosis [ICD-11: BD40]       54.1%   \n",
       "349                           Arthritis [ICD-11: FA20]       54.1%   \n",
       "350  Chronic obstructive pulmonary disease [ICD-11:...       54.1%   \n",
       "351              Diabetic nephropathy [ICD-11: GB61.Z]       54.1%   \n",
       "352              Diabetic retinopathy [ICD-11: 9B71.0]       54.1%   \n",
       "353  Human immunodeficiency virus infection [ICD-11...       54.1%   \n",
       "354                 Inflammation [ICD-11: 1A00-CA43.1]       54.1%   \n",
       "355                Inflammatory pain [ICD-11: MG30.42]       54.1%   \n",
       "356          Insulin-resistant disorder [ICD-11: 5A44]       54.1%   \n",
       "357                            Melanoma [ICD-11: 2C30]       54.1%   \n",
       "358              Metastatic cancer [ICD-11: 2D50-2E2Z]       54.1%   \n",
       "359                  Multiple sclerosis [ICD-11: 8A40]       54.1%   \n",
       "360                  Neuropathic pain [ICD-11: 8E43.0]       54.1%   \n",
       "361                   Pancreatic tumour [ICD-11: 2C10]       54.1%   \n",
       "362  Respiratory syncytial virus infection [ICD-11:...       54.1%   \n",
       "363            Solid tumour/cancer [ICD-11: 2A00-2F9Z]       54.1%   \n",
       "364    Anaplastic large cell lymphoma [ICD-11: 2A90.A]      53.89%   \n",
       "365                    Brain metastases [ICD-11: 2D50]      53.89%   \n",
       "366                 Colorectal cancer [ICD-11: 2B91.Z]      53.89%   \n",
       "367       Diffuse large B-cell lymphoma [ICD-11: 2A81]      53.89%   \n",
       "368                       Lung cancer [ICD-11: 2C25.0]      53.89%   \n",
       "369                       Lymphoma [ICD-11: 2A80-2A86]      53.89%   \n",
       "370                     Neuroblastoma [ICD-11: 2D11.2]      53.89%   \n",
       "371        Non-small-cell lung cancer [ICD-11: 2C25.Y]      53.89%   \n",
       "372            Solid tumour/cancer [ICD-11: 2A00-2F9Z]      53.89%   \n",
       "373       Acute lymphoblastic leukaemia [ICD-11: 2A85]      53.87%   \n",
       "374          Allergic inflammation [ICD-11: 4A80-4A85]      53.87%   \n",
       "375                  Breast cancer [ICD-11: 2C60-2C65]      53.87%   \n",
       "376                     Graft rejection [ICD-11: NE84]      53.87%   \n",
       "377         Haematological malignancy [ICD-11: 2B33.Y]      53.87%   \n",
       "378              Mantle cell lymphoma [ICD-11: 2A85.5]      53.87%   \n",
       "379            Nasopharyngeal carcinoma [ICD-11: 2B6B]      53.87%   \n",
       "380        Non-small-cell lung cancer [ICD-11: 2C25.Y]      53.87%   \n",
       "381                             Obesity [ICD-11: 5B81]      53.87%   \n",
       "382                           Pain [ICD-11: MG30-MG3Z]      53.87%   \n",
       "383            Solid tumour/cancer [ICD-11: 2A00-2F9Z]      53.87%   \n",
       "384                     Dermatitis [ICD-11: EA80-EA89]      53.52%   \n",
       "385            Solid tumour/cancer [ICD-11: 2A00-2F9Z]      53.52%   \n",
       "386                              Asthma [ICD-11: CA23]      52.87%   \n",
       "387            Solid tumour/cancer [ICD-11: 2A00-2F9Z]      52.87%   \n",
       "388                     Thrombosis [ICD-11: DB61-GB90]      52.87%   \n",
       "389                       Lymphoma [ICD-11: 2A80-2A86]      52.44%   \n",
       "390            Solid tumour/cancer [ICD-11: 2A00-2F9Z]      52.44%   \n",
       "391         Abdominal aortic aneurysm [ICD-11: BD50.4]      52.05%   \n",
       "392                              Asthma [ICD-11: CA23]      52.05%   \n",
       "393                         Bone cancer [ICD-11: 2B5Z]      52.05%   \n",
       "394                 Cancer related pain [ICD-11: MG30]      52.05%   \n",
       "395  Chronic obstructive pulmonary disease [ICD-11:...      52.05%   \n",
       "396                           Cirrhosis [ICD-11: DB93]      52.05%   \n",
       "397                Coagulation defect [ICD-11: 3B10.0]      52.05%   \n",
       "398               Coronavirus infection [ICD-11: 1D92]      52.05%   \n",
       "399            Gastrointestinal disease [ICD-11: DE2Z]      52.05%   \n",
       "400                            Glioma [ICD-11: 2A00.0]      52.05%   \n",
       "401                           Hair loss [ICD-11: ED70]      52.05%   \n",
       "402            Henipavirus Encephalitis [ICD-11: 1D63]      52.05%   \n",
       "403  Middle East Respiratory Syndrome (MERS) [ICD-1...      52.05%   \n",
       "404                  Multiple sclerosis [ICD-11: 8A40]      52.05%   \n",
       "405                  Psoriasis vulgaris [ICD-11: EA90]      52.05%   \n",
       "406                Rheumatoid arthritis [ICD-11: FA20]      52.05%   \n",
       "407  Severe acute respiratory syndrome (SARS) [ICD-...      52.05%   \n",
       "408            Solid tumour/cancer [ICD-11: 2A00-2F9Z]      52.05%   \n",
       "409             Acute myeloid leukaemia [ICD-11: 2A60]      51.93%   \n",
       "410            Advanced malignancy [ICD-11: 2A00-2F9Z]      51.93%   \n",
       "411         Haematological malignancy [ICD-11: 2B33.Y]      51.93%   \n",
       "412                 Diabetic neuropathy [ICD-11: 8C0Z]      51.89%   \n",
       "413                 Parkinson disease [ICD-11: 8A00.0]      51.89%   \n",
       "414                        Allergy [ICD-11: 4A80-4A85]      51.87%   \n",
       "415                 Inflammation [ICD-11: 1A00-CA43.1]      51.87%   \n",
       "416                  Plaque psoriasis [ICD-11: EA90.0]      51.87%   \n",
       "417                   Alzheimer disease [ICD-11: 8A20]      51.48%   \n",
       "418                   Alzheimer disease [ICD-11: 8A20]      51.48%   \n",
       "419                          Aneurysm [ICD-11: BD51.Z]      51.48%   \n",
       "420              Hypertensive emergency [ICD-11: BA03]      51.48%   \n",
       "421                    Hypotension [ICD-11: BA20-BA21]      51.48%   \n",
       "422                Tobacco dependence [ICD-11: 6C4A.2]      51.48%   \n",
       "423                Tobacco dependence [ICD-11: 6C4A.2]      51.48%   \n",
       "424             Acute myeloid leukaemia [ICD-11: 2A60]      51.37%   \n",
       "425                     B-cell lymphoma [ICD-11: 2A86]      51.37%   \n",
       "426                        Brain cancer [ICD-11: 2A00]      51.37%   \n",
       "427                 Colorectal cancer [ICD-11: 2B91.Z]      51.37%   \n",
       "428                     Depression [ICD-11: 6A70-6A7Z]      51.37%   \n",
       "429              Gastric adenocarcinoma [ICD-11: 2B72]      51.37%   \n",
       "430                            Glioma [ICD-11: 2A00.0]      51.37%   \n",
       "431                Head and neck cancer [ICD-11: 2D42]      51.37%   \n",
       "432                       Lung cancer [ICD-11: 2C25.0]      51.37%   \n",
       "433                       Lymphoma [ICD-11: 2A80-2A86]      51.37%   \n",
       "434                            Melanoma [ICD-11: 2C30]      51.37%   \n",
       "435               Merkel cell carcinoma [ICD-11: 2C34]      51.37%   \n",
       "436            Nasopharyngeal carcinoma [ICD-11: 2B6B]      51.37%   \n",
       "437        Non-small-cell lung cancer [ICD-11: 2C25.Y]      51.37%   \n",
       "438                      Ovarian cancer [ICD-11: 2C73]      51.37%   \n",
       "439                   Pancreatic cancer [ICD-11: 2C10]      51.37%   \n",
       "440                   Prostate cancer [ICD-11: 2C82.0]      51.37%   \n",
       "441           Recurrent glioblastoma [ICD-11: 2A00.00]      51.37%   \n",
       "442                Renal cell carcinoma [ICD-11: 2C90]      51.37%   \n",
       "443            Solid tumour/cancer [ICD-11: 2A00-2F9Z]      51.37%   \n",
       "444                 Autoimmune diabetes [ICD-11: 5A10]      50.95%   \n",
       "445             Autoimmune disease [ICD-11: 4A40-4A45]      50.95%   \n",
       "446                 Inflammation [ICD-11: 1A00-CA43.1]      50.95%   \n",
       "447                  Breast cancer [ICD-11: 2C60-2C65]      50.89%   \n",
       "448                 Follicular lymphoma [ICD-11: 2A80]      50.89%   \n",
       "449              Non-hodgkin lymphoma [ICD-11: 2B33.5]      50.89%   \n",
       "450                   Prostate cancer [ICD-11: 2C82.0]      50.89%   \n",
       "451            Solid tumour/cancer [ICD-11: 2A00-2F9Z]      50.89%   \n",
       "452                     Type-2 diabetes [ICD-11: 5A11]      50.73%   \n",
       "453            Acute heart failure [ICD-11: BD10-BD13]       50.5%   \n",
       "454  Human immunodeficiency virus infection [ICD-11...      50.38%   \n",
       "455               Renal transplantation [ICD-11: NE84]      50.38%   \n",
       "456             Spinal muscular atrophy [ICD-11: 8B61]      50.38%   \n",
       "457               Diabetic complication [ICD-11: 5A2Y]      50.33%   \n",
       "458                             Obesity [ICD-11: 5B81]      50.33%   \n",
       "459                     Type-2 diabetes [ICD-11: 5A11]      50.33%   \n",
       "\n",
       "    Model accuracy  \n",
       "0           98.95%  \n",
       "1           98.95%  \n",
       "2           78.15%  \n",
       "3           85.94%  \n",
       "4           85.94%  \n",
       "5           85.94%  \n",
       "6           85.94%  \n",
       "7           85.94%  \n",
       "8           85.94%  \n",
       "9           85.94%  \n",
       "10          98.57%  \n",
       "11          90.71%  \n",
       "12          99.23%  \n",
       "13          99.23%  \n",
       "14          91.76%  \n",
       "15          91.76%  \n",
       "16          91.76%  \n",
       "17          91.76%  \n",
       "18          91.76%  \n",
       "19          91.76%  \n",
       "20          91.76%  \n",
       "21          90.08%  \n",
       "22          93.31%  \n",
       "23          93.65%  \n",
       "24          93.65%  \n",
       "25          93.56%  \n",
       "26          93.56%  \n",
       "27          93.67%  \n",
       "28          93.67%  \n",
       "29          93.67%  \n",
       "30          93.67%  \n",
       "31          93.67%  \n",
       "32          93.67%  \n",
       "33          93.67%  \n",
       "34          93.67%  \n",
       "35          93.67%  \n",
       "36          93.67%  \n",
       "37          93.67%  \n",
       "38          93.67%  \n",
       "39          93.67%  \n",
       "40          93.67%  \n",
       "41          93.67%  \n",
       "42          93.67%  \n",
       "43          93.67%  \n",
       "44          93.67%  \n",
       "45          93.67%  \n",
       "46          94.73%  \n",
       "47          95.71%  \n",
       "48          95.71%  \n",
       "49          97.14%  \n",
       "50          97.14%  \n",
       "51          97.14%  \n",
       "52          97.14%  \n",
       "53          97.14%  \n",
       "54          97.14%  \n",
       "55          97.14%  \n",
       "56          97.14%  \n",
       "57          97.14%  \n",
       "58             89%  \n",
       "59          96.47%  \n",
       "60          96.47%  \n",
       "61          96.47%  \n",
       "62          96.47%  \n",
       "63          96.47%  \n",
       "64          96.47%  \n",
       "65          96.47%  \n",
       "66          96.47%  \n",
       "67          96.47%  \n",
       "68          96.47%  \n",
       "69          96.47%  \n",
       "70          96.47%  \n",
       "71          96.47%  \n",
       "72          96.47%  \n",
       "73          96.47%  \n",
       "74          98.59%  \n",
       "75          98.59%  \n",
       "76          98.59%  \n",
       "77          98.59%  \n",
       "78          98.59%  \n",
       "79          98.59%  \n",
       "80          98.59%  \n",
       "81          98.59%  \n",
       "82          98.59%  \n",
       "83          98.59%  \n",
       "84          98.59%  \n",
       "85          98.59%  \n",
       "86          95.71%  \n",
       "87          95.71%  \n",
       "88          95.71%  \n",
       "89          95.71%  \n",
       "90           92.5%  \n",
       "91           92.5%  \n",
       "92           92.5%  \n",
       "93           92.5%  \n",
       "94           92.5%  \n",
       "95           92.5%  \n",
       "96           92.5%  \n",
       "97           92.5%  \n",
       "98            100%  \n",
       "99          92.78%  \n",
       "100         92.78%  \n",
       "101         92.78%  \n",
       "102         92.78%  \n",
       "103         92.78%  \n",
       "104         92.78%  \n",
       "105         92.78%  \n",
       "106         92.78%  \n",
       "107         92.78%  \n",
       "108         92.78%  \n",
       "109         92.78%  \n",
       "110         92.78%  \n",
       "111         92.78%  \n",
       "112         92.78%  \n",
       "113         92.78%  \n",
       "114         92.78%  \n",
       "115         92.78%  \n",
       "116         92.78%  \n",
       "117         92.78%  \n",
       "118         92.78%  \n",
       "119         92.78%  \n",
       "120         92.78%  \n",
       "121         92.78%  \n",
       "122         92.78%  \n",
       "123         92.78%  \n",
       "124         92.78%  \n",
       "125         92.78%  \n",
       "126         92.78%  \n",
       "127         92.78%  \n",
       "128         92.78%  \n",
       "129         92.78%  \n",
       "130         92.78%  \n",
       "131         92.78%  \n",
       "132          89.5%  \n",
       "133          89.5%  \n",
       "134          89.5%  \n",
       "135         93.03%  \n",
       "136         98.57%  \n",
       "137         98.57%  \n",
       "138         98.57%  \n",
       "139         98.57%  \n",
       "140         98.57%  \n",
       "141         98.57%  \n",
       "142         98.57%  \n",
       "143         98.57%  \n",
       "144            98%  \n",
       "145          96.9%  \n",
       "146          96.9%  \n",
       "147          96.9%  \n",
       "148           100%  \n",
       "149           100%  \n",
       "150           100%  \n",
       "151           100%  \n",
       "152           100%  \n",
       "153           100%  \n",
       "154           100%  \n",
       "155         96.37%  \n",
       "156         93.89%  \n",
       "157         93.89%  \n",
       "158         93.89%  \n",
       "159         93.89%  \n",
       "160         93.89%  \n",
       "161         93.89%  \n",
       "162         90.24%  \n",
       "163         90.24%  \n",
       "164         90.24%  \n",
       "165         90.24%  \n",
       "166           100%  \n",
       "167           100%  \n",
       "168         94.42%  \n",
       "169          97.5%  \n",
       "170          97.5%  \n",
       "171          97.5%  \n",
       "172          97.5%  \n",
       "173          97.5%  \n",
       "174          97.5%  \n",
       "175          97.5%  \n",
       "176          97.5%  \n",
       "177          97.5%  \n",
       "178          97.5%  \n",
       "179          97.5%  \n",
       "180          97.5%  \n",
       "181          97.5%  \n",
       "182          97.5%  \n",
       "183          97.5%  \n",
       "184          97.5%  \n",
       "185          97.5%  \n",
       "186         92.62%  \n",
       "187         92.62%  \n",
       "188         92.62%  \n",
       "189         92.62%  \n",
       "190         92.62%  \n",
       "191         92.62%  \n",
       "192         79.09%  \n",
       "193          97.5%  \n",
       "194          97.5%  \n",
       "195            92%  \n",
       "196            92%  \n",
       "197            92%  \n",
       "198            92%  \n",
       "199            92%  \n",
       "200            92%  \n",
       "201            92%  \n",
       "202            92%  \n",
       "203            92%  \n",
       "204            92%  \n",
       "205            92%  \n",
       "206            92%  \n",
       "207            92%  \n",
       "208            92%  \n",
       "209            92%  \n",
       "210            92%  \n",
       "211            92%  \n",
       "212            92%  \n",
       "213         87.67%  \n",
       "214         91.19%  \n",
       "215         91.19%  \n",
       "216         88.42%  \n",
       "217         88.42%  \n",
       "218         88.42%  \n",
       "219         88.42%  \n",
       "220         88.42%  \n",
       "221         88.42%  \n",
       "222         88.42%  \n",
       "223         88.42%  \n",
       "224         88.42%  \n",
       "225         88.42%  \n",
       "226         88.42%  \n",
       "227         88.42%  \n",
       "228         88.42%  \n",
       "229         88.42%  \n",
       "230         88.42%  \n",
       "231         88.42%  \n",
       "232         88.42%  \n",
       "233         88.42%  \n",
       "234          97.5%  \n",
       "235          97.5%  \n",
       "236          97.5%  \n",
       "237          97.5%  \n",
       "238          97.5%  \n",
       "239          97.5%  \n",
       "240          97.5%  \n",
       "241          97.5%  \n",
       "242          97.5%  \n",
       "243          97.5%  \n",
       "244         99.52%  \n",
       "245         99.52%  \n",
       "246         99.52%  \n",
       "247         99.52%  \n",
       "248         96.43%  \n",
       "249         96.43%  \n",
       "250         96.43%  \n",
       "251         96.43%  \n",
       "252         96.43%  \n",
       "253         96.43%  \n",
       "254         96.43%  \n",
       "255         96.43%  \n",
       "256         96.43%  \n",
       "257         96.43%  \n",
       "258         96.43%  \n",
       "259         96.43%  \n",
       "260         96.43%  \n",
       "261         96.43%  \n",
       "262         96.43%  \n",
       "263         96.43%  \n",
       "264         96.43%  \n",
       "265         96.43%  \n",
       "266         96.43%  \n",
       "267         96.43%  \n",
       "268         96.43%  \n",
       "269         96.43%  \n",
       "270         96.43%  \n",
       "271         96.43%  \n",
       "272         96.43%  \n",
       "273         96.43%  \n",
       "274         96.43%  \n",
       "275         96.43%  \n",
       "276         96.43%  \n",
       "277         71.67%  \n",
       "278         71.67%  \n",
       "279         71.67%  \n",
       "280         71.67%  \n",
       "281         71.67%  \n",
       "282         71.67%  \n",
       "283         71.67%  \n",
       "284         71.67%  \n",
       "285         71.67%  \n",
       "286         71.67%  \n",
       "287         71.67%  \n",
       "288         71.67%  \n",
       "289         71.67%  \n",
       "290         71.67%  \n",
       "291         71.67%  \n",
       "292         71.67%  \n",
       "293         71.67%  \n",
       "294         71.67%  \n",
       "295         71.67%  \n",
       "296         71.67%  \n",
       "297         71.67%  \n",
       "298         71.67%  \n",
       "299         71.67%  \n",
       "300         71.67%  \n",
       "301         71.67%  \n",
       "302         71.67%  \n",
       "303         71.67%  \n",
       "304         71.67%  \n",
       "305         71.67%  \n",
       "306         71.67%  \n",
       "307         71.67%  \n",
       "308         71.67%  \n",
       "309         71.67%  \n",
       "310          96.9%  \n",
       "311          96.9%  \n",
       "312            97%  \n",
       "313            97%  \n",
       "314            97%  \n",
       "315            95%  \n",
       "316            90%  \n",
       "317            90%  \n",
       "318            90%  \n",
       "319            90%  \n",
       "320            90%  \n",
       "321            90%  \n",
       "322            90%  \n",
       "323            90%  \n",
       "324            90%  \n",
       "325         91.07%  \n",
       "326         91.07%  \n",
       "327         91.07%  \n",
       "328         91.07%  \n",
       "329         91.07%  \n",
       "330         91.07%  \n",
       "331         91.07%  \n",
       "332         91.07%  \n",
       "333         91.07%  \n",
       "334         91.07%  \n",
       "335         91.07%  \n",
       "336         91.07%  \n",
       "337         91.07%  \n",
       "338         91.07%  \n",
       "339         91.07%  \n",
       "340         91.07%  \n",
       "341         91.07%  \n",
       "342         91.07%  \n",
       "343         91.07%  \n",
       "344         91.07%  \n",
       "345         91.07%  \n",
       "346         91.07%  \n",
       "347         98.57%  \n",
       "348         98.57%  \n",
       "349         98.57%  \n",
       "350         98.57%  \n",
       "351         98.57%  \n",
       "352         98.57%  \n",
       "353         98.57%  \n",
       "354         98.57%  \n",
       "355         98.57%  \n",
       "356         98.57%  \n",
       "357         98.57%  \n",
       "358         98.57%  \n",
       "359         98.57%  \n",
       "360         98.57%  \n",
       "361         98.57%  \n",
       "362         98.57%  \n",
       "363         98.57%  \n",
       "364         96.86%  \n",
       "365         96.86%  \n",
       "366         96.86%  \n",
       "367         96.86%  \n",
       "368         96.86%  \n",
       "369         96.86%  \n",
       "370         96.86%  \n",
       "371         96.86%  \n",
       "372         96.86%  \n",
       "373         91.24%  \n",
       "374         91.24%  \n",
       "375         91.24%  \n",
       "376         91.24%  \n",
       "377         91.24%  \n",
       "378         91.24%  \n",
       "379         91.24%  \n",
       "380         91.24%  \n",
       "381         91.24%  \n",
       "382         91.24%  \n",
       "383         91.24%  \n",
       "384         94.75%  \n",
       "385         94.75%  \n",
       "386            83%  \n",
       "387            83%  \n",
       "388            83%  \n",
       "389         95.36%  \n",
       "390         95.36%  \n",
       "391         96.61%  \n",
       "392         96.61%  \n",
       "393         96.61%  \n",
       "394         96.61%  \n",
       "395         96.61%  \n",
       "396         96.61%  \n",
       "397         96.61%  \n",
       "398         96.61%  \n",
       "399         96.61%  \n",
       "400         96.61%  \n",
       "401         96.61%  \n",
       "402         96.61%  \n",
       "403         96.61%  \n",
       "404         96.61%  \n",
       "405         96.61%  \n",
       "406         96.61%  \n",
       "407         96.61%  \n",
       "408         96.61%  \n",
       "409            99%  \n",
       "410            99%  \n",
       "411            99%  \n",
       "412         86.92%  \n",
       "413         86.92%  \n",
       "414            95%  \n",
       "415            95%  \n",
       "416            95%  \n",
       "417           100%  \n",
       "418           100%  \n",
       "419           100%  \n",
       "420           100%  \n",
       "421           100%  \n",
       "422           100%  \n",
       "423           100%  \n",
       "424         96.38%  \n",
       "425         96.38%  \n",
       "426         96.38%  \n",
       "427         96.38%  \n",
       "428         96.38%  \n",
       "429         96.38%  \n",
       "430         96.38%  \n",
       "431         96.38%  \n",
       "432         96.38%  \n",
       "433         96.38%  \n",
       "434         96.38%  \n",
       "435         96.38%  \n",
       "436         96.38%  \n",
       "437         96.38%  \n",
       "438         96.38%  \n",
       "439         96.38%  \n",
       "440         96.38%  \n",
       "441         96.38%  \n",
       "442         96.38%  \n",
       "443         96.38%  \n",
       "444         80.78%  \n",
       "445         80.78%  \n",
       "446         80.78%  \n",
       "447         94.33%  \n",
       "448         94.33%  \n",
       "449         94.33%  \n",
       "450         94.33%  \n",
       "451         94.33%  \n",
       "452         94.78%  \n",
       "453          82.5%  \n",
       "454         98.03%  \n",
       "455         98.03%  \n",
       "456         98.03%  \n",
       "457         91.96%  \n",
       "458         91.96%  \n",
       "459         91.96%  "
      ]
     },
     "execution_count": 25,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "sp_ind = pd.read_csv('20_3_files/Indications.csv', sep=',')\n",
    "sp_ind"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2023-10-13T21:06:33.025763Z",
     "start_time": "2023-10-13T21:06:33.009789Z"
    }
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Target Name</th>\n",
       "      <th>ChEMBL-ID</th>\n",
       "      <th>Indication</th>\n",
       "      <th>Probability</th>\n",
       "      <th>Model accuracy</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>count</th>\n",
       "      <td>460</td>\n",
       "      <td>460</td>\n",
       "      <td>460</td>\n",
       "      <td>460</td>\n",
       "      <td>460</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>unique</th>\n",
       "      <td>69</td>\n",
       "      <td>67</td>\n",
       "      <td>235</td>\n",
       "      <td>69</td>\n",
       "      <td>58</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>top</th>\n",
       "      <td>Platelet-derived growth factor receptor</td>\n",
       "      <td>T53524</td>\n",
       "      <td>Solid tumour/cancer [ICD-11: 2A00-2F9Z]</td>\n",
       "      <td>55.66%</td>\n",
       "      <td>71.67%</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>freq</th>\n",
       "      <td>33</td>\n",
       "      <td>55</td>\n",
       "      <td>30</td>\n",
       "      <td>33</td>\n",
       "      <td>33</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                    Target Name ChEMBL-ID  \\\n",
       "count                                       460       460   \n",
       "unique                                       69        67   \n",
       "top     Platelet-derived growth factor receptor    T53524   \n",
       "freq                                         33        55   \n",
       "\n",
       "                                     Indication Probability Model accuracy  \n",
       "count                                       460         460            460  \n",
       "unique                                      235          69             58  \n",
       "top     Solid tumour/cancer [ICD-11: 2A00-2F9Z]      55.66%         71.67%  \n",
       "freq                                         30          33             33  "
      ]
     },
     "execution_count": 26,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "sp_ind.describe()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2023-10-13T21:09:10.423400Z",
     "start_time": "2023-10-13T21:09:10.414423Z"
    }
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Target Name\n",
       "Platelet-derived growth factor receptor                    33\n",
       "Serine/threonine-protein kinase mTOR                       33\n",
       "Androgen Receptor                                          29\n",
       "Platelet-derived growth factor receptor alpha              22\n",
       "Indoleamine 2,3-dioxygenase                                20\n",
       "Cathepsin B                                                19\n",
       "Neuronal acetylcholine receptor protein alpha-7 subunit    18\n",
       "Ghrelin receptor                                           18\n",
       "Cathepsin L                                                18\n",
       "C-C chemokine receptor type 2                              17\n",
       "PI3-kinase p110-delta subunit                              15\n",
       "P2X purinoceptor 7                                         13\n",
       "Adenosine A2b receptor                                     12\n",
       "Cyclin-dependent kinase 1/cyclin B1                        11\n",
       "Histone-lysine N-methyltransferase EZH2                    10\n",
       "Voltage-gated N-type calcium channel alpha-1B subunit       9\n",
       "ALK tyrosine kinase receptor                                9\n",
       "Trypsin I                                                   9\n",
       "Voltage-gated T-type calcium channel alpha-1H subunit       8\n",
       "Toll-like receptor 4                                        8\n",
       "Acyl coenzyme A:cholesterol acyltransferase                 7\n",
       "Serotonin 3a (5-HT3a) receptor                              7\n",
       "Cytochrome P450 19A1                                        7\n",
       "Neuronal acetylcholine receptor; alpha4/beta4               7\n",
       "C5a anaphylatoxin chemotactic receptor                      6\n",
       "Vitamin K-dependent protein C                               6\n",
       "PI3-kinase p110-alpha/p85-alpha                             5\n",
       "Acyl-CoA desaturase                                         4\n",
       "Sodium/hydrogen exchanger 1                                 4\n",
       "Melanocortin receptor 3                                     4\n",
       "Cystic fibrosis transmembrane conductance regulator         4\n",
       "Protein kinase C alpha                                      3\n",
       "Melanocortin receptor 5                                     3\n",
       "Plasminogen activator inhibitor-1                           3\n",
       "Macrophage migration inhibitory factor                      3\n",
       "Tyrosine-protein kinase ITK/TSK                             3\n",
       "Isocitrate dehydrogenase [NADP] cytoplasmic                 3\n",
       "Hexokinase type IV                                          3\n",
       "C-C chemokine receptor type 1                               3\n",
       "Sodium channel protein type III alpha subunit               3\n",
       "ADAM10                                                      2\n",
       "Casein kinase II alpha/beta                                 2\n",
       "G-protein coupled bile acid receptor 1                      2\n",
       "Glutamate receptor ionotropic, AMPA 2                       2\n",
       "Formyl peptide receptor 1                                   2\n",
       "3-phosphoinositide dependent protein kinase-1               2\n",
       "Integrin alpha-V/beta-3                                     2\n",
       "Histone deacetylase 2                                       2\n",
       "Cathepsin D                                                 2\n",
       "Galectin-3                                                  2\n",
       "PRMT5/MEP50 complex                                         2\n",
       "Cytochrome P450 3A4                                         2\n",
       "Cysteinyl leukotriene receptor 2                            1\n",
       "Cyclin-dependent kinase 5                                   1\n",
       "Cyclophilin A                                               1\n",
       "Relaxin receptor 1                                          1\n",
       "11-beta-hydroxysteroid dehydrogenase 2                      1\n",
       "Glycine receptor subunit alpha-1                            1\n",
       "Histone deacetylase 10                                      1\n",
       "Aminopeptidase N                                            1\n",
       "G-protein coupled receptor 55                               1\n",
       "Cyclin-dependent kinase 5/CDK5 activator 1                  1\n",
       "Protein-tyrosine phosphatase 2C                             1\n",
       "Pregnane X receptor                                         1\n",
       "Multidrug resistance-associated protein 1                   1\n",
       "Ras-related protein Rab-9A                                  1\n",
       "Sphingosine 1-phosphate receptor Edg-8                      1\n",
       "Solute carrier family 40 member 1                           1\n",
       "DNA topoisomerase II alpha                                  1\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 29,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "sp_ind['Target Name'].value_counts()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "В модели \"Показания предсказанных мишеней\" наиболее часто (n=33 из 460) встречаются рецептор тромбоцитарного фактора роста (PDGFR) и серин-треониновая протеинкиназа мишень Рапамицина млекопитающих (mTOR). Оба белка участвуют во внутриклеточных сигнальных путях при различных видах рака. В качестве наиболее вероятной (Probability=91,51%%; Model accuracy=98,95%) указана мишень Катепсин D, относящаяся к лизосомальным аспартил протеазам."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Tools4miRs  \n",
    "Пока не разобрался как пользоваться этим инструментом. Предполагаю, что в него нужно вносить РНК интересующих мишеней. Поиска по веществу не нашел. Возможно не там искал..."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "BY2DuSBRPPzn"
   },
   "source": [
    "__*Комментарии преподавателя:*__<br>\n",
    "*Дарья Бородко・Преподаватель<br>*\n",
    "\n",
    ">*\n",
    "*\n",
    "\n",
    "~__**Исправлено**__~"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "accelerator": "GPU",
  "colab": {
   "provenance": []
  },
  "gpuClass": "standard",
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.17"
  },
  "nbTranslate": {
   "displayLangs": [
    "*"
   ],
   "hotkey": "alt-t",
   "langInMainMenu": true,
   "sourceLang": "en",
   "targetLang": "fr",
   "useGoogleTranslate": true
  },
  "toc": {
   "base_numbering": 1,
   "nav_menu": {},
   "number_sections": false,
   "sideBar": true,
   "skip_h1_title": false,
   "title_cell": "Table of Contents",
   "title_sidebar": "Contents",
   "toc_cell": false,
   "toc_position": {},
   "toc_section_display": true,
   "toc_window_display": false
  },
  "varInspector": {
   "cols": {
    "lenName": 16,
    "lenType": 16,
    "lenVar": 40
   },
   "kernels_config": {
    "python": {
     "delete_cmd_postfix": "",
     "delete_cmd_prefix": "del ",
     "library": "var_list.py",
     "varRefreshCmd": "print(var_dic_list())"
    },
    "r": {
     "delete_cmd_postfix": ") ",
     "delete_cmd_prefix": "rm(",
     "library": "var_list.r",
     "varRefreshCmd": "cat(var_dic_list()) "
    }
   },
   "types_to_exclude": [
    "module",
    "function",
    "builtin_function_or_method",
    "instance",
    "_Feature"
   ],
   "window_display": false
  }
 },
 "nbformat": 4,
 "nbformat_minor": 1
}
